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Vimla Iiamoas for the aimrd «f th^* Ph»P. de^yee of tho 
fhQ worlg pa?0Qettted l a oliaptera 1*1? of tli© tlisslo 
i s drigi!i«l in natua?^* I* hmm <Ji»ita?ibut«d t t oitr under©tanfitng 
ef tJie a^<l0 of a^stldii Qf prog^Btmtinatstl ©teroifla, paJ^tiottlarly 
tl)>@ir mQtfiboXiQm i a th® bod^« loqalieatiOB in the tiseUQS, 
t l ie lr exor^tlon in %k^ mi,lk and a i t e of action for l i^i lblt lon 
of oviilatlon* 3Ehe studlea on the ©xeretloa of progestational 
s teroids in tli@ lailk: and a Sofflonataratlon of the eetrogsniolty 
of the e^eoroted ateroide in the atillc haa heXj^ ed to knoir that 
ITo -^ «th;piyl««l Sknor ateroid e*gt norethynodrel ahoold h© avoided 
for f e r t i l i t y oontrol duri»g lae ta t ion while \7^- aoetoxy 
i^rogeaterone derivative e*g* chlonoadJnone aoetate may ho 
uaed for b i r th control dnrizia lactat ion* QtvAl^tQ on the 
ae tabol iss and t iseue uptalce ot progestational ateroide have 
revealed that etorage of ohlormadinoae aoetate in the fat 
may provide a meohanlem by which the ateroid i e sloirly releaeed 
and thue eontributea to i t a long ha l f - l i f e and lev aetabolio 
in the plaofiia clearance r a t e and prolonged exoretion in the 
urine* l&e higher oonoentratlon of the eterold in the ovary 
ae oon#ared v i th other reproductive tieeuee mto euggeetive 
of » di rect action of progeetational i teroida on the ovaxy* 
i 
«• 2 *** 
fh© maimer la vihlah prog0etattoaal 3t9rol<2a a l t e r *'a*#stradiol 
ttptale«» in the utorrUa and thus briag about a liormooal Ifflbalanee 
l a the uterus suggested a raeohani^a hy irhloh progestational 
steroids aot on tho sndoiaetriuai and thus pr«irent implantation* 
fhs supprsesion in the plasaa progesteron© lerels after th© ® 
adarilniatration of progestational steroids» m measured hy 
radioliattunoasaay method t Indicated tlbie ovulation InhlMtiag 
aotlon of the steroid and oonsefuent ahsenoe of asirpus luteuis 
funetlon« fhe high eff^etiir^neas of |>rogesta1;ioaaX fiteroids 
In the ©ontrf»l nf oono©i>tloa la thxn 4jxplatned« All these 
findings are original sad hairs yellded oonoepts »fhich are of 
great iaportanee in the field of h l o l o ^ of .Tuproditetion and 
f e r t i l i t y control* 
jLt^ ntgact of the tlweia natitlM ^^MtmUn m the lfe>A» <if Aetioa 
<^ f Bc>eg>atatloiiaI ataroida* eyteBil,1?te4 J?3r VJaOa JDftnaag toy th» 
ftyaapA of the Jb.P, dagr^a of the Miimrli Mualla Hiilyegaity. 
A H 4 jtv^fc 4ttl£'^ 
ThB woilE that haa hsea 0Oi»|>tlita Isato this thesis 
ip«aate® to th@ aoa© of actioa of pi«o^e9tatioa8X ©t«a?oM9» 
thei? ti^ @i2$ distribtttliaii loonllsiationt mata^ oXlsm Sm hQdf$ 
exeifetion £3 JiLUfe @M their €it@ of motion for li^hiMtion ^f 
oimIatioti« 
fh« tlestto uptal5«i and loeaa,isjatioa studies of^ 
th» progistatiosal steroids !•#• ehlorsaaSiaone m^m%ut& and 
norethyBoaroi hair© h«eii oayrioa oiit h3r <?oii»tsiit isafu»10h ana 
ein^l« tajection teohnl^adSt a»l those have yetealed the . 
pattern of aietrihutiom of the ate2P0i<5g in the hody and 
their looRiiEfitiott in. the target tieemeo. Both the yrogeeta* 
tlooaXe »t©«>ids, shewed a highoy uptfulce i» the oimry than 
the other reproduotire tieenes aisggeeting a posalhility 
of direot ootioa of the progeetatioaal steroids oa the ovafy 
aad thias leading to fert i l i ty oonts^ol* ^he high uptake of 
ohlormadiaone aoetate i s the fat indicated a poaaihiXity 
cf i t s retention in the f&t and alow release therehy loaintainHsg 
a higli level in the plasita even after adatinietration of onljr 
0«$ ng ohlonsadinone aoetate daiiy* fhe oontraoeptive 
effeotivenesa of low dose adftinietration of ateroide la 
thisa hrottght out* 
She dxoretioa of prog^ttationaX steroids« noretlaynoAr^ 
and @hloriBadiao2i@ ao0tat« in the nllle of Xaotating irotten and 
the deiadnetratloa of the edtrogenio aotl-ritj ia the expreeeea 
siUc reireaXeS that after the adioinietratioa of 19«»&or steroids 
like aorethyaodreX the estrogealo aotlvity oouXd be deteoted 
ia the milkf .therefore! the aee of suoh a frogestationaX steroids 
during Xaotatioa ma^ he at'oided heoause of the fO«8ihiXity of 
traaefer of the estrogeaio aotiiritsr present ia the miXk to 
the iafaat heiag aursed* the use of 1 7 ^ «aoetOJQr progesteroae 
deriiratiire Xike ohlonaadinoae aoetate is reiK^meaded for 
eoatraoeptioa dtiriag Xaotatioa due to the faot that the 
adiaiaistratioa of this steroid to Xactatiag voaea did aot 
Xead to the ezoretioa of &ia^ estrogeaie aotiirit:r ia t^e 
expressed milk. The px%»Xoaged eaEoretioa of ohXorisadiaoae 
aoetate ia the miXk of Xaotatiag womea for §«»6 dara supported 
the oheervatioa preseated ahoire that ohXennadiaoae aostate 
is stored ia the fat aad thea released gradumXXy* 
Aaother phase of i^e work reXated to the 
metahoXi)^ of ohXox^nadiaoae aoetate ia hXood aad exoretioa 
ia ariast IDhe Xow metaholio oXearanoe rate (t05 L/day) aad 
Xoag haXf«»Xife of the order of 33*i hrs of ohXonoadiaoae 
aoetate was ia ooatrast to the short half-Xife of the oi^er 
of a fev Aiautes aad high metaboXio olearaaoe rate of aatural 
sex steroids, Xike estradioX aad progesteroae* The high 
uptake of this steroid ia the fat» ooatlaued exoretioa ia 
the oiXk together vith Xov metaboXie oXearanoe rate aad 
- 5 -
long iialf<*Xife in plasaa goes in favour of the abov® prestanptlon 
tliat th6 8to3(%^€ in tat aztd ©loir roXessa fi^ om it» nm^ r l»e leading 
to th« aoouauiatidn of h i ^ I«ir6l0 of this @toiroid in the plaeiiia» 
and ooao«(ittont high oonts^ooptivo effeotivonosa at lov &&&e of 
0»3 ing/daia^. 
'&$ stitaulator^r or intuhitox^ effeot of Xotr and 
high dosoa of pjfogd@tatioaaI ateroidi? on tho uptaico of. 
%<«>«6traaioi in th0 uteru@ rovealoS that tho prog#atationai 
0t@roi4a after a^siiniatration tmw ^^ diatorhing th^ nonaaX 
ioir«l0 and aotion of mtraAXol in the mteruo and oaueing 
a hormonal imbalanoo whioh in turn int orforfts with the 
implantation* fheao sttidioa oontrihut^d to the understanding 
of th© antifortilitjr action of progeatational ©turoida at the 
utarftno loiral« 
A radioiififfitmoaaaay for pro^^starone iras atandardiaed 
and the progeaterona levela were measured in the rhesue i!ionka|%^ „^ 
beforef during lanA after the traatment vith Snavid (2*5 »g 
norethynodrel •i' 0») lag i&estranol) to atudjr the site of notion 
of progeatational ateapoid for inhihition of oimlation« Konkejr 
due to ita oloee relationship with huoan eOuld aerve as a 
Tory uaeful model for inirestigating the effeot of the ateroid. 
The aupreeeed plaoma progesterone levela during the luteal 
phase of the o^le after the adminiatration of Bnavid 
indioated euppreeeion of ovulation and oonaequent inhibition 
of oorpua luteum function* 
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INTHOOTCTIOH 
The pioneering vork of a?egory Uncus In 
the late fifties on the use of progestational steroids 
for control of fertility ushered In a new era In the 
history of contraception. It has now become one of 
the very Important methods for conception control and 
is widely practised by women around the world* Oral 
contraceptives, for the first time provided a method 
which Is one hundred percent effective in controlling 
fertility if the "pill" Is taken regularly according 
to the reglmen» Over the years, the dose of the 
progestational steroid and the estrogen taken along 
with it have been reduced and small doses of progestins 
alone are also being used. Newer delivery systems 
for the administration of the progestational steroids 
are being explored* One such promising lead Is the 
use of steroid-releasing implants. 
I 2 t 
A nimber of side effects have been enoounteredi 
with the use of progestational steroids for the control 
of f e r t i l i t y . In the development of new formulations 
attempts have been made to reduce these side effects* 
However, except for minor improvements, there has not 
been much sigaificant progress in this area* Itirthermore, 
In Spite of the enormous worici the mechanism of action 
of progestational steroids i s not fully understood* 
Pincus (1957, 1966, 1966) suggested that the oral 
contraceptives act t h r o u ^ the suppression of pi tui tary 
gonadotropins and thus inhibi t ovulation* More recently^ 
when new drugs and different dosages have been used, 
i t has been recognised that these steroids have other 
s i t e s of action and at times these may act at multiple 
s i t e s giving evidence of their wide range effectiveness 
in controlling fe r t i l i t y* Suggestions of their action 
a t the level of cervical mucus (Martlnex-Manautou, 
Giner-Velasquess, Cortes Qallegos, Jtenar, Ha^os Oultterz-
Najop and Rudel, 1967a), action a t the ovarian level \ i . 
(France and Hnous, 1964, Yadava and Xiaumas, 1969), and 
rapid transport of the ovum from the fallopian tubes 
to utarus leading to failure of f e r t i l i s a t ion (Chang, 
1967a, 1967b) have been made* I t has become evident 
I 3 t 
that tfad drusi dosagt and aodd of adolniBtration 
wotald doteriaitie Its site and neehanism of aotlon* 
ftiT^ot pi*o^eS8 in this area requires a 
major l>re«kthrou^ «^ Bie^ faXussr (1971) in }iis 
ledture in the Kotoel Symposiism has reviewed and 
listed five ftetors vhieh sife interfering idth 
fiufther developments in the field of eontraoeptive 
steroids, these relate to a laek of knowledge on 
the distrihiitiony transport and metabolism of the 
various oontraoeptive steroids in the human and 
animal speeies, espeoialljr those animal speoies 
y^ith are used for toatioit^ studies« A knowledge 
of their aotion at the eellular level is lacking. 
The ohjeotive of the work taken up in this 
thesis was to learn about the distribution, meta* 
bolisffli excretion and site of action of progesta;* 
tional steroids« 
The progestational steroids i one noret^omodrel 
belonging to 17o(-ettjynyl 10-nor steroid category and 
the other ohlormadinone acetate belonging to the i7o<-
aoetoxjr group were used to stud^ their uptake in the 
reproductive tract, various parts of the brain, metabolic 
and excretory tissues of the rat, both by sin^e injection 
i 4 s 
and constant Infusion techniques. These stadles 
ware aimed to understand the patterns of dis t r ibut ion, 
dlaappearanoe and locaXlaatlon of the progestational 
s teroids . The manner in ti^tioh those progestational 
Steroids modify the uptake of H-estradiol In the 
uterus has been Investlgated to learn about the _ 
meohanisms by vhlch these progestational steroids 
act at the uterine level (Chapter !>• 1?he fate of 
these progestational steroids In the body has been 
followed* Their exoretion in the milk of lac ta t lng 
women and goats hat been investigated* The possibi l i ty 
of the exoretion of estrogenic act iv i ty due to the 
progestational steroids has been explored (Chapter II>» 
Besides mllK, the progestational steroids are excreted 
through urine and faeces, tim patterns of disappearance 
of the progestational steroid in the blood, i t s 
metabolic clearance ra te and profiles of exoretion 
in the urine have been studied (Chapter I I I ) . While 
the major part of the administered steroid i s metabollaed 
and excreted, a very small amount is tsOsen up a t the 
s i t e of action to produce I t s effect . 'Bae effect of 
these small amounts on the corpus luteum function 
I 5 • 
either through hypothalaao-pltuttfflpy axis, or a 
direct action on the ovary has been investigated 
by measuring plasma progesterone levels using a 
highly sensitive radioimmunoassay (Chapter IV>. 
Cumulatively, these investigations have thrown 
l i ^ t on the fate of the progestational steroids 
in the bodyi and provided guidelines for the mechanism 
of action of these steroids. 
^mnm Of wsmAHsm 
INTIK)l»CTXOH 
Tim progestational steroids used as 
eontraceptives are of two oategoriest-
(1) 10-iiop steroids 
( i l ) 17c< -aeetoxy progesterone derivatives* 
ThB 19-nor steroids are derivative of 19-nor 
testosterone* Sils category: of oompoimds is oharaoterlaed 
by the absence of the C-19 angular methyl group attached 
to the C-lO position* Mother characteristic feature 
of the progestational steroids of this category is 
the presence of ethynyl group in the 17o( -position 
of the steroid molecule vhich is responsible for the 
hi#i oral activity of these synthetic steroids. 
Particular examples are norethynodr«a.| norethlndronoi 
eithynodiol diaoetate, lynestemolf etc. 
The 17o^-aoetoxy progesterone derivatives 
constitute another class of orally active steroids* 
They are characterised by the presence of an acetyl 
group in ttie 17c3< -position of the progesterone molecule* 
I ? f 
They aastty e i ther a methyl group or a chlorine atom 
in the 0«6 position* Some contain a double bond 
between C-6 and C«7* the substitution at C-6 enhances 
thei r oral potenc^r* Isamples of such compounds are 
uegestrol acetate} medroicyprogesterone acetate» 
ehlormadinone acetate e t c . 
Besides the above progestational steroids^ 
compounds possessing estrogenic activit^r are also 
used in some oral eontraceptive preparations. These 
are derived from estradiol-17B and possess an ethynyl 
group in 17o( -position* The examples are ethynyl 
estradiol 3-methyl ether (mestranol) and %7oi -ethynyl 
es tradiol . 
Over the years different modes of administration 
of these contraceptives have been developed* These arei 
1, combination therapy, the progestational 
steroid' i s orally administered in 
combination with an estrogen, 
2. sequential therapy, estrogen i s given 
from day S • 15 or 20 and the progestagen 
from 16 or 21 to 25, 
3# low dose continuous administration of 
a progestagen* 
t 8 t 
Besides the above there are other modes of 
administration which are being e l in ica l ly tested. 
These includei 
4 . long acting injectable preparation 
5« steroid releasing implants 
6* post-coital contraceptives 
7 . long acting p i l l s • 
in combination and sequential therapyi the 
amount of the estrogen administered may vary from 50 Aig 
to 150 >ttg, vhlle the progestin may vary from 1 mg to 
5 mg* The amotmt of the progestin in the combination 
preparation i s being reduced. On the basis of accumulated 
experience, i t has been decided that not more than SO>ag 
of mestranol or ethynyl estradiol be used in the 
combination therapy, 
Low dose continuous administration of 
progestagens involves the administration of progestagens 
l ike chlormadlnone acetate (0,5 mg> continuously, 
Norgsstrel in as small an amount as 30^g has been 
successfully t r ied as a continuous low dosage progestir 
(Kesseriii I.arranga,Hertado and Benavides, 1972), 
Coutinho and De Souza (1968) have successfully used 
I 0 t 
moreettrel (0*5 ag) with <0*0S mg) eth^mrl 3St]fadU.oX 
m m eyarir-ofher-day pill for ©oatPaceptioii* ^ t 
amg i« takda on aiteimat^ Aflr* from Aa^ 5 to dar 25 
of th» menstimal osrelo* 
In onoo & ttontli pill or long acting pill 
tilera^f a orolopantansr^ other of e^bis^s'l estradiol 
(^uinostrol) is a<&iinistered at a S*0 mg tahlett 
vith a progestin of Ahort deration of aetion l ^ e 
ohlorma<Sinone acetate* 
Steroid releasing iaplaats are feeing investi-
gated for fertility oontrol* Implants oontaining 
aegestrol aoetatoi norgestrel and norethindrone are 
being olinioail;^ tested* 
^B^mit deliverr systems for ^ e adbiinistration 
of eontraoeptiire steroids in low doses is one of the 
oarrent prohlems of investigation in mai^ laboratories^ 
mmMMum 
Pinoos (19S7) first reported that the 
probable mode of aotlon of oontraoeptive drags is by 
inhibition Of ovulation. Ihis was further eonfirmed* 
I 10 t 
tsjr the stadlet on anlmaXt and vomen* Till raoently 
inhibition of ovulation vas ooniidered ai the jprlneipal 
mod« of aetlon of oontraoeptlve drufs* Hoveveif, <luo 
to a oareftil stttdST of Hartinos^Hanttiitott, Oortez, 
(Eaeri Asn«?, Oatsasola and mdttl <1966), It i s 
]peall3ied that inhibition of ovulation Is not a 
"oondltio: ulna qua non«| for antifertUity offecta 
of steroids* the antifartllity effect eo^d also 
be aehieved by the aetlon of oontraoeptive steroids 
at o^ier sites like endottetriuMi fallopian tabes ^  
eervioal sacms, ovary etc*, iihi(^ are directly 
involved in the prooesses of reprodiiotlon* 
In spite of extensive studies, very l l t ^ e 
i s kxixivn about the exaet mode of aotlon of contra* 
eeptive steroids* Sisorepemoies ariso probably due 
to the failure to realisa that olosaly related 
eoiipoiuids may have distlnotly different modes of 
aotlon at different dose levels and ^at eompotmds and 
theireoabination aey have umltij^e mode of action* 
Hovever, various sites of aotlon of oontraeeptlve 
stexoids mvjt be emaaerated as follovsi 
!• Pituitary gland and hgrpothai anus 
2» Ovarian responsiveness 
f 1 1 t 
3* Tubal factors 
4. Cervloal factors 
5. Endometrial factors, 
Kormally the pitultary^ ^and icmder the 
stimulation of the hypothaiaaus seoretes two gonado-
tropic hormones, fo l l i c le stimulating hormone (FSH) 
and luteinizing hormone (XH)« FSH stimulates thd 
ovarian fol l icular development and function and Lfl 
b r i n ^ about ovulation and formation of corpus luteum. 
Since oral contraceptives inhibi t synthesis or release 
of these gonadotropins^PSH and LH, ovulation Is 
inhibited. This is also evidenced by the fact that 
the ovary a t laparotomy shows an absence of freah 
corpus luteum in women taking oral contraceptives 
(aarciai Fincus and Boek| 1958, Ostergaard, 1964) • 
The ovaries are also reduced in sizoi acquire a smooth 
surface and white juvenile appearance* Their 
histological appearance reveals early arrest of 
fol l icular development* 
Besides the examination of ovary a t laparotomy, 
the ovulation inhibition i s indicated by the estimation 
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of urinary or plasma FSH and LH levels In women taking 
oral contraceptives. The normal urJbiary IiH excretion 
was estimated by bloassay method (Stevens and Yorys, 
1967) and toy radloinanunoassay method <Wide, 1966) • 
Hld^ey and Jaffe (1966) estimated plasma levels of 
LH immunologically. LH secretion estimated by bloassay 
or by radioimunoassay was characterized by a marked 
mid-cycle peak. This mid-cycle LH peak vas much more 
marked in plasma than in urine probably due to the 
low renal clearance of LH as compared to FSH (Kellar, 1966) 
Serum FSH leveiffi have been found to r i se 
during menstruation and are high early in the prol i -
ferative phase. lEhey then decline to a preovulatory 
nadir just before mid-cycle LH surge (Taymor, Asnoi 
Pheteplacei 1968, Boss, Cargi l le , Lipset t , Hayford, 
Marxwall, S t ro t t , Rodbard| 1970) and r i s e again to a 
second pee^ r o u ^ y coincident with LH peak. This 
paraovulatory FSH peak i s neither as dramatic nor as 
consistent as that seen for LH« 
The effect of contraceptive drugs on LH and 
FSH levels has bean studied by many workers (Taymor, 
1964| Kaiser, Wide and Gemzell, 1966, Lauritsen, 1966., 
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Stevens and Vorys, 1967, Boll, Rerbst, Krishnasmrtl, 
Loraine, Hears, Jackson and Garela, 1967, BLczfalusjr, 
Goebelsman, Johannisson, Tillinger and Hide, 1969| 
Larsson-cohn, Johansson, Wide and Qemsell 1970)* On 
the basis of their ^rk i t Is eoneluded that both 
estrogens and progesteiesns interfere with pltuitarsr 
gonadotropin fimotion* She Immediate effect of 
esta^ogens being directed towards the diminution of 
FSH seoretlon while that of progesta@ans towards the 
abolition or suppression of mid<**oyol6 LR peak, Bath 
together inhibit the FSR end LR secretion mid thus 
prevait ovulation. 
Progestagens given alone generally suppress 
the mid* cycle LR peak (Laurltsen, 1966, Saume and 
Kaiser, 1967) but %^ 6n administered continuously in 
low doses such as 0*5 m^day of ehlormadinone acetate 
CLarsson-Cohn, Johansson, Wide and Gemzellf 1970, 
Diosfalusy, Goebelsman, Johannisson, Tillinger and 
Wide, 1969), 2.5 mg lynestrenol (Sohmidt«Slmendorff, 
Kaiser ahd Kopera, 1967) and 0*1 mg norethisterone 
(Biczf alusy j | | j ; ^ * , 1969), these do not suppress the 
mid«-cyele LR peak consistently. Instead, suppressed 
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or abortive LH peaks are formed which may or may not 
be aocompelled by high pregnanediol excretion In the 
urine (Dlezfalusy ^ ^ t , 3J969)« thus I t is evident 
that the contraceptive effect of low dose progestagens 
may or may not be ovulation inhibition* they may 
have other s i t es of action. 
That contraceptive steroids may inhibi t ovarian 
response to gonadotropic stimulation^is suggested by 
animal experiments (Starup and Ostergaardi 1966) 
Mears, 196S| Dlozfalusy, 1965# Revievs) and also by 
reports that the administration of progesterone (Gemzelli 
Diczfalusy and Tll l inger, I960) or contraceptive 
steroid combination (Gual, 1967, taur l tzen, 1966), 
suppresses ovarian reaction of women to exogenous 
gonadotropins. Other investigatory using different 
compounds and dosage schemes could not demonstrate 
such an effect of contraceptive s t a b i d s on the ovary. 
Xnd«&ed|. in two <ia8es, exogenous gonadotropins vere shovn 
to induce ovulation in 16 out of 18 treatmmit cycles 
on combination contraceptives (Starup and Ostergaard, 
1966| Johannisson, t l l l i nge r and Diczfalusy, 1965)• 
However I In these two cases, the gonadotropin stimulation, 
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was undoubtedly dxeessive. ©lerefor©, the possibi l i ty 
cannot be <ilsregai»ded that certain contraceptive 
steroids diminish the ovarian sens i t iv i ty to gonado-
tropic stimulation, but that this effect can be over-
come by the addition of increased amount of gonado-
tropins . 
Contraceptive steroids may also interfere 
with the biogenesis (Ostergaard and Stavup^ 1968) and/or 
metabolism (Goldman, 1967> of progesterone in the 
ovary. This has been suggested on the basis of 
reports that In K^Ssmen on continuous low dosage 
progestagen, fresh corpora lu tea and secretory 
endometrium have been found accompanied by low 
pregnanedlol levels (Martlne2*Manautou, Giner -
Velasquez, Gortes-Gallegos, iUmar, Hojas, Gultterez-
Kajar and Rudel, (,1967b) • The same was reported by 
Ostergaard and Stamp (1966) in a study of 7 women 
on ethynyl estradiol and megestrol acetate, separately 
or in Sequential therapy. 
Spermatozoa undergo certain physiological 
changes termed capacltation, in the female genital t rac t 
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-bafora they are «apal»l© of f©rtlll«iag the egg. tn 
most mmmetXQt spormatozoa hav« to be oapaoltated. in 
the female genital traet* 0noapaoitated 8pea*mato2oa 
are unable to penetrate through the mn& pelXuolda 
of the eggs (Justini 1967) • Shis pi?oeess which stay 
take place in the uterine or tubal oa^rities hoM the 
role of enabling the speriaatoKoa to under^s an 
aerosome reaotloni yhioh In turn oauaes release of 
hyaluronldase and the ensyme makee i t possible 
for the sperntatosoon to pass throu^ the eumulus 
(iiuetin) 1067) • l^ hle iseeha:iisia seems to be operatlire 
in human speeles too (Edwards| Donahue| Baramki 
and ^onesy 1966)* 
Contraceptlire steroids teay possibly interfere 
with the proeess of oapacitatlon is based upon the 
observation that administration of progesterone to 
rabbits inhibits the eapaoltation of spermatozoa in 
the female genital traet (Changi 19S8)* Further studies 
W Chang < 1967a) have shown that pretreatment of 
rabbits with progestational steroids causes a distur-
bance in the sperm transport and sperm capaeltatlon. 
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Tubal transport of ova may be one of the 
processes Influsneed by the contraoeptive s tero ids . 
In rata (Hncus, 1965) and rabbits (Chang and Harper, 
1966) i t i s established that administration of 
estrogens a day or two after insemination induces 
degeneration of blastocysts due to the rapid 
transport from the tube td the uterus and expulsion 
from the uterus* CJhang C 1967b) has reported th»t 
treatment of rabbits with progestational compounds 
produces a marked effect on the transportation of 
egj^t causing some disturbance in f e r t i l i s a t i on , 
degeneration of e g ^ in the uterus mid their expulsion 
from the uterus, !Ehe moti l i ty of human fallopian 
tube is known to be influenced J a yi t ro by p i tu i ta ry , 
adrenal and ovarian hormones (Rorie and Newton, 1965, 
Sandberg, Ingelman-Sundberg, Lindgren and Rydon, I960), 
^be i a YiyQ effect of hormones on the tubal moti l i ty 
in the human is being investigated (Ooutinho, 1970)•' 
Summari25ing, one could say that tubal factors 
are certainly of impdvtance in ensuring fe r t i l i za t ion 
and proper transport of ovum, Bstrogens and progestins 
are capable of interfer ing with these factors in several 
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flpeoittS. Whethei? thigr Ao to in th» Isuiaan is not knovn* 
Cervietl isaout tmderecist o|r9ll« ehangds» daring 
tho normal nenstrual ojrolo indisocd Ixf estrogtns in tht 
folliotilar pHaso and laf profdstorontt in tha lute«l 
phase* Befort or at the tia* of oiirulation the oervioal 
suoni i s exeessi'^rely thin and watery. It i s oharaeteri* 
sed la^ low Tiseosif^rf a diminished ooneentration of 
alhuainy a aarkedljr increased ooneentration of non-
migrating ffluooid, as well as Ijgr i ts ^hility to show 
fern pattern and inoreased spinnbarkeit <Hos!hissi} 1966a 
and 1966h| Hoi^issi and Heuhans, 1966)* These changes 
are in fairour of sperm penetration through oervieal 
mnous (lotella-Llusiai 1964) and are estrogen indnoed* 
mring l&e luteal phase eervioal muous is thiok, taeksr 
and cellular* I t shows poor spinnbarkeit and lads of 
fern pattern* ^ e ratio of albumin to miuooid is muoh 
hi|MP than in the mld-orele anious* Suoh ohanges In 
the oervioal muous are hostile to sperm penetraticm 
(Botella-Llusla, 1964), and are induced \3iy progesterone* 
Thsse progesterone and estrogen indaoed changes in the 
oervioal mucus can be duplicated bgr t ^ administra-
tion of estrogen or progestagsns (Hofi^issi, 1966a)* 
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mm administration of eoablned eontraoeptlirtt result 
in pro89steroiid>co&dltloned ehangdS in the oervieal 
nmoui* these changes are oonaidered significant for 
the oontraoeptiTe effeets (ZanartUf 1964) as they 
definitely inhibit spero^migratlon throu^ oervieal 
muous (Ho^asii 1966ft| Odebladf 1966)* 
Sequential oontraoeptive therapy has no effeet 
on t^e ee'rvieal snious prior to the administration 
of progestagens (Cohen and Feres-I>elae8| 1965>« 
fhereforei hii^ eon^aoeptiire effioaoy of this regimen 
must be imrolvlng other points of attaok (Ckial, 
Beoerra, lioe-Wray, Goldsleheri 1967| tyieri 1966)« 
The administration of low dosage progestageiotf 
results in non^suppresslon of endometrial ohanges 
aooomypiAed W ohanges in the visoosity and spinn-
barkeit of oervloal muous« Since low dosage proges-
tagens are effective eontraoeptiireS| their antlfertillt^ 
aechanisa has been suggested to involve an ii^bltory 
effect on cervical mucus < Cohen and Peres^ ^PelaeSi 196S)t 
But recent studies of Martine2«M«nautou and his 
associates (1967b) on the effect of 0.5 ag ohlormadinone 
acetate in Sims^ Bohner post*coital test of cervical mucus 
showed that in 80^ of 11$ cases, the sperm motility 
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was lacking, while in .20^ th© number of apermatoaoa 
was fair to good and exhibited good motility* therefore, 
the f e r t i l i t y pi^teetlon offered by low dose progestagen 
could not be attributed to I t s effeot on oervleal mucus 
alone* I t may have other loci of action too* 
the human endometrium exhibits characterist ic 
changes In each menstrual cycle under the sequential 
stimulation of ovarian hormones* In the f i r s t part 
of th^ cycle, the fol l icular phase» the endometrium 
i s under the Influence of estrogens. There i s then 
a gradual transit ion at the time of ovulation laid as 
the luteal phase progresses, the effect of progesterone 
becomes dominant* These morphological effects are 
associated with In t r ica te biochemical changes* Animal 
experiments Indicate that endometrial changes, 
regulated by delicate estrogen*progeSterone balance, 
are c r i t i c a l for implantation In several species 
(Bishop, Borell) Mczfalusy and Tll l lnger, 1962, 
Pincus, 1965)*' 
Xt is well known that a l l the changes 
characterist ic of a proliferative endometrium can 
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be Induced by the administration of estrogen and 
those seen in the secretory endometrium can be 
duplicated following administration of various 
progestins, l a xX^<^ effect of estrogen and 
progestins on endometrium in culture has also been 
shown to be similar to their j ^ vivo effeotCGsermely, 
Hughes and Demers, 1971). I t can be expected, 
thereforei that the histochemical pattern of the 
endometrium exhibits s i ^ I f l e a n t difference according 
to the type of hormonal contraceptive administered. 
Indeed the patterns found in women talcing combined 
p i l l were markedly different from those found in 
sequential treatment, whereas during continuous 
progestagen a ^ i n i s t r a t i o n i tvo patterns emerga -
one consistent with ovulation and another suggesting 
anovulation* 
Oomtfined p j l l t * The combined estrogen and 
progestagen pUl i s generally administered from day 5 
to day 25 of the menstrual cycle. In an ovulatory 
cycle of women, secretory changes be^n in the uterus 
after ovulation and formation of funtional corpus luteum 
around day 16 and reach a peak on day 19-ao to be 
followed by rapid regression* %en a woman i s administered 
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eoffiblndd eontraceptlve on dajr & of the cgroXoi -
there is an early and transitory ^andular response 
and secretory changes in the endometrium reaoh a 
peak within 4«5 days of drug administration* (Eandular 
regression then begins to ooour. At the conclusion 
of the 30 day regimen the endometrium may show complete 
absence of glandular seoretion &nA tor tuosi ty to one 
with some cellular and intraliuainal secretion and 
minimal to moderate toruosity of the gland* The 
stage of a fully developed secretory endometrium 
i s rarelyi if ever reached* (Maqueo-lbpetei Perez-Vega, 
Goldaieher, Martlnea-Manautou and Rudel| 1963, Maqueo-
Topete and Slce-Wrayi 1966)* A thinning of the 
endometrium takes place after a few cycles, but cyclic 
changes are known to occur even after long term 
administration (Garcia, 1967)* Btoweverf the menstrual 
floW| subsequent to the discontinuation of the 
treatment with the combined p i l l , i s usually associated 
with nonsecretory atrophic appearing endometrium 
(Durkin, Lin and Kim, 1965). I t shows no daily 
variation in volume and i s significantly reduced as 
compared to that seen in women with normal cycles 
(Callard, Litorsky and Pe Merre, 1966)* 
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aequential pill»« The setjuentlal p U l 
administration results in a marked proliferation of" 
endometrium followed by the appearance of early 
secretory changes <I>urkin^^,, 1965). There is 
no appearance of exhausted or atrophic glands* The 
endometrium has the appearance of elgjiteenth to 
nineteenth day endometrium of an ovulatory cycle 
of a normally menstruating woman, and does not become 
thinner on continued administration. The menstrual 
flow following sequential regimen Is associated with 
a secretory endometrium (DurJpln s^ ^*, 1965) and Its 
duration approximates the normal. Following a long 
term use of sequential contraceptive therapy, the 
post-treatment endometrial regeneration is significantly 
more rapid than in those taking combined pill« In 
sequential regimen where estrogen is given for 11 days 
and estrogen and progestagen for 10 days, the 
appearance of ^dometrlum at various phases of 
treatment approaches that of normal (Hears, 1965)^* 
Coi^tlnuoua progestagen admii^istratloni* Mien 
contraception is based on continuous progestagen 
administration, the histologic appearance of the 
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endometrlua shows much gpe&tep variation than in 
other types of hormonal contraceptives. I t ranges 
from inactive to secretory vdth a fair amount of 
irregular secretory type (Martineg*Mansatou g% a^*^ 
1966 and 1967)»>« I t is of sigtiificanee that secretory 
endometritim i s found more frequently even after long 
term use of the progestins (Martineg-Manauton ^ A . f 
X967W • 
the importance of endometrial changes 
introduced by contraceptive drugs may not be over-
emphasizedi but i t i s evident that any imbalance of 
estrogen and progesterone r a t i o , other than in normal 
o y d e affects implantation in many species (Enders, 
1968;, PinouS| 1965), HtastocT^ts in many rodents will 
implant in almost any tissue (Kirby, 1967) but the 
endometrium cer ta inly represents a most importsumt 
exception in this respect (Bnders, 1963, Pinous, 1965) • 
The anti-implantation action of a drug l ike clomiphene 
in the r a t i s on the internal milieu of the endometrium 
rather than the blastocyst (Prasad and Kalra, 1967) • 
Although much is not known about the human, yet i t 
may be possible that estrogen and progesterone given 
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In the early proliferative phase may be able to 
create a "hormonal Imbalance* interfering with 
noriaal endometrial development and Implantation 
(Budel ana Martlnez-Manautou, 1967)• 
Jensen and Jacobson (1962) have made the 
pioneering studies on the uptake of estradiol In 
the target organs of the rat uterus. After a single 
subcutaneous Injection of 0.1 jug of 6t7»H*estradiol 
of high specific activity (60 Ci/mM) the hormone is 
incorporated and retained in the rat uterus and 
vagina, in contrast to the other tissues like liver, 
kidney, adrenal, muscle, bone and blood, !fhe pes^ 
of estradiol uptake in the uterus is reached between 
1 to 2 hours and thereafter a gradual decline over 
the succeeding hours was obtained with a significant 
drop at 16 hours* The amount of estradiol present In 
the uterus is only a small fraction never exceeding 
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0*1 to 0«2)C of the administered dosdt tJpto six 
hours after the aaiQlnlstratlon of ph^^iologlcaX 
amounts of t r l t i a t ed estradiol the ozily s i gulf lo ant 
radioaotlve substanee present In the uterus i s 
free es t radiol . Furthermore when a mixture of 6 | 7 - % 
estradiol and estradiol 17- vere employed, i t vas 
seen that neither the immature nor the ao t lv^y 
growing uterus is capable of oxidizing estradiol to 
estrone* On the other hand two hours after the 
administration of t r l t i a t e d estrone, the uterus 
contains t r l t i a t e d estradiol which i s l/lO of the 
content result ing from the same dose of estradiol 
i t s e l f . This s t ron^y suggests that estradiol stimulates 
uterine growth without undergoing metabolic t rans-
formation and that estrone exerts i t s hormonal action 
in the uterus, after being converted into estradiol• 
Kato and Villee (1967) demonstrated preferential 
uptake and retention of estradiol by th© anterior 
hypothalamus and the anterior hypophysis of the r a t t 
The same selective uptake was also shown i a v^tro by 
Kato (3^70). Other investigators (Elsenfeld and 
Asfcelrod, 1966, Laumas and Parooq, 1966a, Laumas, 
1967, 1969> have reported similar observations on the 
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selective uptake of estradiol by the pituitary and 
the ]:!ypothal%nus. 
Stone and Martin (1964) studied the uptake 
of %-estradlol and estrone In the uterus of ovarl-
ectomlzed mouse after local applloatlon. Both estra* 
dlol and estrone reaehed peak eonoentratlon In the 
uterus approximately one minute after applleatlon 
followed hy a steady decline over next 12 hours* !Ehe 
rate of decrease In activity was more rapid with 
estrone than with estradiol, and may explain lo\^r 
biological activity of estrone In local tests. 
Studies of Sweatf Bryson and toung (1967) 
have shown that In human bo^ endometrium and myo-
metrium In the proliferative phase are able to taems* 
form estradlol-17B Into estrone* The capacity of 
endometrium Is 40 times that of myometrium* Tt& 
reverse Reaction 1*6* estrone to estradiol Is of less 
magnitude than that of the forward reaction* Krlshnani 
Rlngoranl and X«aumas (1971) have reported that human 
endometrium and myometaplum In both the proliferative and 
secretory phases of the cycle are able to convert estradiol 
to estrone* Such a transformation Is found to be less 
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in the secretory phase theun in the proliferative 
phase* 
Jensen, Susmki, Kavashimai Stumpf, JungbXut 
and Be Sombre (1968) have sho^m that ethinyl, estradiol 
and aestranol administered in the same amounts as 
t r i t i a t e d estradiol are tafe:en up by mteriae t issues 
in a manner similar to that found with es t radiol . 
3-Cyclopentane ether of this compound (Quinestrol) 
has been sho^m to be stored unaltered in the brain 
and fat (Meli, Steinet2 | Beach, W>Xft and Qiannina, 
1966). 
Centrifugal fractionation experiments 
demonstrated that B0% of the estrogen was present in 
the nuclear myofibrillar fraction and another 30^ vas 
present in the 105,000 % g (cytoaol fraction)* The 
remaining estrogen was found in the mitochondrial 
and microsomal fractions (Koteboom and (brski , 1965)» 
A number of other investigators have reported a 
similar localization of estradiol in the nuclear 
and cytoplasmic fractions of the r a t uterus , vagina 
and pi tui tary (Talwar, Segal, Evans, Davidson, 1964, 
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King, Cowan and Xnmani IdSSa, Klng^ Gordon and Xnman, 
1965b, liAumas, 3S67, I«atimaS| 1969, Breaker and Wbtiss, 
19691 Shyamala and Gorskli 1969, Jensen ^ ^ t , 1968)» 
Stumpf (1968) using autoradiography technique has 
shown that after an injection of ^ - e s t r a d i o l to 
immature r a t s , 68?! of the radioactivity was associated 
with the nuclear oompartment of a l l the uterine tissues* 
Further, Se^m&n ^ ^ « (1968) have suggested that the 
interaction of estradiol with target t issues involves 
a two-step mechanism of uptake and transport, fhe 
hormone associates spontaneously with an extra nuclear 
^uptake receptor* to form 9,S S complex. This 9.6 S 
complex transfers estradiol to the nucleus by a 
temperature dependent process which consimes 9*5 S 
receptor* The formation of S S complex by the nucleus 
requires the presence of supernatant fraction contaljilng 
estradiol In the form of 9.5 S complex* I t is suggested 
9«6 S complex may be transformed into the nuclear 5 S 
complex by cleavage of the 9.5 S receptor molecule. 
Earlier attempts to demonsitrate the selective 
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localization of progesterone in the r a t uterus were 
not sueoessful because ei ther very low speeifie 
act ivi ty progesterone was used in their studies or 
properly primed animals were not used < Hie gel^ 
Hartopi Kittingeri 1950) • For the f i r s t time using 
estrogen primed rats i t was demonstrated by liai^as 
and Farooq (1966b» 1967) that progesterone i s rapidly 
taken up in the uterus with an i n i t i a l rapid dis* 
appearsaaoe followed by a slow disappearance* The slow 
disappearahoe part of the curve Indicated retention 
of the steroid* Higher uptake of the steroid was 
found in the uterus, ovary, p i tu i tary and hypothalamus 
as compared with blood. Long term experiments on 
3 
the upta&e of H-pifogesterone showed that i t i s 
selectively taken up and retained by the hypothalamus 
and the pi tu i tary , indicating the presence of proges-
terone binding receptors in these tissues* The 
uptake of progestational steroids norethindrone, 
norethynodrel and ethynodiol diacetate were studied 
by watanabe, Saha and Layne (3968) • IDiey showed that 
there i s selective upt^ Oce and retention of these 
steroids by the tissues of the rat* Various tissues 
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studied Included ovary, u te rus | vagina, p i tu i tary , 
hypothalamus, adrenal, l i ve r , kidney etc# 
Haass, frams and l ^ ^ e r (1969) shoved that 
following intraoardlal Injection of ^'H-progesterone 
to r a t s , 6-20jS of the radloaetlvity was found in the ^ 
uterine nuclear fraction and the Uulk of the steroid 
vas found in the supernatant and mitochondrial fractions 
Wlchaann (196?) foimd that after administration of 15-
progesterone to pregnant ra ts about 60^ of the radio-
act ivi ty as to ta l or as progesterone was present In 
the nuclear myofibrillar fraction arid about 25j8 in 
the 108,000 X g supernatant fraction. The res t of the 
Steroid vas present in the mitochondrial and mici '^mal 
fraction. By using radio autography technique Stumpf 
3 (1968) showed that after the injection of H-norethynodrel 
to immature r a t s , radioactivi ty vas not concentrated 
in the nuclei of uterine tissues but vas randomly 
distributed especially over the extra cel lular space 
and cytoplasm. 
Milgrom and Baulleu (1968, 1970) showed a 
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tpeoifie Dinding of laroeaitorone to a protein in 
the rat utdplod cytosol* tliis protein vm simHast to 
Qortioosteipold binding i^obolin in ^Bioo-ohoaieaEl 
criteria •noh «i iedlttentation ooeffieientf eleotro* 
phretto aobilitr and f^ermostabiiitr* fhe protein 
was found to inerease in paraiiei with other proteins 
vm^BT the effeot of eitradiol (Hil^oa and B«uiien« 
1970) • the tfediaentation ooeffioient wai fonnd to 
he 4 S» the binding protein was not deteotable in 
the kidner or diaphraga* Bao and Wieit (1970) demons* 
trated the p^esenoe of a progeeterone binding protein 
in t&e peeudo-pregnant o^rarieotomised rabbit ntemi« 
Timf found 60^ of the radioaotiirits^ in the uterine 
< t^osoX fraotion* fhe binding protein wae ehoiAi to 
have sedlQientation vaine of 5 S. Verma and I»ai]aas 
(1973) have demonstrated that huoan endometrial and 
a^ome^ial o^rstois oontain reoeptor proteins for 
progesterone* the sedimentation ooeffioient of the 
endometrial binding protein has been found to be 4« 5 8 
and that of t3te oiy-ometriai binding protein 4*1 S« 
Svidanee has been presented to show that the endo* 
metrial and •sromettial progesterone binding proteins 
•re different from eortioo-steroid binding protein* 
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MUgPom, At gar and Batafeu (1970) showed a 
progeaterone reoeptor In. the guinea pig uterine 
eytosol with a sedimentation value of 6.7S# The 
uterine receptor was shown to be different from 
that of the guinea-pig progesterone binding plasma 
protein* MO Quire and De Delia (1971) also shoired 
a progestagen receptor In the r a t and rabbit uteri« 
3 
H-norethlndronei chlormadinone and progesterone 
were found in the 3am& region of the sucrose gradient 
and the binding of progesterone was completely 
antagonised by progestagens* 
The contraceptive s tero ids , l ike endogenously 
secreted Sex hormones undergo inactlvatlon in the body* 
Only a small part reaches the target s i t e for e l i c i t ing 
i t s hormonal action. The major portion of the steroid 
i s metaboliaed in the l iver and other t issues and then 
excreted in the urine and faeces* Although considerable 
amount of information on the reactions leading to the 
metabolism and inactlvatlon of natural ly occurring 
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storold sex hormones Is availablei yet similar 
information on the metabolism and excretion of 
synthetic contraceptive steroids is lacking. 
MQtabQ3r3^ 3a ir^  the mrlnet* Aral, Golab, Layne and 
fincus (1968) studied the metabolism after the oral 
administration of ^ -norethynodrel in rabbits. It 
was found that the B0% of the radioactivity was 
excreted in the urine» althou^ analysis of the bile 
of cannulated rabbits indicated that there was consi-
derable enterohepatlo circulation of the Ingested 
material* Layne^ Golab^ Aral and Plncus (1963) 
studied the metabolic fate of orally administered 
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H^norethynodrel and norethindrone In women. Hhe 
urinary excretion accoxmted for nearly dB% of the 
radioact ivi ty after the administration of norethynodrel 
and 50-70JS after the administration of H-norethindrone. 
Considerable amounts of radioact ivi ty was present in 
the bi le and faeces also. One of the metabolites 
identified was l7of-ethynyl-19-nor-androst»4-ene*3p, 
lOp 17B-trlol which was l a t e r found to possess 
estrogenic act iv i ty (Bialy, Layne and Plncus, 1965). 
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Fotherby and coworkers (Potherby, 1971) 
have studied the metabolism of 17o(-ethynyl steroids 
in women* fhe progestational steroids studied vere 
lynestrenol (Kamyabi Fbtherby and Klopperi 1968k)| 
norethisterone (Kamyabi Jbtherby and Klopperi 1968b>| 
norgestrel (Li t t le ton, Fotherby and Dennis, 1968). 
The to ta l excretion of the steroid in the urine 
over 6 d«^s was S3*9jS for norethisterone, 43«7^ 
for lynestrenol and 43»1S^  for norgestrel . However, 
in the case of eawsh progestational s teroid , the time 
taJseai for the administered radioactivi ty to decrease 
to X% was approximately 5-6 ^ayBt> Mologloal half 
l i f e (the time required for the urinary excretion of 
radioactivity to decrease by one half) was 19 hours 
for norethisterone, 95• 6 hours for lynestrenol and 
24 hours for noregstrel . In contrast to these, the 
biological half l i f e of 17o(-ethynyl-estradiol was 
31 hours (Kamyab, Fotherby and Steele , 1969)• 
Work of a number of investigators on the 
nature of the urinary metabolites after the admini-
s t ra t ion of 17o(-thynyi-19-nor steroids in animala 
and man has shown that a l l the urinary metabolites 
retained the 17c<-ethynyl group.(Layne ^ ^ . , 1963, 
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Williams, Layne, Hbbcrick, Nilsen, Bg a^hey, 19671 
Car g i l l , St0lnetiS| Oosnelli Beaeh, Mell, Fa^lmoto 
and Reynolds, 1969, Ibthepby, Kamyab, Li t t le ton 
and Kloppor, 1968) • Fotherby ja;^  j j ^ . (1968) have 
presanted evldance which suggests that urinary 
metabolites obtained after the administration of 
norethlsteron© or lynestrenol were similar in the 
free, ^ucuronide and sulphate fraction. This may 
be due to the conversion of lynestrenol into 
norethindrone jja 3&SS.* Conversion of lynestrenol 
into norethindrone has been shown l a vi t ro by Maaaheri, 
Fotherby and Chapman (1970) using l i ve r homogenate. 
An jya yl t ro study of the metabolism of norethynodrel 
in the human endometrium and myometrium has shown 
tha t , amongst the metabolites, a considerable amount 
i s present as norethindrone (Murugesan, Hlngoranl 
and Laumas, 1973).* 
of 
After the admintstrationAMAP (medroxy 
progesterone acetate) to women, Helmrlch and Huseby 
(1962) reported the Isolation of 6o( -methyl*6jS, 17,21 
trihydroxy-pr9gnan«3,20»dione-17-acetate as the major 
urinary metabolite of MAP, 1?h© major portion of 
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t)i« wetabolltt v«t exorateA at a ^uottroaia* 
oon^ugatd* Bai^ i Vo i^rsy tUlofyi Bartir and Coari 
< 1966) vapo^tad that-tlui wiaary aicaratlm «f %• 
m&^QWpTGBfiatmQm aaatata ovair 5 dairat in ppa^naiit 
and aon^pra^iaat faitaMfi patiaatSf variaa liatvaaa 
0»8Sjt and 4*0d$( of tha tdtal doaa. 
lf^t^^U««^ |q WiW^il* llia.diaappaaranaa of progas* 
taroiia ( t i t l i o t fa l t f f a i t wid Etlmm&Tmtf W0i6) 
and astradioi (Satidl)etg and SlauniMtat 3^^) liaa INan 
inrasti gated* the <m»|ippdaranoa ouvro haa liaan 
aathasatio^lir ana3.rsad imd tha aetaboliaa diacraasad 
on t^a baiia of a tuo ^fflp4]*tHant nodal* flit in i t i a l 
h^t l i f e moA tha anhaaQtiant aiovar heUt l i f a haira 
bean oalouXatad firoa tha diaappaaranoa ourva* l»ittla 
^ j^» (1966) foimd m i n i t i a l half U f a of 0*96 wAn 
and aaaond half l i f a of 10*7 nin for proftataioiit 
idiila for aatradiol Sandhotg and Slaunvhita iWBB} 
$mf an in i t i a l half l i f a of ^ ain foUovad Iqr a 
aaoond alovav half l i f a of 70 ain* She diaappaaranoa 
cvatttt haa alao paraittad tha eidoulation of irolnaat 
of diatrihntion and rata oonatanta of aataboliaa 
(Tait and Burataint 1964)* fha ovarall aataboliaa 
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Of A hovtaon^ h&» been desorlbeil ligr t^e e&louXatlon 
of i ts metabolie elearanoe rate (MaR>| 14I1I0I1 liat 
Heea defined as the amotint of i^ atma vhioh i t oXeared 
oompXetely and Irifeversiblir of i ts tteroid oontent 
in & wait time* She HOB of 84443 X/day and i|360 l/daar 
has been found fof pifogesterone and estradiol respeoti* 
veir <Littie JSI Ji*f i966| I.onfeope« i^ aame and S&itf— 
1968) • Xn contrast to this M.^ MCR vaXnof eontra-
oeptiire steroids show irery low nm vaXiie* Tan der KoXen 
M JbL* (1969) have reported an MCR vaXue of 25 X/dsgr 
for Xynestrenol and its Metabolites* Ifee MCR vaXnes 
of 30 X/day and 4S*6 l/dagr respeetlveXsr have been reported 
for norethynodreX and i ts aetaboXites and oiaornadinone 
aoetate and its metaboXites (Laomas, Homgesan and 
lingoraniy X97X| SugwekaTi Har^a and Lauaas, X973a>. 
These oonsideratiims l ^ s snggest that Idie fev oontra* 
eeptive steroids vhieh have been studied showed a sueh 
smalXer HCR vaXne eompared with estradioX and progesterono^ 
thereby shoving that these progestatlonaX steroids 
are sXonXjT oXe$red from the bodf* A Xover MOR 
mar ^ suggested as a oriterion for the inoreased 
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potency of a (Sntg citioa thi« vma4 lead to 
pepslatlng itvttl* of tha iterold in tlio blood 
aad thiui faoilltato its aoo««« ^ tii« tor got 
OVglSOla 

After administration the progestational 
steroids In general| disappear from the bloody 
get metahollsed in the body^  and are excreted in 
the tirln© and faeces. Only a very small amotmt of 
the progestational steroid i s taken up in the target 
t i ssues , I t would be of in te res t to find out 
whether progestational steroids are incorporated 
and retained in the target t issues l ike uterus and 
vagina as has been fo\md in the case of estradiol 
(Jensen and Jacobson, 1962). Farther, to understand 
the mechanism of action of a progestational s teroid, 
i t i s necessary to determine i t s uptake In the 
target tissues and also to study as to hov i t modifies 
the accumulation of other hormones, part icularly 
es t radiol , in the uterus. 
13iis chapter detoribes a comparative 
study of the uptake of a 17oc -ethynyl 19-nor steroid -
norethynodrel and a 17o( -ac^toxy progesterone 
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derivative - ehloraadlnone acetate after a single 
injactlon and a constant Infusion, The effect of 
priming with norethynoOrel and ohlonaadinone aoetatd 
on the uptake of H»e»tradiol in the uterus has 
bean investigated* 
Ar^ j.malst* Mult female rats, 3-4 months old, from 
Haffkine Institute, Bombay were used* Immature 
female mice 22-23 days old were obtained from the 
animal colony of the AIIMS* All animals were housed 
in air •conditioned quarters and were maintained on 
pellet diet supplied by Hindustan Lever Ltd., Bombay. 
Radioaetive ateyoidst- Tritium labelled norethynodrel 
was prepared by the exposure of inert norethynodrel 
to tritium gas according to the technique of Wilzbach 
(1967). Tritlation was carried out at the Bhabha 
Atomic Besearch Centre, frombay, Bombay* 1!he 
escoess of free tritium was removed by equilibration 
with methanol* The labelled norethynodrel was puri-
fied by a slight modification of the technique, of 
t ^ t 
* ^ ^ &^ JSH C196S)» The radiochemical pisrlty of 
the purifle<3 steroid was checked In the l^8h 
chromatography tystem, with cyclohexane t l»ensene 
(itX) B» the mobile phase and methanol t vater (4 i l ) 
as the stationary phase* Ihe %*norethynodrel was 
spotted aiongwith radioinert norethynodrel and 
chromato graphed in the above system. The radioinert 
norethynodrel was located by spraying antimony 
tr ichloride on the strip* The s t r i p containing 
radioactive norethynodrel was cut Into 1 cm wide 
pieces« and the paper pieces were put In sc in t i l l a t ion 
vials* The vials were counted in a li<juid s c i n t i l l a -
tion counter* A sini^e sharp peak of radioactivi ty 
corresponding to the radioinert norethynodrel 
indicated radioaohemical purity of %-norethynodrel. 
In l a t e r eatperiments, specifically l&belled 
norethynodrel as 6f7«%«norethynodrel (sp, act* 
0*53 mCi/mg>was obtained from 0*!>* Searle & Co* 
and used* The results obtained with this preparation 
were similar to thos© obtained with randomly labelled 
preparation of norethynodrel, lo{» 
acetate (sp« act* 0*222 laCl/mg) was obtained from 
S* Merck, I>armstadt, Germany* 6 i 7 A - e s t r a d i o l 
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(sp. aot. 40 Ci/i9M> was obtaindd froA th« New 
^^and Nuelea^i Boston, Mas,s«| U.S.A. It was 
purified bjr celit© column chromatography befoi?e u»a* 
Soyethynodrol (Lot Ho. MA-Q-924) free of estrogeaaio 
contamination was a gift from !>?• Victor A, Drill 
Of 6.B. Searle A Co* The rats used for H*Borethynodrel 
uptake stud^ were pretreated with 16.6^^100 g body 
weight of norethynodrel daily for 3-4 weeks while 
3 those used for H*chlormadinone acetate uptake 
studies were pretreated with ohlormadinone acetate 
SOO Mg/100 g body wei^t for th© same period. Both 
the steroids were admjUiistered orally in 0.^ ml olive 
Oilt 
aeetatat* Single intravenous Injection of 90.0 ;uc 
of the radioactive steroid in 0.5 ml 10^ ethanolic 
saline was given to rats in the femoral vein. Oroups 
of rats, S-6 in each group, were killed by cervical 
dislocation at intervals of IfS,5,10,SO,40,60,80 mid 
160 minutes after injection. Various tissues like 
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or&sr^ utarut^ vagiaat isttsol«i tntesttiiei adrenal i 
liver t ttiyroid, fat | naasar^ ^aad and efe ifere 
taken out. The vhole Ixrain vat reisoved aa re^idlr 
aa poasibXe and was freed of adhering blood iressels* 
'X^ blood iressel* aurroundlug tlie liirpothalaMlo area 
on tbs base of tbe brain vera disseeted awegr and tbe 
blood atloking to the li^po^alaimis vas removed bT a 
filter i^ aper* tbe brain vai keint in a olean petri* 
disb and the irarioaa part* of the brain vere disaeoted 
out. Brom the ventral aide, the entire hjrpothalfiSRif 
vai taken out as a b lo^ liuited anterlorlr W optie 
ehiasma laterally ^ Jbgrpothalamie fissures and 
posteriorly W the posterior laargLn of nanminary 
bodies« from t ^ dorsal side and the oortioal 
ooveringt of bo^ sides of oerebral hemispheres were 
removed exposing the imderlying brain areas, fhe 
various areas of the brain taken out were the hypo-
thiaamos, oingolumi eorpus eailosumi hippooampuSf 
thilamuSi midbrain^ pons varollii oerebellumi 
medulla oblongata and pineal body* the pitultaapy 
gland vas removed from the sella tureloa. Bach tissuOf 
idien taken ottt| vas gently blotted, vel^ied on a 
torsion balanoe and dissolved in hyamine hydroxide 
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(0.5 i&I>« Oompietd solubillsatlon in i^ amlne hjrdroxldd 
vas achieved hy kaaplng the vials at SS^ C overnight* 
fflg^dinone s^oetatei* ^ e radioactive steroid in 4#1 ad. 
volume vas infused at a oonatant rate of 0»0138 iBl 
per minute for 6 hours into the feaoral vein of the 
rat* The infusion was carried out with the help of 
a mioroinfnsion puap model 600*^00 (Harvard Apparatus 
Co*>* After the completion of infusion the animals 
were Icilled and the tissues were taken out and dissolved 
in hyamine hydroxide f as described above* Honorethgr* 
nodrel (3S«8 AIC) was infused in saline containing 10^ 
3 
ethanol and 10% propylene glycol* H*chlormadinone 
acetate (44*0 MO} was infused in 10^ ethanolic saline* 
ai^ d es^adiol on %«estradiol uptakei» To study the 
priming effect of noretdiynodrel on the uptake of e-?"-
3 R-estradiol, immature female mice were pretreated 
with different doses of norethynodrel for different 
periods of time* Norethynodrel was administered sub-
cutaneously in 0*1 ml volume* The injection solution 
\ta» prepared in 5jC ethanolic saline. Mhen large doses 
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Of norethynodrel were administered the proportion 
of ©thanol vas increased to sushlove aolublllssation 
of noretliynodrel • 
Eiitradiol pretreatment vas glv«n to 
liomature female mice a t a dose of 0*01 ug es t radio l / 
0«1 laX 5^ eth£molio seOLine subeutaneousiy* 
H*estradloi uptake vas studied In Immatura 
©ice after pretreatment with norethynodrel and 
estradiol• 6i7*%-e8tradlol (S;ao> was adminlsterad 
suboutaneously to saoh animal* the mptake of 
estradiol vas a l v a ^ studied by injao.tlng I t one hour 
before kill ing* Slit to ten lismature female micef 
81*23 days old, were used per group. At sacrlf lcei 
the u te r i were quickly removed, freed of extraneous 
t issue and uniformly blotted to remove exoess fluid* 
Uteri were welgbed on a torsion balance and direct ly 
transferred to counting vials* i^amine hydroxide 
(0*3 ml) vas added to the samples to dissolve the 
tissues* Complete solubii isation in hyamlne hydroxide 
vas achieved by keeping the samples at $6^C ovemli^ t . 
aeetate (CAP) on ^H«estradiol uptak^i^ A^iult ovarleotomiz< 
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»«ts mT9 sTdtreattd v l ^ dlftwent 4o»«i of CAI>t Slie 
«td?oid was dissolved In 10^ o^aaolie sali&d and injeet«d 
intpaperitonsallj'* ISie aniaais tyare saorlfiosd 4 h&wtM 
after I3i« injection* One hour before the saorifioe these 
animals vera Intravenouslir Injeoted vlth %«e8tradiol 
(lS«6jiifit/0«5 na 10^ ethmoXie saline par animal) # At 
saorlfloe the uteri ware removed and mlnoed and the 
radloaetlvltjr was ex^aoted idth aeetone and methanol* 
Baoh uterus tissue vas eattraoted thrlee with aoetona and 
twloe with methanol eaoh time using 2*0 vH of the solv^it* 
Hie aaetraots fi^ om eaeh sample were pooled In a solntlllatlon 
vial I dried under nltrofen and oounted (pearlmani DeHerto^i 
l,aunas and Fearlman ld69>» 
fo s t u ^ the long term effeot of pretreatment with 
OAP on %-estradlol uptake, tm groups of rahblts were 
pretreated with 0*S mg and 0*S mg OAF dallr* After 6 
months of treatment with GAPf the animals were saerlfleed 
and uptake of %-estradlol was studied in the uterine siloes 
by Inoubatlon of the tissue with 0.44 ;tte i*00$Mg^ of %-
estradiol for 2 hours In Krebs^ Hlnger phosphate buffer. At 
the end of the Inoubatlout the tissue vas removed| washed 
with lee eold buffer | blotted gently and the radloaotlvll^ 
was extracted as desorlbed above. 
Determination of radloaotlvltr In thu tlssuest Simple 
selntillfttion lljjuld was used as a medium for the oountlng 
of radloaotlvlty. I t was prepared by dissolving 4.0 pi 
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Of PPO (2,S*0lFlienyloxazoXe> and 0.1 m of l>o^p (X*4« 
bis«(2->4»mdth3rl*S-lti6n3^oxa8oly3.>-bdn2Sd]iQ) in 1 l i tre 
of rddistillod toIudBO* Zn samfiles vher9 th« water 
Qonteiit vaa ft XittX« novo <llotol sointlllatlon ilquia 
vai usod \^loh ooataiHed 3»SS #i of ?P0| 0*065 ^ of 
f>oPoP guild sa 00 of nepthalefio in S50 nd. dioxazii 230 ml 
toluene and 150 vH methanol* 
fo eaoh dried extraot of the tissut or to ^le tissue 
solublllaed in Ispuljae l93rd?oxidef 10 i^ of simple aeintlllib-
tlon liquid wad added and tbe eamiiles were eounted for 
radloaotivity in tlie lilquld Solntlllatlon Speotrometer 
(Paokard, Model 3314). Tim (|uenehing oorreotloas were 
earned out with tlie help of an Ijitemal standard* 
Uptake of Vnoreth!modrai in the uterus, oiriafy^  pituitary 
ai^ d l^ potha3,aBtttSi She uptake and dlaappearanee of %• 
norethynodrel in the uterus, ovarFt pltultarr and li^ po* 
thalamus after a single injeotion of %*norethynodrel Is 
shovn in Fig* 1» Xt may be seen that within two ainutes 
of the injeotion, aaxlmum uptake of ^adloaotlvi^ due to 
norethjrnodrel and i ts metabolites is attained in the 
uterus after vbloh i t disappears rapidly upto a period 
of 20 minutes* Subsequent to that, the radloaotivi^ 
disappears sloViy and at 80 minutes radioactivity 
beoame lov. ths radioaetlinty which remained at 160 
minutes was quite low* the uptake of radioaotlvitjr in 
the ovary shoved a pattern similar to that seen In the 
Uptdte® aM aiaappesrance of radioactivity la 
the ut©ru8| ovary, hypothalaisus and pituitary 
after a s in^e Injeotioa of 20*0 JUO of 
norethynodrel. The j*es\ilt9 are expressed as 
DMI/mg wet tissue* 
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case of the uterus except that the maximal uptake 
In the ovary was higher than that in the uterus 
and the disappearance after ^ minutes was quite 
slow* Pituitary also showed an uptake pattern 
similar to that of ovary in its rapid uptake and 
disappearance of radioactivity. However^ in the 
case of pituitary, the maximum uptake was attained 
after 5 minutes of the infection and there was a 
rapid disappearance upto ^ minutes, the rate of 
disappearance of radioactivity between 40*160 minutes 
was quite slow* In the ease of hypothalamus, maximum 
uptake of radioactivity was seen within one minute 
of the injection and it disappeared rapidly upto a 
period of W minutes t After 20 minutes the rate of 
disappeareaice of radioactivity was slow* 
adrenals•» The uptake of radioactivity due to norethy-
nodrel and Its metabolites in the case of liver, 
kidney and adrenal Is shown in Pig, 8. ^ e uptake 
of radioactivity in the liver was highest of all the 
tissues studied and showed a similar pattern of uptake 
as found in other tissues* The highest uptake of 
radioactivity was attained within 5 minutes of 
Ilniiffii ratilJ I in. 
Uptake and dlsapuearaioe of radioactivity 
In the adrenal, l iver and kidney after a 
3 
n i n ^ e injection of aO.O -uo of H-noretby-
nodrel, lUm resul ts are exprasted as Om/mg 
wet t i s sue . 
4000-
e ADRENAL 
A LIVER 
• KIDNEY 
l?5,IO 20 
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lnj0otlon and then thes^ e v ^ a rapid dis appearance 
of radioactivity upto a period of 40 miautes* After 
40 minutes I the rate of disappearance of radioactivity 
was very 8low« the uptake in the kidney was ais« 
quite h i ^ . Kaxintum levels of radioactivity could 
be foimd within one minute of the intravenous 
infection of HK-norethynodrel* Howeveri after 
5 minutes the rate of disappearance vas very slow 
and measurable levels of radioactivity could still 
be found at 160 minutes* Xt may be noted that in 
the adrenal the uptake of radioactivity was much 
hlghar than that in the other endocrine organs 
like the ovary and the pituitary* !iovever» the 
m&%iMvm uptake of radioactivity in the adrenal 
;<as obtained within two minutes of the injection and 
after that it disappeared rapidly upto a period of 
10 minutes. Subsequent to that the rate of disappea* 
ranee of radioactivity was rather slow, 
JH'^norethynodrelt* The data on uptake and distribution 
of radioactivity due to norethynodrel and its meta* 
bolites in different tissues after constant infusion 
of ni«norothynodrel into female rats are given in 
Uptalce of raaioa£>tlvlt7 in the genital f 
endocriaei aetabolio, excretory and other 
tissues after a constant Infusion of 
32.8 m of ^f'norethynodr©!. Itoo results 
are exprossod as Dm/mg wet tissue. 
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Fig* 3 and 4« Fig* 3 gives the uptake of radio* 
act ivi ty in the geaitali eadooriaei metabolici 
excretory and other tissues* Fig, 4 showt the 
uptake In the p i tu i tary and various parts of the 
brain* 
The uptake of radioaotivity due to nore-
thynodrel and i t s metabolites in the uterus and 
the ovary after a eonstant infusion of %*n©rethyaodyel 
was quite small and of the order of 6*S x 10 H and 
•7 
4*0 at 10 M respectively* However, as also seen 
in resul ts with s i n ^ e Injection, the uptake in the 
ovary was h i ^ e r than that in the uterus* 
ThB adrenal s^and showed a very h i ^ 
uptake of the steroids which was next only to 
l iver* Amongst the endocrine t issues studied, the 
adrenal showed a comparatively very M ^ uptake* 
However, l iver had the highest uptake of ^ -nore thy-
nodrel and i t s metabolites* |.ike l ive r , kidney 
and intest ine had also a high uptake which was 
sigaif ioantly higher (F<0^001) than that in the 
muscle* An almost negligible uptake was seen in 
the eye. 
iilTii'flilffti i iB 
Uptake of radioactivity in the pituitary 
and the various areawi of the brain after 
3 
a constant infusion of 32^S VLQ of H-
norethynodrel. The resul ts are expressed 
as Bl^/mg vet tissue* 
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fhe pituitary shovad a somevhat higher 
uptake than the various areas of the brain (Fig, 4)» 
The hypo thai anus and other areas of the hrain shoved 
a similar uptake which was not sieaifioantly different 
from that found in the museXe* Although the anterior 
and posterior parts of the hypothalamus had a 
s u b t l y higher uptake compared with the middle 
part yet i t was not s i ^ f i o a n t . 
l^ he mamaayy 4andt- The data on the uptake and 
disappearance of Icsf-TB-CAP and i t s metabolites in 
the uterus, ovary, vagina and mammary gland are 
^ven in Fig. 5, I t may be seen that after an i.v* 
injection of lof-^-CAP there Is a rapid uptake, the 
maximal uptake in the uterus, ovury And. vagina of the 
steroid is attained within a period of 5 minutes. 
The level of uptake in the uterus and the vagina 
are almost the same, but the ovary shoved an uptake 
which was much higher than that of the uterus and 
vagina. In the uterus, after the maximal uptake at 
5 minutes, the levels at 10, SO, 60 and ISO minutes 
were almost in the same range. In the case of the 
vagina, there was a decline in the level of radioactivity 
Uptake of radioactivi ty due to ohlormadlnone 
aoetate and I t s metabolites In the uterus, 
ovaryi vagina and mammary gland of r a t after 
a single Injeotlon of 20*0 AIO of Xo< 
oblormadlnone acetate . The results are 
expressed as DMP/mg wet t issue weight* 
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b«tveen 5 and 20 minutes and subsequcoit to that 
the levels were almost in the same range upto IPO 
minutes* Hoveveri in the case of the ovarii there 
vas a rapid decline in the levels of the steroids 
between 6 and 60 minutes| followed hy a slower 
disappearance at ISO minutes. The levels of CAP 
and i t s metabolites in the ovary at a l l time inter* 
vals were higher than those in the uterus and vagina* 
The uptake in the manmiary ^and showed a continued 
increase at the different time intervals studied. 
At 1 ^ minutes when the experlm^t was terminated, 
i t had the maximal uptake. The molar concentration 
of CAP in the mammary gland at ISO minutes was 
3.0 X lO'^M, 
g,BtffliKf M Mf M imu ,U%% Mnr , an4 ,,»tohflX»* These 
three tissues showed a higher level of uptake (Fig. 
6) compared with the reproductive t i ssues . There 
was a continued uptake of the steroid and i t s meta* 
boli tes in the fat for 60 minutes when the maximal 
uptake was attained* Subsequent to that there was 
a s l ight decline in the leve?. of the steroid a t 120 
minutes. In the case of the adrenal, the highest 
mmmJmMtmmm 
Uptake of radioaotivlty due to ohioriaadlnone 
aoetate and I ta metabolites in the fa t , l lvar 
and adrenal of r a t after a single in;}eetion of 
SO.OAIO of l^-nE[-ohlormadinone aoetate* The 
resul ts are expressed as Dm/mg vet t issue 
wolghtt 
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Uptake was noted a t 2 minutes* 1!^ ere was a rapid 
ddQline a t 5 minuted and also between 10 and 60 minutes. 
Subsequent to that the levels of the steroids were 
almost the same between 60 and 120 minutes« tbte 
maximal uptake of 0 ^ was attained in the l i v e r a t 
6 minutes followed by a rapid decline a t SO minutes* 
The levels of radioactivity between 90 and 120 minutes 
were almost the same* 
j:^ vpQtha3^s^8i*» These three neural t issues followed 
an almost similar pattern of uptake and dieappearance 
of %»GAP and i t s metabolites (Fig* ? ) • There was 
a maxima uptake a t 2 minutes | with a rapid decline 
a t 5 minutes followed by a slow disappearanoe for 
120 minutes* Xn the ease of the cerebral cortex and 
hypothalamus I a s l igh t r i s e in the levels of the 
steroids was noted a t 10 minutes compared, with the 
levels at 5 minutes* ?^he uptake of Ti*CAF and i t s 
metabolites in the p i tu i ta ry was s l igh t ly hif^er than 
that in the hypothalamus and the^ cerebral cortex 
a t a l l the time intervals studied* 
the resul ts presented in fig* 8 show that after a 
Fig. 7 
Uptake of radioaotivity due to chlorraadlnon© 
aoebate and i t s metabolites in the p i tu i tary , 
cerebral cortex and hypothalamus after a 
s i n ^ e Injection of 20.0 .uo of lof-%» 
ohlorraadinona aeetate . The resul ts are 
e3E;pressed as £»lP/sig wet t issue weight* 
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0ptak:« of radioactivity du9 to chloraadlnone 
a<$0tate and lts> rii^tabolltes in the various 
tissues of ra t after a constant infusion of 
3 
44*0 jue of lo<- H*chlopiaadlnon© acatate ovor 
a period of S hours• fhe results are expreased 
as JMf/mg wot tissue weight. 
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eonstait- JUifiiBlon. of GAl*|~the - ovary-showed- a muelt 
highei* uptake compared with the uterus i whloh was 
i ta t ia tic ally significant (P<0»01). !Hie molar 
eoneentration of CAP and i t s metabolites vas Sl,4 X 
10 M in the uterus and 6«6 E 10 'H in the ovary* 
!,iirer shoved the highest uptake of al l the tissues 
studiedf followed hy fat and adrenal* fhe concen-
tration of 04P and i t s metaholites in the fat was 
1?(10 M« !l!hese tliree tissues were noted to have 
a hif^er upte^e in the s l n^e Injection studies also* 
fhe pituitary showed a higher uptake 
compared with the hypothalswus and th@ ceretsral 
oorteact the difference | however was not s ta t i s t les i ly 
significant4 
i^tert^Sf- I t may bo seen (fig# 9) that 0#OlAig of 
estradiol pretreatment to immature female mice produced 
a s ta t is t ical ly s i ^ i f i ean t increase in the uptake of 
"U •estradiolI when pretreatment; w4s:,given for 8| 4 
or 6 bourse lit^ hen pretreatment with the sama dose of 
estradiol vas given for e i ^ t hours, i t did not produoe 
fiiiliij I j a 
tJpt^o of nH-estradlol in the mouse uterus , 
af ter pre-treatment "with 0.03, Mg 0Stradiol-17p 
or 0«01«g norethyiaocbfeX for 2,4,6 and 8 hours* 
The ^ - e s t r a d i o l uptake was studied by in^eoting 
3 
2 uc of H-estradlcl 1 hour before saorifioiug 
the animal* Tti^ radioactivity was estimated as 
BBf/mg wet t issue w e i ^ t and expressed as 
peroent of the control• 
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any effect on the uptake of ^-estifadlol in the 
uterus« pre treatment with 0#Ol;ag norethynodi?©! 
for 2^ 6 or 8 hours did not produoa aajr signifioant 
Increase or decrease in the uptake of nK*estradlol« 
However, a pretreatment vlth norethynodrel for 4 hour« 
3 
produced a si^iificant Increase in the uptake of H* 
estradiol. The pattern of uptake of 
after pretreatment with 0*01 >ug of estradiol and 
noreth^odrel shoved similarities in that the maximal 
stimulation is attained when j^etreatment is gliren for 
4 hoars, 
fflB„„IM „WBt{,^Q„„„Qt„ JrQaifr^ d(J^ <i?,,^ H, Jhft „mM^ „Ut}^ m?„i* The 
effect of pretreatment with 0*1| 1«0 and 6*0 ug of 
norethynodrel fo? 4, 8 and 18 hotirs on the uptidKe of 
•estradiol is given in Fig,. 10» l>retreatment for 
4 hours with any of the above doses of norethynodrel 
resulted in a s ta t is t ical ly significant inoreeuie in 
the uptake of '^•estradiol in the uterus* Ifcweveri 
by 8 and 18 hours a decline in the uptake of Tf-
3 
estradiol took place* the H«>estradiol uptake at 8 
and 18 hours after pretreatment with 0*1 and S*0 ug 
of norethynodrel is almost in the range of l^e control* 
3 
Uptake of H-0«ti?adloX la th© mouse uterus 
after pre-treatmeat with O,!, 1»0 and 8#0 
ALg of noTQthynoATQl fop 4 | 8 and X8 hour9# 
the estradiol uptake was studied trjr Injecting 
2t0 jtte of "E-est^adtol % hour before •a)el^ l-
ficing the animalt The radioactivity was 
estimated as HM/mg wet weight and expressed 
as percent of the control* 
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HowQveri p?®tr«ataieat with 3.#0 mg of noretlismoiJrol 
tor 8 aiMl HM hoM^s s t i l l showed a stlisuaatloti of 
uptake of %*estradiol imieh i^ ai sigriifloantly 
hl^oF than the eont]*ol levol. 
the pattern of stlnulatlon of %*estradioX 
uptake aftei* prioliig vith Ot^ t '^•^ ^^ 3*0 ^S of 
noifethyttodffel was stmilai* to l^at presented for the 
pretreatment with OtOl Mg estradiol md O.OI Jttg 
norethynodrel* fhe only noteworthgr difference i s 
that the pretreatnent with 1«0 jag aorethynodrel had 
lasting stiattlatlng effect oa %-estPadlol uptake 
and this oould be ohserved eiren upto 18 hours* 
,g|tiaa3,^ t^ ^n Pf ,%Q8tyftdlo3, ^pt,a^e Va. t^ q ffl<^i^a»t 
H^erys aft?y pr^ y^Q»t?»^ i|^  i 4 ^ ^tte^f1^^% ^oa^B <^ f 
,nQffe^ y^ 9f!|lt^ 3,, ,f<^ ? „4 .M^gftlr »^»» «»*« o^jf *^® effect 
of 4 hours pretreatment with different doses of 
norethynodrel on the uptake of %«estradlol are giiren 
in Fig. 11* It shoved that the maxlaal itimulation 
of %»e8tradiol uptake was obtained with 1*0 XLg 
norethynodrel and doses h l ^ r than 1«0 XL$ pro* 
duoed lesser stiiBulatlon in the uptake of estradiol* 
Pretreatment with 10 xi$ norethynodrel did not show any 
inorease or deorease of ^-estradiol uptake. Hbweveri 
Uptake of ^-ostraaiol la the mouso uterus 
after pre-treatment with 0,01, 0»1, 1,0, 6#0| 
X0*0 and 50,0 Atg of norethynodrel for 4 hours. 
The ^-estradiol uptake was studied by Injeotlag 
2.0 Ais of H-estradiol 1 hour hefore saorlflolng 
the anlmaX, The radloaotlvlty was estimated 
as Dl9i/mg wet weight and expressed as peroent 
of the oontrol* 
3H-ESTRADIOL UPTAKE-*/. OF CONTROL 
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50 jug of norethynodreX. ppoducea a s tat ls t icalXy 
slgalf leant (S»<0.01> decrease In the uptake of 
•'H-estradlol compared with the control* 
MMiM Mim^. M, aUfegf>^ '.^  Amn» ot .,<fM ,M.M^, 
Qptake of V e s t r a d i o l t * Afferent doies of UP i , 
X0|26)S0 and 100 ;ag were intraperitoneailjr admini-
stered to groups of ovarlectoalaed rats^ Three 
hours after the administration of CAP XS.gme of 
6 J 7 - H*estrsdiol was administered to study the 
priming effect of CAP on %h& estradiol uptake. The 
animals were ki l led one hour after the administreu* 
tlon of nEi-estradiol« The resul t s given in Table 1 
showed that pretreatment with 1 jug of CAP for 4 hours 
significantly increased the uptake of H-estradlol 
in the uterus and the p i tu i tary . Kretreatment with 
higher doses of CAP| i«e, 10^ 25 and 50 Jug caused a 
decrease in the uptake of *TI»estradiol in the uterus 
which was s t a t i s t i c a l l y significant only at the 100 4ig 
levels In the case of the pi tui tary also there was 
a decrease in Tt^estradlol uptake after 4 hours pre* 
treatment with 10,25|Sb and 100 Aig df-OAF and this 
was significant only at the 50 and 100 Aig levels . 
The decrease in the uptake of %*e8tradiol was not 
s i ^ i f l e a n t in the hypothalamus and vagina. 
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y a l ^ l t f The restilts on the long terra pretreatment 
with 0»S mg and O.S mg of CAP on the uptake of 
e i t raa io l are given In Table 2« Thesie shoved that 
the uptake was s i e i i f i can t ly deereased'in the uterus 
a t both the dose l eve l s . In the maiamary inland the 
decrease was s ta t l s t lca l l ;^ si@ilflcant In the 0,S ag 
pretreatment group vhUe i t r^as not significant In 
the 0*5 mg paretreatra^t gi:»oup» There wcm no slgnl« 
noan t ^ r re rence in «.e V e . t r a a l o X u p t . e In the 
v a ^ a i dlaphragoi and pl tui t j^y a t the dose levels 
of treatment studied* 
M,Bt#S9 mA ,^mvnmmmM: Mt%%km9^^l mi Srhf 
The study of the uptake of "^-norethynodrel 
and TJ-ehlormadinono acetate in the various tissues 
of the rat after an intravenous injection showed that 
these steroids are taken up rapidly in the genital, 
neural and other tissues of the rat* The steroids 
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in i t ia l l ;^ disappear rapidly folloved by a slow 
disappearanoe from these tissues* I t thus bdcaae 
otovious that a l7o(-ethynyl-19-nor steroid l i ke 
norethynodrel shoved s imi lar i t ies in i t s profile of 
uptake with a 17o(-a)eetocy progesterone derivative 
l i ke chLormadinone aoetate, and in th is respect both 
norethynodrel and ohloriaadinone acetate showed 
s imi lar i t ies to progesterone (liaumas and Farooq^ 
ld66b) which hm also been foimd to be rapidly taken 
up by these t issues and then disappears i n i t i a l l y 
rapidly followed by a slow disappearance. The slow 
disappearance part of the ctsrve indicated some reten-
tion of the progestational steroid and/or i t s meta-
bolites* In contrast to the neural and csenital 
tissues I mammary gland showed a continued uptake of 
CAP upto 190 minutes when the experiments were terminated* 
Fat also showed a continued uptalee upto 60 minutes 
and this was followed by a slow decline upto ISO minutes. 
Thus in the action of CAP i t s storage in the fat and 
retention in tJrc mammary gland may have an important 
bearing on i t s mechanism of action* 
The uptake of GAP or norethynodrel and 
their metabolites in the ovary was higher than that 
t 61 t 
in the uterus aad vagina* fh© molar conoentratlon 
of CAP and its metabolites in the ovary was 6»6 x 
mff 
10 M ¥hich was h l ^ e r than the molar cone en tp at ion 
of S*4 X 10 M in the utemis after constant infusion 
of l<5(-%«CAPt l a fact both single injection and 
constant infusion studies showed retention of small 
amounts of CAP and i t s metabolites in the ovary, 
A similar pattern of retention was observed after 
the administration of^noretfcqmodrel* The uptake of 
norethynodrel and i t s metabolites in the uterus and 
ovary was 5,8 % 10 M and 4.0 % 10*"H respectively* 
In women also, a higher uptake of %-CAP and i t s 
metabolites in the ovary has been found (i:^gwekarf 
Narula and LaumaS| 1973b) • llhese resul ts are suggest* 
ive of a direct action of norethynodrol and CAP on 
the ovary. A direct action of contraceptive s teroids 
on the ovary has been debated C Mozfalusy, 1968)« 
Norethynodrel and other contraceptive steroids have 
been reported to reduce ovarian sens i t iv i ty to 
gonadotropins (France and Plncus, 1964, Purshottam, 
Mason and Pincus, 1961). I t has been found that 
prolonged treatment of rabbits with norethynodrol 
t 62 t 
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„cau«es lnereai«4 Incorporation of 0*0 -^u<so§« 
into l ip ids and proteins of tho ovar^r (Tadara and 
Laumaai 1969)9 thoroby indicating that norethynodrel 
causes a dlsturbaneo in thd usual bloeh^mical ohwig«8 
in the ovary* iifter administration of CAP to women, 
increased urinary excretion of estrogens has been 
found in some cases duggestjngan a l t ^ e d biosynthesis 
of estrogens in the ovary (Larsaon-Cohn j l j ^ . i 1970) • 
Whether CAP» l ike norethynodrel (Yadava and Laumas, 
1969)I causes disturbed biochemical changes in the 
ovary i s not kno«n# Mthoufh the evidence so far 
accumulated in the l i t e ra tu re i s indicative of a 
direct action of the contraceptive steroids on the 
ovary I conclusive evidence for the same needs to be 
provided. 
A high uptake of radioactivity was observed 
in the l ive r and the kidney after the administration 
of ^-norethynodrel or This h i ^ uptake in 
these t issues may be attr ibuted to their metabolic 
and clearance role* Similar high uptake of radio-
act iv i ty in these tissues has been found after a 
s i n ^ e injection or constant infusion of radioactive 
I 63 I 
09tfadiol C^ensdn an§ Jaoobseit| 196S| LatimaBi 1967), 
progdatd?one (l.auMas and Farooqy ld66b, Falk and Bardln, 
1970)I testosterone {^y St* and Launas, 1969) and 
diethylstllbeatPol (Laymas, 1969)• A high uptake 
of padtoaotlvlty in th© adrenal after ^-CAP or ^ -
norethynodrol administration was interesting* I t 
has been found that norethynodrel suppresses the ra te 
of l ip id I WiA and protein sjntthesis in the adrenal 
(Yadat>a sn6. Laumeuii 1969)* Besides norethynodrel 
and C4i>, a h l ^ uptake of estradiol (Laumas, 1967} 
Laumasi 1969)« progesterone (Laumas and Farooqi 1966b) 
ana diethyls t i l bes t ro l iL&ard&M^ 1969) has also been 
found in the adrenal* 
No analysis of radioaotivity was made 
after the uptake te the various tissues* Therefore 
i t represents the to ta l radioaotivity due to norethy-
nodrel or CAP and their metabolites* I t i s not known 
whether norethynodrel or CAP as such would also show 
the samepattern of disappearance* 
the demonstration of an almost insignificant 
uptake of norethynodrel and i t s metabolites in the eye 
indicated that the progestational compound may not 
have any direct action on the eye. The possibi l i ty 
of an indirect action needs consideration. 
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An I n t ^ e a t l a g feature of tha resul t s 
with the uptake studios of TI-CAP was a h i ^ uptaike 
of CAP and I t s metabolites In the mammary gland and 
the fat*« In the mainmary gLand, a continued uptake 
of GAP mi& i t s metabolites vas noted uptb ISO 
i&inutesa suggestive Qt Incorporation and ret<^tion 
of the steroid in the manmary ^and^ CAP has been 
found to cause the deir^opment of nodules in the 
breast of bea^e bltehes <Qoldenthaly 1968, 1069) • 
Howeirerf I t i s not yet knoim how CAP oauses the 
formation of nodules in the breast* The bioohemlcsal 
meohanisms leading to the partloipatlon of the steroid 
in this process i s not fully understood* I t i s 
possible that there are speoies variations in the 
effect of CAP on the mammary ^ m d , as in bea^e 
bitches CAP i s reported to be 43 times more potent 
than in women ( H i l l | Averkin, 3rovn« Gagne leid Segroi 
1970)• On the other hand, prolonged treatment of 
monkeys with CAP for nearly two years did not 
produce any apparent nodules in the breast (Laumas, 
unpublished observation)• CAP showed an i n i t i a l 
rapid disappearance with a half*l i fe of 3*25 hours 
^ t 66 f 
followed tigr a maoh slower (Sis appearance with a long 
half l i f e of the order of 81 hottrs in the plasma of 
women (OugwekaT) Nartaa and tmmaB^ 1973a). fhe 
prolonged half«-life In the plasma explains the 
oontlntted excretion of OAP and i t s metabolites in 
the mUk of laotatiag women for 7 dsgrs or longer 
after the oral administration of 1 o( •*'H-CAP. Tim 
present observation of a prolonged uptake of G4P 
in t&e mammary gland indicated that this tissue has 
a speoifie affinity for ooneentrating OAP from the 
blood and consequent excretion in the milk* I t i s 
possible tliat CAP mii^t have Some receptor sites in 
the mammary ^andf which need to be investigated* 
Squally significant was the observation of 
a high uptake of CAP in the fat. Investigations on 
women have alio shown that CAP is retained in the 
fat (G£LLlegos, Qonzales*>Dlddi| Herino and Hartines-
Mahautou, 1970| Sugwekari Narula and I.aumaS| 1973b>» 
Xn fact storage of CAP in t ^ fat and its slow release 
from there has been suggested to account for the pro** 
longed haQ.f*llfe in plasma and continued excretion of 
the steroid in the urine of women and monkeys (mgwekar, 
Laumas and STarulai 1973a9 and see Chapter lit)* 
I 66 t 
the uptake and dtsappearanoe of CAP or 
norethyaodpel In the pi tu i tary and the hypothalamus 
followed a pattern alaiost similar to that obser^d 
In the case of the genital t i ssues . I t i s well*knowti 
that oral progestins bring about suppression of 
pi tui tary gonadotropins by a negative feed back 
meehanlsm on the lu>rTisone releasing oentras In the 
anterior hypothalamus (Harris and Naftolln, 1970)• 
1!he Increase of eosinophil oel ls end Fj^ reacting 
substanoes smA decrease of p i tu i ta ry weight after 
long term use of eontraoeptlve steroids In animals 
has been Interpreted as an Indirect or direct effect 
of the steroids on the pi tu i tary (Toth, 1964>« ^there 
are reports In the l i t e r a tu re which show that admini-
s t ra t ion of CAP to women resulted In the suppression 
of mid cycle I.H peak (faymor and LeveSque, 1971) • 
I t Is possible that small amounts of GAP retained In 
the hypothalamus produce this effect. On the other 
hand there Is abundant evidence to show tha t norethy-
nodrel In combination with mestranol causes suppression 
In the pi tui tary LH levels In women (Byani Goss and 
Reld| 1966, Bell, Herbst, Krlshnamurtl, Loralne, Hears, 
Jackson and Garcia, 1967) •> No direct evidence of 
teteatlon of CAP OF norethynodijfel in tha t^^thaXaanis 
1« «ivaila%>l0 except that the later pai?t of th@ di»* 
appearmod oiir^e of t^ese stemids in the hypothalamus 
Indloatefi a irer^ slow 4iiappearance which might be 
interpreted as their retentioE in the h^pothalamu$9 
and this nay participate la the aetloa of the 
progestational steroid in the (»S* 
these atwdies showed that priming with 
norethynodrel or GAP stiatilated or depressed the 
H^estradiol uptake depending upon the dose of the 
steroid* Th^ studies with norethynodrel further 
showed that the time of pretreatment with the Steroid 
sd.90 modifier? the estradiol uptake* Pretreatment 
for 4 hours with 1*0 jnz of norethynodrel caused the 
maidmuia stimulatory effect on the ^-estradiol uptake 
while prolongation of time of ptretreatment with 
norethynodrel to 8 or 18 hours did not stimulate the 
I 68 I 
uptake of ^-estradiol. A higher dose of 60.0 M$ 
of norethynodrex produced m. Inhlbltioa of the 
uptake of ^-estradiol in the mouse uteruis. 
Slzailarly^ 4 hours pretreatment with 1 jug 
of OAP produoed etimuXatorjr effect on the uptake of 
%-estradlol in taie pat ttteru» and pituitary, i»hile 
a dose of 100 jag of CAP inhibited the uptake in ho^« 
In l^e pituitary, the uptake of ^-estradiol was 
also inhibited at a s t i l l lower dose of SO Mg CAP 
pretreaf3aent# Xt has been reported that 1 hour pre* 
treatment with CAf in doses of X « 100 jug intravenously 
produced a competitive inhibition of "^-esta^adlol 
uptake (Hosner, Haeome, Dinar! and l>e Carli, 1973a)* 
When l&e CAP pre treatment was esctended to 4 hoU3*s 
as in the present study, 1#0 jug OAF pretreatanent 
produced a stimulation of %*e8tradlol uptake instead 
of the inhibition observed W Sosner ^ j i . < 1973a). 
However, Hosner, apeta, De Perez, Ouerra (197gb) 
observed l^at prolonged trealaaent with CAP in organ 
culture increased ^-estradiol uptake in the rat 
uterus* Of all doses only a h i ^ dose of 100/ Jug 
of CAP produced a competitive inhibition of %* 
estradiol in the uterus and a dose of SO and 100 jug 
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CAP in the pituitary* Thus like noreth^odrelf 
•hort term GAP priming under different conditions 
ft 
inhibited or stimulated H*estradioi uptake while on 
the other hand long term treatment with GAP inhibited 
the uptake of %*e$tradloX in the uterus at both the 
dose levels studied* At a dose level of 0*S mg| 
CAP was also effeotive in inhibiting the uptake of 
K-estradlol in the mammary ^and» 
These results showed for the first time 
that a progestational steroid like norethynodrel, 
not only inhibited the uptake of %*e8tradiol in 
the uterus and aoted as i ts ccmpetltive inhibitor 
but also stimulated i ts uptake* Bisenfeld and 
Axelrod <ld66) using a h i ^ dose of norethynodrel 
(220 jug/100 gm body wel ght) for the priming of 
aniraeas found m. inhibition of H*estradiol uptake* 
They oonoluded that norethynodrel aoted as a oompe« 
titive inhibitor of estradiol uptake* Sauoieri 
Banerjeof Braseau and Husain (1970) shoved that 
administration of 100 Aig norethynodrel per 100 0a 
body weight to rats 15 minutes before and 16 minutes 
after the administration of ^•estradiol produced 
reduction in the uptake of %*estradiol* These 
authors also concluded that norethynodrel produced a 
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competitive inhibition of the uptake of ^-estradiol* 
The present results are in agreeaent with the above 
Studies, ^en a relatively high ^se (SO.O ug) of 
norethynodrel Is used for the pretreatment* the 
findings of stlaiulation of ^-estradiol uptake by 
relatively small doses of norethynodrel have a 
slmllari'^ to some of the earlier reports (T^renlus, 
1965« Laumas, 1967, 19691 Kraay and Hack, 1970) in 
vhloh pretreatment v i ^ small dose of estradiol were 
showi to oause stimolation in the upte^e of %-^  
estradiol by the uterus. I t was seen that 0.03 ;ttg 
estradiol pretreatment for 3- 6 hours {srodueed a 
maximal stimulation of nS-estradiol uptake* 
In the present study, the stlmiilation of 
^•estradiol uptake vtith noretfaynodrel priming may 
be due to two possibilities* Firstly, i t may be due 
to the inherent estrogenic activity of norethynodrel* 
Horethynodrel has been reported to possess 3 - 5 per 
cent (Drill, 1966) or 7 per cent (Edgren, ^ones and 
Peterson, 1967a> of the estrogenic potency of estrone* 
the second possibility may be due to estrogenic 
metabolites of norethynodrel ^loh may be exerting a 
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mild estrogenic effect on the uterus as also noted 
with very email doses of estradiol* I»aynej Qolab, 
Aral and Plncus (1963) isolated VfcK -ethynyl| 19-
noff andi*o»t«4»en©-3pi lOp, I7p t r i o l as one of the 
major urinary metabolite of norethynodrel from voraen, 
which has been found to possess estrogenic ac t iv i ty 
(Blalyi Layne and Mncus, 1965). I t Is possible that 
the mild estrogenic act iv i ty of this metabolite of 
norethynodrel stimulates the uptake of %»0Stradiol 
in the uterus. Tadava and Laumas (1969) studied the 
14 
metabolism of U-C vi^ucose in the rabbit uterus 
af ter prolonged administration of norethj^odrel and 
found an increased rate of synthesis of l i p id , Wk 
and proteins* th is observation further^ confirmed 
the estrogenic properties of norethynodrel and i t s 
metabolites since estrogens are known to increase 
l i p i d , Mk and protein synthesis in the uterus (Ui 
and Mueller, 1963)« However, the mechanism by which 
mild estrogenic act ivi ty of norethynodrel j2§£ ^a^ 
or that of i t s metabolites can stimulate the uptake 
of estradiol i s not completely understood^t The effect 
on ce l l permeability, transport , protein synthesis 
and possible increase in estradiol binding s i tes 
are worth consideringr 
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The resul ts further brought out that 
priming with 0*01 >ag of estradiol for 4 hours produced 
364 percent uptake of H-estradiol when the uptake 
in the control uterus was taken as lOOJ?. A similar 
mai^iltude of uptake of %-est radiol was observed 
with the priming dose of 1.0 ^g of norethynodrel for 
the same period of time* I t thus becomes obvious 
that a priming dose of norethynodrel which i s 100 
times more than that of estradiol produced an effect 
similar to estradiol pretreatment. According to this 
c r i t e r ion , norsthynodrel may be 1,0 percent 1JI 
estrogenic act ivi ty compared with es t radiol , an 
estimate which i s comparable with the ear l ie r reports 
using bioassay procedures (Dr i l l , 1966, Bdfren, Jones 
and Peterson, 1967)• 
CAP is a progestational steroid with no 
estrogenic act ivi ty (Dr i l l , 1966)• Although urinary 
and other metabolites of GAP have not yet been Isolated 
these may not be possessing my estrogenic act ivi ty 
because the parent steroid i s not estrogenic, fhere-
fore the possibi l i t ies enumerated above to explain 
stimulatory effect of norethynodrel on the uptake of 
^ - e s t r a d i o l may not be valid in the case of CAP, I t 
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i8 possible that CAP m&y increase the cell permeability 
and thus contribute to i t s stimulatory effect of ^ -
estradlol uptake in the uterus and p i tu i ta ry . 
3!he9e investigations on the prlmliig effeet 
of norethynodrel and CAP on Ti*estradlol uptake show-
ing stliBulatlon and Inhibition of %-estradiol 
uptake4 point to the faot that these contraceptive 
steroids may be disturbing the norm&O. make up of 
the uterust A very delicate r a t io of estrogen 
and pit>g8»terone is necessary for Implantation* I t 
i s p&ssible that in the presence of contraceptive 
steroids the uterus may become non-receptive and 
prevent iJiplantation« I t has been postulated by Maqueo-
Topete jsil j | ^ % (1963) that CAP produces morphological 
modifications in the human endometrium vhich could 
be held responsible for the failure of implantation* 
fhere are several reports about the mode of action 
of CAP which indicate that i t s primary s i t e of action 
i s not a t hypothalamo-pltultary axis . The tU peaks 
after continnous daily administration of 0,5 mg of 
CAP are not abolished (X«arsson-Cohn ^ ^ . , 1970), 
instaad abortive LH peaks are formed which may or 
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may not toe aocoajpanied toy ovulatory pregaanedlol 
excretion In the urtne (Dloasfalusyi Ooetoelsman, 
Johannissoa^ t i l l lager and ¥ldG| 1969) • This 
c lear ly indicated that the effect of loir dose of 
CAP may or may not be ovulation inhibi t ion. Martlnea-
Manautou ^ ^ « <1966) Indicated that contraceptive 
effect of CAP (0,5 mg dally) i s due to i t s an t i -
esitrogenic effect on cervical mucus while Maqueo-
Topete jal ^ f (1963) s c r i b e d i t to the abnormal 
endometrial changes which prevent implantation of 
the blastocyst, !Eh5 present work supports the view 
that the a n t l f e r t i l i t y action of CAP may be at the 
endometrial level* On the other hand norethynodrel 
alone (Saunders, 1964) or in combination with mestranol 
i s known to act by suppression of ovulation (Ryan, 
Goss and Held, 1966, Bell , Herbst, Krlshnamurtl, 
Loraine, Hears, Jackson and Oarcla, 1967)* However 
in those cases where '•break-through* ovulation may 
take place norethynodrel l ike CAP could s t i l l produce 
a n t i - f e r t i l i t y action a t the endometrial level* 

After «attlQistratlon| titd progdstatlmial 
iteroidi are tak«n up in tlie tltiuos f^on tht ^Iood| 
iieta1)oli2dd in th* bodar and axoreted in tli« isrina 
and faaeea. lamping lastatlcm thasa najr be exo^ated 
in 1 ^ nilk of laotating aothara* iSie (|i»aUon of 
axesfation of proiestationiO. ataifoids and their nata^ 
bolitea in the milk and the possibility of anjr 
biologioaX aotivil^ of tba axoratad pifoduets in tHa 
ffiiXk assnaids great signifioanoe if these drnp are 
used for ferti i itr oontrol during laotation* further^ * 
mora I iaetational amenorrhea i s qpiite a prolonged and 
indefiidte period* I t is estisiated that the mean 
laotation time in some woaen is of t^e order of Id*5 
months (Maikani and Hirehandani| 1960) • I t thus 
beoomes imperative to provide laotating vomen vril^ a 
safe and effective method for oonoeption oontrol« 
The use of progestational steroids is m. effective 
method for fertilitjr control during laotationi hoiraver 
the problem of excretion of these steroids in the mUIc 
and the possibUitr of transmission of these to tho infant 
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being nursed remained to be inireatigated* This 
chapter deali with the excretion of norethjwodrel and 
ohlormadlnone aeetate in the milk of laotatlng votmn 
and goats. The estrogenic aotiv^lty of excreted 
compounds in the milk has been estimated by bioassay 
procedures^ 
Bub.lectt*' The vomm used in this study were indoor 
patients from the Obstetrics Ward of the ^1 India 
Institute of Medical Sciences Hospital* fhe vomen 
had been delivered of s t i l l births* The experiments 
were carried out after day 4 or 5 of parturition* 
Qt^ ai^ Sf The female goats were of a local breed* 
They were housed in air-conditioned quarters* They 
were fed soaked grams, green vegetables and had free 
access to water* 
Bft<(j^ 9'^ l^lffg1> ^,%^r<iXm* 'ShB radio-inert steroids used 
in this study werei 
1> Bnovid (Horethynodrel 5*0 ag • Mestranol 
0*075 mg)* 
I T7 I 
8> ffoffethyaodrel 5.0 mg (17p(-©thyiiyl X7B-
hydrexy S (3.O)-e«tr0ii«3»oa«) bateh Ho, 
MA*Q«^ 24« Bstpogen free itorethynodrel was 
provided by &r» Vie tor I>rlXl of 0»Bt Searle 
(& Co#f Chicago• 
3) Chlormadiiione acetate 0.5 ©g (6*-0h3Loro-l?«f-
hydwixy |B»ega«»4*6-dieae 3,20 dlone acetate). 
4) Megestrol acetate S»0 ag (6*methyl*17o( • 
hydroxy pregft-4, 6»dl0n<3e«3|2O dlone acetate) 
?li«>My^ 1s^ m^ y^Qlf Vaorethysiodrel was obtained as 
mentioned on page 41*43 ot thle thesis* The HHi-
norethynodrel was mixed with radio-inert norethynodrel 
whenever necessary. It was filled in gelatin ©apsiales 
and administered orally at 0 a«m* I»rlor to the admini-
stration of women received Enovld 
C6«0 iig tablet) for two days, 
?II'*g^ ffiCTaa3i.mil,^  ftq§^at^ir 1«-^»GAF was supplied by 
Dr, Heokt Iiukarif E. Kerok, Oarmstadtf W, Germany in 
the form of tablets containing $0 juCi chlormadlnone 
acetate per 0#5 rag tablet* \ebman were orally admini-
stered tablets containing ^-CAP| \^ile in tim case 
of goats I each tablet was suspended and dissolved in 
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0*5.an olive oil m& fed to them throu^ a stomaoh 
tubea Both voaen and goats vera pretraated with 
radio*inert steroid (0*5 rag dail^ r) for 3 * 4 dears 
and on dajr five OAP was administered* 
gQlleetion of milk settlest* Milk samples from 
women vera oollected 4 hottrl^ r during tlie daf for a 
period of S - ? da^ St In the ease of goats the animals 
were milked in the morning and the evening* 
In studies on the detection of estrogenie 
aetivit^r in htiman axiA @oat milk after the administra* 
tlon of oral progestins| the human or goat milk was 
expressed twioe dall^ at 8.00 a»m« end 8*00 p«m» 
for 3 daj^ s. Ilhe milk oollected for three days hefore 
the administration of the drug was labelled ••Control 
milk*** For the following three days oral gestagens 
were administered and t^e breast milk was again 
escpressed twiee daily. This milk was labelled as 
«Post gestagen Milk". Estrogenic activity was assayed 
in IS specimens oollected from each subject (human 
or goat)* 
Estimation of radioactivity in the mil,ki^  In the 
earlier experiments, radioactivity in t^ milk was 
T\AO\ 
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estimated by adding aa equal volume of lOjt trlchloro* 
aoetl« acid to precipitate the proteins* The super-
natant was then added to dlotol sc in t i l l a t ion l iquid (10 ml) 
and counted in a Liquid Sc in t i l l a t ion Spectrometer 
(paokardj Model 3314) • The precipitate was soluhlllzed 
i n hyamine hydroxide and counted as usual« Quenching 
corrections were carried out with an internal standard* 
Snhseguent investigations In the development 
of a rapid and an accurate procedure for the estimation 
of radioactivity iai the milk led to the use of a method 
in which 0ii3 nil of the raUk was dissolved in an equal 
volume of 10^ KOH* 15 ml of diotol sc in t i l l a t ion 
l iquid w«i8 added to each sample and the samples were 
counted as usual« Both the methods gave comparable results* 
Counting radioaeti^itys'^ Diotol sc in t i l l a t ion l iquid or 
simple so in t i l l a t ioa l iquid was used for counting of 
samples as described in Chapter X« 
,gff^ B«ff^ UmnfflX,ffU^ ffl^1?gW^|8,l" ^v studies on estrogenic 
ac t iv i ty In milky the to ta l quantity of milk In each 
specimen was refluxed with an equal volume of alcohol 
for 30 minutes and was centrifuged at 2000 r*p.m. for 
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15 minutes, llhe residue vas discarded and the 
supernatant was concentrated under vacuum to half I t s 
volume* Milk proteins vere precipitated \dth acetone 
and centrifuged. This was repeated 4 to 6 times un t i l 
the supernatant was clear and free of proteins* The 
supernatant was then evaporated to a volume of about 
2 ml. I t was transferred to a v ia l smid dried under 
nitrogen, Bie residue was dissolved In 0 4 ml olive 
o i l , 
Bioassay for estroftenic act ivi tyi* Both the "control 
milk'* and wpost-gestagen milk* specimens were assayed 
for estrogenic act ivi ty l5y the uterine we l^ t response 
in thd immature mouse (Mgren and Calhoun^ 19SS^). For 
the study of control and post-gestagen Speelmeny 6 
mice welding 6 - 8 g were used per group, !I7he milk 
extract of each control or post-gestagen milk specimen 
wad dissolved In 0.6 ml olive o i l and was administered 
a t a dose of 0,2 ml/mouse/day for 3 days either W 
injection or by gavage, Jbitopsles were performed on 
the fourth day; u t e r i were wel0ied on a Holler Smith 
torsion balance. The body w e i ^ t of th# mice was 
determined. A s t a t i s t i c a l l y s ig i l f leant increase in the 
uterine w e l ^ t In th<i post« gestagen group as compared 
to the control group was considered as an Index of 
estrogenic act ivi ty . 
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tkm excretion of radioaotlvlty In the milk 
due to ttoipethynodrel and I t s metabolites after the 
3 
administration of H-norethynodrel to laota t lng women 
la presented in fable I , I t may be seen that after 
the administration of different amountsof radioactlir^uy 
noretl^^odrel containing varying amounts of the iner t 
s teroid , the percent radioactivity coming out in the 
milk ranged from 0*45 to 1«S@ par cent. On an average 
1»1?8 of the administered H-norethynodrel was excreted 
in the milk over a period of five days* 
The dally pattern of excretion of radioacti* 
v i ty in the milk of patients B,K,, S*B,| 0«I>. and L*S. 
are presented in Figures 1, 2, 8 and 4 respectively* 
Table I I gives the percent excretion of radio-
act iv i ty over a period of 6-7 days in the milk of 10 
laota t lng women after the oral administration of 50 juo 
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lor-*'H-CAP, fhe volum© of milk of different patients 
i s also shown in the Table and presented in the 
descending order* I t may be seen that linemen yielding 
h i ^ e r milk volume shoved higher exoretion of steroids 
in the milk while low excretion of radloaet ivl ty in 
the milk was found in women having low yield of milk* 
Patient H*A.« had a to ta l milk volmae of l,54d«0 ml 
and the radloaotlvlty excreted was 1»0S per cent of 
the administered oral dose* On the other hand the 
lowest araotmt of radioactivity excreted in the milk 
of patient A*&* was 0,164 per cent with a to ta l milk 
volume of 180*0 n l . 
Details of the daily excretion of radioactivi ty 
and the dally milk volumes of the 10 women are shown 
in ^igs» S) 6 and 7* I t may be SQen that in general» 
the volume of milk had a profound effect on the anKtunt 
of radioactivity excreted in the milk« The amount of 
radioactivity was direct ly proportional to the volume 
of milk obtained* Vfherever the milk voltime was low or 
high the excretion of radioactivity followed the same 
pattern. 
Since some of the women in the group did not 
have ati established l ae ta t ion | repeated expression of 
mmmmmiSLmmiat 
fi Mft Patient*8 Xotal Milk Baaioact lv i ty % 
" • « " • BJaiag Vol.Craiy Oral BoS© ®EC. 
1« H*A« 
2 . B«D, 
B«Xt« 
4 . S«A# 
5 . sa . 
6 . . J.w, 
7 . s«s« 
8 . A«D« 
9 . M»* • 
1 0 . A»S, 
MIIMMlM«HM>4HHir-r^ 
1546,0 1.05 
610*5 0,696 
S04«0 0.485 
517.0 0.45 
370^0 0.331 
360.0 0.25 
392.4 0.24 
213.0 0.185 
134.0 0..ta4 
1B0#0 0.164 
Average 0.38 
Fattorn of excretion of radioaatlvlty In the 
milk of four lactatlng women, S,l*«, B#Ii., A#Dt 
and M#J, after th® oral administration of tablet 
3 
containing 60,0 ^c of I P T - H-eWLoi'madinone acetate, 
The resijlts are expressed as percent excretion of 
the to ta l dose administered* 
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miXk tdth the help of a breast pump resulted In slight 
Inorease in the volume of milk on day 4 and S aftex* the 
adminlstratlosi of %^hXo,.adin,ne ».tat,. Ihls resulted 
in a oorresponding inorease in the exoretion of radlo*^ 
aetivity in the milk* 
Another interesting feature of the results was 
the fact that the lovels of radioaetivity in the milk 
due to CAP and its metabolites did not decline oompletely 
even by 6 th or 7th day* 
Three goats were administered ^-CAP and milk 
samples were oolleeted for a period of S*6 days* fhe 
amount of radioactivity excreted in the milk over a 
period of 5*6 days was 0*68^, 0*319 and 2*80^ for goat 
No* I, II and III respectively as shown in fable III* 
Table IV gives the analysis of estrogenic 
activity in the milk of ^even women, after the oral 
administration of Enovid^ norethynodrel and chlormadlnon* 
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aoetatQ* When lieiovid vat administered to 3 voaen 
eatrogenlo activlt^r was found in S vomen H«K* and B*B» 
as shovn toy a s i gaifleant Inoareas© (PCO^OI.) In the 
weight of Immatuife mouse uterus . 
After the administration of norethynodrel to 
s ix woment milk extrast of two women (A*N« and KK,) 
caused a significant Increase (P<0.01 aaid P<0*08 
respeetively) In the uterine w e l ^ t of Imaiature moiiae 
indicating thereby the presence of estrogenio act iv i ty 
in the milk of these two women. No estrogenio act iv i ty 
eould he detected in the milk of other four patientsi 
S*l., M.J#, V.W. and S,S. 
The milk extracts of two women ft«E« and S»Y« 
processed after the administration of CAF did not show 
any estrogenic ac t iv i ty . 
Four goats were administered norethynodrel 
(S«0 mg> dally. The control and post*gestagen milk 
samples were assayed for estrogenic ac t iv i ty . The 
resultsCTable V) showed the presence of estrogenic 
ac t iv i ty in the milk of 3 out of 4 goats,» One 
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was adialziistered 5^0 mg megast^ol aeetate* the 
po3t>g33tae0n milk extraot of this goat did not 
slgnifioantly increase tba vdii^t of iivnature mouso 
uterust thereby indicating the absence of SB^ 
estro genie aetivitjr in the milk* 
The results revealed that progestational 
steroids and their metabolites are exc3?@ted in the 
milk \^en administered during lactation* I t vas 
found that after the administration«^-norethynodrel 
on an average 1*1 per oent (range 0*45 to 1*5S^ 
of the administered dose was excreted In the milk 
as noi^ethynodrel and i t s metabolites, thus 1*1^ 
excretion of the steroid, vhen calculated on the 
basis of 5,0 mg of norethynodrel injj^ovid tablet 
vould mean that 55.0 ug of noretliynodrel and i t s 
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ittdt&bd}.ltes (assiunlng the moleoular weight of the 
metabolites Is approximately the sam^ as that of 
norethynodrel) are excreted in the breast nlik* 
This i s quite a s i ^ f l e a n t amount of the steroid 
and i t s metabolites but i t Is not knoi^ whether 
the l a t t e r represent biologicall;ir aotive or inactive 
compounds* 
The studies on the excretion of chlormadlnone 
acetate and i t s metabolites in the mills of 10 lacta t lng 
women showed that on an average 0*38 per cent of the 
administered dose (range 0*124 to 1*05^ was excreted 
in the milk after the administration of a table t 
containing SOO jtig of %-GAP* 4 direct relationship 
between the volume of the milk and the amotmt of the 
steroid excreted in the milk became evident* The women 
yielding higher milk volume excreted h i ^ e r lUQonnts of 
s teroids , while the women having lower volumes of milk 
excreted lower amounts of s teroids. Such a conclusion 
was further supported by the data on the excretion of 
''H-chlormadinone acetate and i t s metabolites in the 
milk of goats where the h l ^ milk yielding goats excreted 
higher amounts of H-GAP and i t s metabolites* This 
suggestion was also obvious when dally milk samples of 
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women and tii& amount of steroids excreted in I t vere 
compared* These resists^therefore^lead to the 
suggestion that a woman yl<^dlng higher amounts of • 
silkoKfity ttmtth^wtlBk of exoretlag higher amounts of 
steroids In the mlXk» And Suoh a high milk volume 
®ay have higher proportion of blor.ogically active 
8ubston..<si8» 
The data on the exeretlon of chlormadinone 
acetate in the milk showed that the radloaotlvlty due 
to CAP and i t s metabolites, did not deollne by f i f th 
and sixth day after the oral administration of one 
tablet containing 0«@ mg %«C4P» I t thus indicated 
3 
that H-CAP was possibly stored in the body and was 
getting slowly released into the plasma and thus excreted 
in the milk. Other work carried out In this laboratory 
showed tha t chlormadlnone acetate has a long hal f - l i fe 
of the order of 80*1 hours In the plasma of women 
(Dugwekar, Nainala and l,aumas, ld73a) and of the order 
of 35.1 hours In the plasma of monkey (Chapter I I I ) . 
I t was seen that CAP showed a high uptake in the fat 
(Chapter I) of the r a t . Similar results on the h l ^ 
uptake of chlormadlnone acetate In the fat have been 
reported in the women (Gallegos s3k^»t 1970, Bugwekar 
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^ t J^>f 1973b). I t thus led to the <sonQluslon that the 
CAP was stored in the fat and was slowly released Into 
the blood and from the hlood i t was eontlnuously exoreted 
in small amounts in the milk over a number of days4 This 
explained the reasons for the observation that the 
levels of chlormadinone acetate In the milk did not 
deoiine by five to six days after the oral admlnlstra^ 
3 tion of R«ohlormadihone aoetate« I t has been shown 
that the mammary gland takes up hormones» antibodies, 
minerals and other chemical constituents from the blood. 
(Linzel^ 1969}« fhe prolonged hal f - l i fe of norethyaodrel 
<I,aumaS| Murugesan and Hingorani, 1971 and CAP (Chapter 
I I I ) in the plasma showed that these steroids were 
available in the blood to be taken up by the mammary 
gland and excreted in the milk. tOie progestational 
steroids and their metabolites may not be jus t lying 
absorbed in the mammary ^and but may be bound to 
receptor proteins* Sinae retention of CAI> in the 
mammary gland has been found in the other studies 
(Chapter I ) , i t i s possible tjiat the milk proteins may 
have a higher aff ini ty for the progestational steroids 
and i t s metabolites, and thus h i ^ e r volumes of milk 
having more amounts of milk proteins may be able to 
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remove more of the steroids from the mammary glands 
Into the mllk« the women yielding h i ^ e r amotints of 
milk e:ccreted h i ^ e r amounts of steroids in the milk. 
I t suggests that the h i ^ e r amounts of milk or the 
milk ijroteins may be able to remove the correspondingly 
higher amounts of steroids bound to the receptor-
proteins in the mammary gland and thus exorete them 
in the milk of women yielding high amounts of milk« 
The question of th0 biological ac t iv i ty of the 
excreted steroid and i t s metabolites in the milk i s of 
considerable practical importance when women taking 
progestational steroids for f e r t i l i t y control breast feed 
the baby at the same time because i t i s possible that 
the active metabolites of the administered steroid 
excreted in milk may exert biological effects on the 
infant I i t i s known that extremely small amount of estrogens 
(Jensen and Jacobsoni 1962} Stone and Martin, 1967{ 
Laumas, 19671 1969) and progesterone (Lawson said Pearlmani 
1964f Laumas and Farooq* 1966b| 1967) ape taken up by the 
target t issue when physiologic doses of these hormones 
are administered. These findings are corroborated W 
the reports in the l i t e ra tu re about the effects of 
stelsoids and their metabolites which are transmitted to the 
infant through milk* (Curtis (1964) reported gynaecomastia 
in a male infant vhose mother was taking Bnovid and 
at the same time feeding the infant. Vaginal changes 
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resembling those after the administration of estrogen 
vere seen in ehildren whose mothers were breast feeding 
and at the Q6m& time taking oral contraceptives (Lauritseni 
1967) • Breibart, Bonglovani and Eberleln <1963) have 
observed advanced skeletsd development in 5*6 breast-
fed infants whose i!K)thers were taking l^anone (r7<f-
ethynyl testosterone) or Horlutln (17«f*ethynyl-17 
hydro3qr-4*0Stren-3-on6) as oral**contraoeptive* 
fhe present res ta t s showed that the presence 
of estrogenic act ivi ty can be demonstrated in the milk 
after the orsa administration of some oral contraceptives* 
Enovid which is a combination of a progestagen (norethy** 
nodrel) and an estrogen (mestranol) was administered 
to three women and biological ac t iv i ty was demonstrated 
in post-gestagen milk of 2 women* Ifftiether the estro-
genic act ivi ty was due to both the components of the 
Bnovid tablet viz* norethynodrel and mestranol needed 
further evaluation. I t has been reported that mestranol 
hai low metabolic clearance rate and a prolonged half 
l i f e of the order of 40-60 hours (Wl^menga and van der 
Molen, 1969) and i t is excreted In the milk (Abdel-
Assiz, Blalyi Keith and Williams, 1969)* Xt i s thus 
possible that the observed estrogenic act ivi ty In the 
milk after the administration of Biovid may either be 
I 91 I 
du© to mestranol or norethjrnodpel and I t s metabolites or 
<3ue to both* In order to t e s t this point experiments 
vere oarried out where norethynodrel alone was admlnl»» 
stered t» women and estrorenlo act ivi ty of the milk 
was tested* In these experiments astrogenlo act ivi ty 
was detected in the milk of two out of a group of six 
women* The variations in estrogenic act iv i ty found 
in the milk of women aamlnistered norethynodrel may be 
due to varying amounts of the steroid and i t s metabo-
l i t e s excreted into the milk« lioweveri no correlation 
of the estrogenic act ivi ty with the amount of milk 
could be established. On the other hand estrogenic 
act ivi ty could be detected in the milk of 3 out of 
4 goats I who had been administered norethynodrel* I t 
thus appeared that the volume of daily secretion of 
milk which i s much larger in the case of goats may have 
an effect on the excretion of norethynodrel and i t s 
metabolites in the milk* Norethynodrel per ^ has 
some estrogenic act iv i ty (Dr i l l | 1966)* l7«<-ethynyl 
19 norandrost*4»ene 3B, 10B| l7B- t r i e l | which Is a 
metaboltte of norethynodrel has also been shown to 
possess estrogenic act ivi ty O i a l y ^ ^ * , 1965). 
I t i s possible that unchanged norethynodrel or any of 
i t s astrogenij? metabolites may contribute to the estrogenic 
I 92 t 
activity fonind in t2i8 milk* !lllia estpoeenie aotiiritar 
detested la the milk of ^ e t«o women after the 
aiSminletratlon of noretlgroodlrel %» hoveveip slgaifleantf 
fhe eetpogenlo adtlTitjr viui estimated Iggr 
three Asy immatare mouse uteriite velght asea^ r* The 
milk extraoti were injeeted into tlie mioe in 9ome 
experimeata \^i3.e in other ea&periments these were 
ottlXt aaninistered to the.mioe airnia^tlng a situatloii 
as i t preiraUs in praotioe of a hreas% feC infant* 
Bielf ^ Il3hf <3.d63> haire shown that the metabolite of 
noretl3^noarel possessing estrogenie aotiirltjr iri$« 
l?of-eth3Wl-19*aor aiidro8t*4*ene»3j8»10 ,^ l?p-triol 
i s aetiire %gr hoth injection and oriO. route* 
Pinoos^ BialiTf I*a3rne| paniagna and Williams 
(1966) did x»it find aaar estrogenie aotivitr ia the 
milk of Xaetating women after the oral administration 
of norethynodrel and etl^odiol dlaeetate. Bowever, 
the plan of assay of estrogenie aetivit^r used hy 
these authors differed from l^e present in'vestigation* 
pincms ^ j^^, (1966) injeoted onljr half the milk 
extraot to a mouse while in the present investigation 
the total extraot from i milk sample was administered 
to 1 mouse* AUdel^ A^sis ji^ ^ , (1969) have shown that 
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me«tranol and van der Molen ^ j i » (1969) have shown 
that lynestrenol are also exoreted In the milk of 
lac ta t lng vomen« 
% l l e the data dlseussed abovd related to the 
analysis of estrogenic aet lvl ty after the administra-
tion of progestational steroids which were derivatives 
of 19*nor s teroids, I t remained to b© seen whether 
progestational s teroid* ¥hiah are derivatives of l7of • 
aoetoxy progesterone gave ris© to any estrogenic ac t iv i ty 
in the milk. Chlormadlnone acetate and megestrol 
acetate per jp have no estrogenic act ivi ty and an 
evaluation of the estrogenic act ivi ty of thei r meta-
bolites i s not yet available* Administration of chlor-
madlnone acetate and megestrol acetate to lac ta t lng 
women and goats did not give r i se to any estrogenic 
act ivi ty as aass^ed by immature mouse uterine weight 
method* 
A number of factors may contribute to the 
passage of contraceptive steroids Into the milk and 
the significance of the observed estrogenio act iv i ty . 
The amount of the steroid and i t s metabolites passing 
into milk depends upon the quantity of the milk and 
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the half-llf© of the steroid In the plasma, vhlch 
will indicate the duration of time for which the steroid 
IS available in the plasma for exeretibn. into the milk, 
Furthspfflore the rates at which the steroid and i t s 
metabolites with progestational or estrogenic ac t lv i t l eS | 
present in the blood are excreted into the milk may 
together contribute to the final ra t io of progestational 
and estrogenic act iv i ty in the milk# I t is also possible 
that p3?ogestational effects may be antagonized by estrogens 
and estrogenic effects inhibited by progestins and at 
times there may be certain ^ t en t i a t l ons (Edgren, 
Jones, Peterson and Qtllen, 1967)• Other pharaaeolo* 
glcaX ac t iv i t ies l ike the progestational or androgenic 
ac t iv i t ies of the steroids excreted in milk also need 
evaluation* 
The presenyfindinpt thus lead to the conclusion 
that there Is some possibi l i ty of transmission of 
estrogenic act ivi ty to the breast fed infant of a mother 
taking those pr'ogestational steroids which possess 
estrogenic act iv i ty or are used in cowbinatlon with an 
estrogen. On the other hand, the administration 
of oral progestins which are derivatives of 17c( • 
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aeetoxjr pmm^tevQsm aagr not reaiilt in t%6 ttfins* 
mission of estrOgenio aetivitgr to tlie breast fed 
infant* fhd latter oategofjr of ppogastational 
steroids ootxld ttsxm h& considered for fertil ity 
oon^ol daring iaotation* ^rther studies need to IM 
carried out to sear oil for a iiro gestational steroid 
vhioh will not res^t in t ^ transmisaion of angr 
progestational and astro genie aotiirity to tbt ^east 
fed infant* 
MsfAaoLisM eg pmQESTAfiQiSM.smmim 
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After adninisttatloiii t ^ pji^ofastatioaol 
•tevoidi hriMg alxmt their action tme iietal9oli2«d 
in tb« t»d4sr m^ then exordteA l^ r different routes 
like sweatf stiXk| urine end faeoes* fhe rate of 
disappearanee of the steroid in ^ e Mood refleots 
the rate of netaholism in the hoa^ r and a stndr of 
urinarr fietaholites voiild shov ^ e different 
setaholie alterations that the steroid noleoule 
has nnderione in the hod^ * In the previoiis ohapter 
a stndr of t^e excretion of the progestational 
steroids in the milk was presented* Ihe present 
chapter deals vith m investigation into the dis* 
appearanoe in ^e hlood and urinary excretion of 
the steroids after the administration of lo(-%-
ohlormadinone acetate to sonkesrs* Honker has heen 
ohosen as the experinental aniaal in this stndsr 
hecattse toxicity studies for progestational 
compounds are usually carried out on three dif* 
ferent speoies ot ani»alS| out of vhioh monkey is one 
such speoiesp Furthermore, i t i s generally considered 
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that monkey Is very close to the human species la 
i t s nerirotis and endocrinological hehavlour. I^ls 
makes the monkey a -very useful species for invest i -
gations of the metahollsffl of the progestational 
steroids and correlation of the resul ts with data 
from other animal species on one hand, and at the 
same time extrapolation of the Information to the 
human* This chapter describes the metabolic fate of 
lyS- H*c}ilormadlnone acetate In the plasma and urine 
of female monkeys* In part lculari the plasma dls* 
appearance curve has been analysed mat hematic sCLly to 
calculate the metabolic clearance ra te of the steroid 
and a study of I t s pattern of urinary excretion i s 
presented* 
MATERIM.S AND METmCS 
Anlmi^st* Adult female rhesus monkeys were purchased 
from T.B* Patterson & Co,» Hew Delhi, These were 
housed in air-conditioned quarters and fed on pel let 
diet manufactured by Hindustan Lever, Bombay. The 
animals were given water ^ libitum and were followed 
for their menstrual cycle by taking dally vaginal smears* 
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Those animals i4iioh were reguXarl;^  enroling onA had 
an avdrago mdnstrmaX cycle of 28 ^ 3 dajrs were 
chosen for the studio* 
^niedtion aQlutloni" l^ S-'^ H-ohloMaadliione acetate 
(speolflo aotlviV 2S2;ao/ag) waa kindly provided 
W !3P« Karl H. Kimble of S» Herokf Daiftastadtt 
i^ « Q&rmmsr* SS^Q tio of %«ohloriBadinone aoetate 
were dissolired in 5«D isl of 10^ ethanolie saline and 
injected intefairenoualy to eaoh monkey* 
g^ood a^ d urp&e eolleotioni^ After the injection 
of WtkQ radioactive steroidf blood samples were 
eollected at l^e intervals of 10 mini 30 min» 1 hr^  
4 hrS| 8 hrs, 24|hrs, 48 hrS| M hrs and ISO hrs in 
heparinlsed tubes* !l3ie i^ asma was separated from the 
red cells by oentrifagation« fhe steroid and its 
metabolites were extracted from l^a red cells and the 
plasma samples as described below* 
BKtraolpiQn and separation of steroi^st^ After centri-
fugation of the blood samples, the radioactivity due 
to 1,2»TI-CAP was extracted separately from plasma 
and red cells as per the method of fearlman ^ j^» 
(1968). Hie plasma proteins were precipitated and 
radioactivity was extracted with acetone* To each 
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sampld, two irolumes of aeetone >)ere added «aid It 
vaB shakea tho>ou^3r* ISie iiample vaseentrlfuged 
and the 0Xdax> supernatant was separated* 3!Sie same 
proeedare vas repeated ^iriee with aeetone and tvioe 
with methanol eash time using the same amount of 
the solvent* fhB supernatants were pooled| the 
volume of the pooled extraet vas measured and a 10 
per eent aliquot vas taken for radloaetivitf oount-
Ing. Hie aeetone-methanol extraot represented the 
total radloaotivit;^ eontaining hoth free and eon^u* 
gated steroids* lb separate the free radioaetliriV 
from the conjugated, the remaining 90 per oent 
aoetone-methanol extract vas redteieed in volume to 
about 5,0 ml and made upto 20*0 na h^  adding dis-
til led water, fhis aqueous phase vas extraeted tls^ee 
times vith solvent ether to separate free steroids, 
Saoh time» the volume of ether used vas douhle the 
aqueous phase, ^ e ether extracts were pooled 
and an aliquot vas taken for counting of free 
radioactivity, the remaining ether extract vas 
dried under nitrogen. 
After the separation of the free steroids, 
the aqueous phase vas extracted vith hutanol for the 
conjugated steroids* Extraction vas carried out three 
times, each time the volume of n-hatanol used vas the 
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aame as ^ a t of the aqueous phase, fhe pooled n-
Imtanol ^ t r a o t s oontaiaied ^on^ugated radloaetivltgr 
due to the eonjiigated metabolites of ohlojfmadlnone 
aoetate* An appropifiate ali<;uot vas taken for 
radioaotivity detei^mlnatloti. 
Separation of tr&& radioaotj.irfty AS ahloraadinone 
MMM&S^* ^ e ether extract remaining after taking 
an aliquot for counting was dried under nitrogen gas 
and spotted on a thin isQrer s l l i oa gel chromatogeaphsr 
platei along with pure ohlormadinone acetate standard. 
1?h0 solvent system used was benzene i ether ( 1 t 8 >. 
After the plate was run in the solvent system, ttoe 
spot due to au^ent ie CAP was located under u l t r a -
v io le t l i ^ t . IJhe area oon-espondlng to the standard 
and 1 om above and below was seraped out and thrioe 
extracted for radioactivi ty due to cKLormadinone 
acetate with chloroform t methanol ( 1 » 1 ) • The 
extracts were pooled. Out of the pooled extraoti an 
aliquot was pipetted out for estimation of radioact ivi ty 
and the res t was used for c rys ta l l iza t ion . 
GPVStalligation of GAP to oot^stant apecifio ao t iv i ty i -
The radioactivity obtained as CAP from each i^asma 
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sample or red eelXs of a monkdy VB9 pooled, dried 
and dissolved in S*0 ml aoetone. Crjrstalllzation 
was carried out aeeording to the procedure deserlbed 
by Axelrod, Mathl^esaeni Qoldaleher, and Pulliam (1965) 
with slight modifications* iluthentic chlorMadinone 
aeetate 10*0 mg was added to the eluate containing 
radioactive CAP to act as carrier and dissolved in it. 
The specific activity of the steroid in solution was 
determined lay taking an aliquot for counting and 
another aliquot for determination of s teroid content by 
measuring the optical density at 'SBS iqu, in a Zeiss 
spectrophotometer* The solution was then filtered 
throu^ a sintered ^ass filter funnel under vacuum 
and used for crystallization. The solvent pair used 
for crystallization was acetone and pentane* The solution 
was dried under nitrogen gas to half the volume and 
then heated* Fentane was added drop by drop till the 
solution became cloudy* As the mixture cooled, the 
crystals started to separate* The tube containing the 
crystals imd the mother liquor was centrifuged and the 
mother liquor was decanted in a separate clean tube«( 
The crystals were dissolved in acetone and an appropriate 
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aliquot was taken for <x>untlng and for optical density 
measurement In the speotrophotonteter. Similarly allquota 
were taken from the mother l lquoP| for counting and 
for optical density measurement. The ra t io between the 
steroid content and the radloact t r i ty both in crystals 
fitfid mother liquor gave the speelfic act ivi ty of the 
steroid. The crystal l izat ion was repeated 3 times 
using the same procedure• 
, ^ tm<?n9^ ,.ffl4„.s,^ p .^% ,^iffi,n„.ff^ . 3,t;g?ap(i(|p M Minn,* ^ t e r 
the intravenous infection of Ifa-^-ehlormadinone 
acetate to monkeysjurina was collected daily for the 
f i r s t five days and subsequently a 24 hour \irine ss«npl© 
was collected at weekly or monthly intervals' upto 2-3 
months* Sech 24 hour urine sample was processed for 
the separation of free and conjugated radioact ivi ty . 
The free radioactivity due to the steroid and i t s 
metabolites was extracted twice by using athja acetate, 
volume to volume of urine* Ai'ter extraction of free 
radio act ivi ty I the urine WGUS extracted twice with n* 
butanol for conjugated radioactivity. The volume of 
solveaat used was equal to that of the tarine samjple* 
Appropriate silquots were taken both from the e t l : ^ acetate 
extract as well as from the n-butanol extract for the estima-
tion of free and conjugated radioactvlty due to steroids 
excreted in the urine* 
©pyst^tlliaatlon of ^-ehlosffladlnoae 
^ aoetato to ootistant speelfle activity 
Crystals Mother liquor 
C^ tt/tag Cpn/ng 
l8t orystallizatloii 542 771 
2nd orystallizaticm 501 516 
^ 4 oi^srstailination 481 534 
t 102 s 
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Hatm^ digappeagaaee^ of JLy8>% e^hloriaa(Iittone aeetate 
and i ts matabolltest* After an intraveiious inj action 
of ^-ohlormadlnone aoatata to four different monkeys 
numbered 7| 8, 9 and XO^  the blood damples were 
oollected at different intervals. Bie blood was 
separated Into plasma and red cells* !!!}iese samples 
were anal^ rsed for total radioaotiyltar due to ohlor^ -
madlnone aoetate and its metabolites, fhe total 
tadioaotivi'^ was further separated into free radlo* 
actlvity and oonjugated radloaotivity* The free 
radloaotiv-il^ %nis ehromatograplied on thin layer saates 
and analysed for radloaotivity speeifloaliy due to 
ohlormadinone aoetate* The «Kperlments thus permitted 
the measiu?ement of the levals of radloaotlire ohlor-
madinone aeetate as such, after on intravenous 
inieetlon of l,3»%«ohlonBadinone aoetate to monkeys. 
Figures 1, S, 3 and 4 give the analysis of 
radioaotlvlty into total, free and oon^ugated radio-
aotivity and radioaotlvlty present as ohlormadinone 
aoetate, after axi Intravenous injeotlon of 1,2**%* 
ohlormadinone aoetate to monkeys Mr 7, 8, 9 and 10 
respectively. Fig, 1 showed that total radloactlvltgr 
Fin?., .1, 
Disappearance of nS-cWlormadinona acstat© in the 
plasma of monkey M»7 after ssi intravenous Injeotion 
of S$,0>uo of l,2«Ti*chloraadlnon0 aoetate, 
TtkQ r a d i o s t t v i t y in the plasma due to 
ohlormadinon© acetate and i t s metabolites has 
been analysed Into t o t a l , free and conjugated 
radioactivity* The free radioactivity has been 
further analysed for radioactivity speolfloally due 
to chlormadinon© aoetate as sueh< 
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due to chlormadinone and i t s metabolites after an 
intravenous injection of 1|2- H-ohlormadinone acetate 
to monkey M-7 disappeared i n i t i a l l y rapidly upto a 
period of about 4 hours* Subse<|uently i t disappeared 
rather slowly upto 190 hrs when the aicperiffient was 
terminated. The free radioactivi ty also followed a 
similar pattern of i n i t i a l rapid disappearance followed 
by a slow disappearance, as seen in the oase of total 
radioactivity a l t hou^ the levels at the different time 
intervals were somewhat lower compared with the total 
radioact ivi ty, Hie radioactivity specifically analysed 
as chLormadinone acetate showed an i n i t i a l rapid fal l 
in i t s levels in the plasma followed by a somewhat 
gradual decline in i t s levels with a subsequent slow 
disappearance as noted in the case of to ta l and free 
radioactivity* *Sb.e level of chlormadinone acetate 
a t lao hrs when the experiment was terminated was of 
the order of 0*15 per cent of the injected dose per 
l i t r e of plasma» The conjugated radioactivity repre-
senting the conjugated metabolites of chlormadinone 
acetate showed some fluctuations at the i n i t i a l time 
intervals* However, by S4 hrs a level of the order 
of 0.05 per cent of the injected dose in the form of 
Disappearance of nH-chloraiadlnone acetate in the 
plasma of monlcey 8 after an Intravenous tnjeotion of 
SS,0 Aic of Ija-TJ-chlormadlnone acetate • 
The radioaotivity In the plasma due to chlor-
maainone acetate and I ts metabolites has been 
analysed into t o t a l , f ree , and conjugated radio-
act iv i ty • ISje free radioactivity has been further 
analysed for radioactivity specifically due to 
ehlormadinone acetate as such* 
PERCENT INJECTED DOSE/LITRE PLASMA 
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conjugated radioactivity was present* Almost the 
same kind of level of conjugated steroids was present 
up to 120 hrs* the conjugated radioactivity thus shoved 
almost a constant level towards the l a t e r time Intervals* 
Figure 2 gives the disappearance in the plasma 
of t o t a l , free and conjugated radioactivi ty, and radio-
act iv i ty analysed specifically as chlormadinone acetate 
in the plasma of monkey M»8 after an intravenous injection 
of 1,2-TH-ohlormadinone acetate* She pattern of disappea-
rance of radioactive steroids in the plasma in general 
was similar to that seen in the case of M-7. This ro» 
presented an i n i t i a l rapid disappearance of the steroid 
in the plasmafoil owed by a slow dis appear eycice* The 
conjugated radioactivity analysed specificJ^ly as chlor-
madinone acetate was of the order of about 0*04 per 
cent of the injected dose per l i t r e plasma* 
fhe pattern of disappearance of radioactive steroids 
in the plasma of monkey M-9 • after an intravenous 
injection of 1,2- chlormadinone acetate i s presented 
in Fig* 3* Xn this oeuie eUBO the samples of plasma 
were analysed upto 120 hrs^ and the pattern of disappearance 
of the steroid was^in general^similar to that seen in 
the case of M-7 given in Fig* 1^ The levels of radioactivity 
Disappearance of %-chlormadinone aeetate In the 
plasma of monkey M-9 after on Intravenous infection 
of §5,0 AiQ of l,8»T{-chlormadinone aeetatet 
The radioactivity in the plasma due to 
ctiLorraadinone acetate 4nd i t s metabolites has 
been analysed into t o t a l , free and conjugated 
radioact ivi ty . The free radioactivity has been 
further analysed for radioactivity specifically 
due to ohloraadinone acetate as such^ 
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analysed specifloallir as ohlor&aainond acetate, eovdid 
)»e worked out orHf upto 72 brs slnoe beyond that tlie 
leveXfl of chlormadiaoae acetate a« suoh mre ot the 
order of 0*03 per cent of the Injected dose per l i t r e 
plasma, which was lower than t^at of t o t a l , free and 
conjugated steroids at tha t time. 
Fig. 4 gives the pattern of disappearance of 
radioactive steroids in the plasma of monkey H'^ IO 
aftez" an intravenous injeotlon of 1, 2«> E*tfhlormadinone 
acetate, fhe experiment was carried out upto 96 hrs . 
At that time the level of to ta l radioact ivlV represent* 
ing ohlormadlnone acetate and i t s metabolites was of 
the order of 0.6 per cent, of the injected dose per 
l i t r e plasma* 1!he free and conjugated radioactivity 
levels were of the order of 0.25 per cent of the 
injected dose per l i t r e plasma. On the other hand, 
the level of radioactivity analysed spec i f i c^ ly as 
cblormadinone acetate was of the order of 0.03 per cent 
of the injected dose per l i t r e plasma. 
giasma disappearance of l.g^^H-chlormadiHone aeetatet 
The values for the radioactivity present 
speeifieaily as chlomadinone acetate and fully oorr 
reoted for recovery in plasmm^taken at 10 mini 30 mini 
1 hTf 4 h rs , 8 | 24, 48, 72, 96 and 120 hrs after 
injection of 65.0 ^Ci of l|2-^-chlormadinone acetate 
are shown in Fig. 5, 6, 7 and 8. lOiese are plotted 
Disappearance of K-chlOFamadlnon® aoetate In the 
plogtma of monkey M-10 after an intravenous 
Injootion of 55*0 AIO of 1,S« jH^ehilormadinone 
aeetate in 3 ml of 5^ ethanolio saline* 
ISh© radioactivi ty in the plaama due to 
ohlormadinone acetate and i t s metaboliteS| has 
been analysed into total | free and con;}ugated 
radioactivity* The free radioactlvilqr has been 
further analysed for radloactiid.ty specifically 
due to ohlormadinone acetate as such* 
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Disappearance ©f radlioaotivlty apaolfically 
analysed as oblormadlnone acetate in t!i$ plaema 
of fflonmey M-7 after an intravenous injection 
of 55.0/i© of l«2«%-eliXopmaainona acetate. 
PERCENT WJECTED DOSE/LITRE PIASMA 
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Disappearance of radloaetivl ty specifically 
analysed as ohlopraa«31noae acetate In the 
plasma of rooakey M-8 aftey aa Intravenous 
injection of 55*0AIQ of l,2*-%-chloraadlnone 
aoetate« 
PERCENT 00?E INJECTEO/LITRE PLASMA 
iSiB)ilrSt[ into 
Digappearance of radioactivity speelfloally 
analysed as cWLormadlaon© aootat© In the 
plaaiiia of monkey M-9, after an intravenous 
infection of SS»0 AXO of l|S-%-ohloi?»uadinoae 
acetate* 
PERCENT INJECTED D O S E / U T R E PLASMA 
Blsappeananee of i*adloaotlvity speoifioalXy 
analjrsed as ohlormadlnone aoetate in the plasma 
of monkey M»10 after an Intravenous injection 
of 5S.0 MO of 3.|8»%-'Chlopmadinone acetate. 
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as logarithm of per oent injeoted dose pei* l i tre 
of plasaa against time after inJeetion« IStese 
represent disappearanoe oiurves vhi<^ ii«/e t>een drawn 
as the best f i t throng the aetaal values observed 
at different points. 
In all tile four oases there was an initial 
rapid drop in plasma radloaotirs eoneentratlon to 
about 2 * 84 p©r t$m% of the invested dose per l i t r t 
plasma* the ourve had an initial fall upto about 
4 hrs ¥ith an average half l i fe of the order Of 
63 minutes, ;^m 8 hrs upto about 130 hrs there 
was a very slov deoline in the plasma eonoentration 
of ohlormadinone aoetate* IMs later part of thd 
ourve had an average half l i f e of 3S.1 hrs. 
Qaleulationsi* 23ie disappearance curves^ in general 
shoved two distinct rates of disappearaneot an 
initial rapid disappearance followed hf a slow dis* 
appearance* In one casoi the disappearance ourve 
appeared to show threo rates of disappearance* Howeveri 
for the sake of uniformity all the curves have been 
analysed using biexponential equations for reasons 
explained under **siseussion<*. Tha concentration of 
radioactivity in the plasma due to ohlormadinone 
acetate as a function of time could be deduced from 
the charaoteristics of the disappearance curves and 
expressed as 
t 107 I 
where X «» Injected dose per l i t r e of plasma as 
ehlofaadlnone aeetate at time t . 
B i s the intercept on the ordinate of the extras 
polated part of the otirve, A + B i s the corres-
ponding intercept from the ear l ier part of tbe 
curve* p has been calculated from the equation 
p « ^ ^ . 9n subst i tut ing the values of Ina, the 
equation can be written as yB « ^^^ (units per day). 
Both B and fi have been calculated from the values 
at 8, 24, 48, 72, 96 and ISO hrs , for awnkey 
M-7 (Fig. 5 ) . Hhd B and^ values in case of M-8 
and M*10 (Fig. 6 and Fig. S) have been calculated 
from values between 8 to 96 hrs . the B and p values 
in case df H-9 (Fig. 7) have been calculated 
for values at 24, 48 and 7S hrs . o< i s calculated 
as follows I 1310 l a t t e r part of the otirve i s 
extrapolated intercepting tho ordinate a t B and the 
result ing osleulated plasma concentrations subtracted 
from the measured values. These corrected concen-
trat ions from 0 to 4 hrs are plotted seailogarlthmically 
and the slope i s <n. 
Table I I gives the Values for A, B,c<,B odi^jBtj^ 
and MCE for the four monkeyt studied. Metabolic 
clearance ra te (MCH) has been calculated by the 
following equationt 
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Msappeaganee of 1^a^^-ehlormadlnone aoetate and 
|.t8 matal?Qlit98 in the red eeJ^lSf Aftar an IntJfa* 
vanotvs injeotlon of XtS<-TB*ohXoraadinona acetate 
to monkeys I blood samples were taken at different 
intervals of time* Blood vas separated into plasma 
and red oells . t^e studies in the previous section 
described the disappearance of ohlormadinone acetate 
and its metabolites in the plasma« This section 
deals vith tlie disappearance of ohlormadinone acetate 
and i t s metabolites from the red ce l l s . 
The blood saffljples imre collected at 10 mini 
30 min^  1 hr", 4 | 8, 24, 431 72| 96 and 170 hrs. The 
red cells were extracted for total, free and conjugated 
radioactivity by the procedure similar to that used 
for plasma, fhe free radioactivity from the red 
cells was further chromatographed to determine the 
amount of ohlormadinone acetate as such. Figs* 9 and 
10 give the patterns of disappearance of total, 
free and conjugated radioactivity and also radio-
activity present as ohlormadinone acetate in the 
red cells of monkeys M-7 and M*8. Both the figures 
give radioactivity levels upto 72 hrs. The levels 
,i*irrfi>nuiM5 
Disappearance of H-chlormadlnone aoetata in the 
red ce l l s of monkQy yh7. after an intravenous 
i!i;}eotioa of 55*0 AKJ of 1,2- H-Chlormadljoone acetate. 
The radioactivity in the red cel la , due to 
ehloriaadinone acetate and i t s metabolites has been 
analysed into t o t i l f free and conjugated radioactivity* 
I'he free radioactivity has been further analysed 
for radioactivity due to ohlormadinone acetate as suc^* 
PERCENT INJECTED DOSE IN RED CELLS/LITRE BLOOD 
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of radioactivity In samples collected at 96 and 
ISO fars were rather low and independable, Uiereforei 
these have not been Included* All the results are 
expressed as per cent Injected dose In red c e l l s / 
l i t r e blood* ISie per cent dose i s plotted on a 
seialolog gpaph* 
The pattern of disappearance of to ta l radio-
act iv i ty due to chSrormadlnone acetate and i t s 
metabolites in the red c e l l s , in the ease of H*7 
(Fig* 9) shoved an aliaoat similar pattern to that 
seen in the case of plasma* St shoved an i n i t i a l , 
rapid disappearance followed by a slow disappearance* 
However, the levels of ^ e radioactivity at ^ e 
different time intervals were much lover than ^ a t 
in the plasma, fhe pattern of disappearance was 
also Similar to that of the to ta l r a d i o a c t l v i ^ . ^ e 
radioactivity speoifleally analysed as chlormadlnone 
acetate also shoved an i n i t i a l very rapid drop 
followed by somei^at slower disappearance upto 24 hrs. 
Between 24 and 72 hr t I t declined very slowly. In 
this respect I t appeared to be a curve which showed 
three different ra tes of disappearance* In the case 
of conjugated s teroids , the levels were rather very 
low and these appeared to increase from 1 «• 72 hrs , 
fhe pattern of disappearance of to t a l , freei conjugated 
and radioactivity analysed as chlcrmadlnone acetate 
Disappearaae© of nS-ehlopmadiuone acetate in the 
red cel ls of monkey M*8 after an tntravenoas 
injeetlon of 55.0 >ue or 1,8-%-elslonnadinoa® 
aoetate* 
The radioactivity in the red oella due to 
ehlormadinone aeetate and i t s metabolites hs^ 
been analysed into t o t a l | free an<! conjugated 
radioactivity* The free radioactivity has been 
further analysed for radioactivity due to chlor-
madinone acetate as such* 
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In the oaae of %»B vas in gdneral sinilar to that 
Mem in the ease of M*?* 
trrine was eolleotedi daily foi^  ^ e first five 
daarft after the administration of CAP and subsequent 
to that one 24 hour urine sample was oolleoted 
weekly or monthly upto g - 3 months, 
M9iT,®tipn„M MX^m^§^J^mm, .^^PM%'^...P^^ W 
!5he exoretlon of free radioactivity m& 
conjugated radioactivity after the administration 
of 1|S- B-ohlormadinone aeetate to five monkeys 
M*8, M«9, M»10, M*43| M*49 are presented in Fig. 11« 
12, 13| 14, 15 respectively. Ihe pattern of 
excretion for M-8 (Fig. 11) shoved increased excre-
tion? of free radioactivity upto the 4t^ day and 
then there was a decline. Hie free radioactivity 
levels were hi^er than the conjugated radioactivity 
levels on all the days studied. Free radioactivity 
could be detected in the .oirine after 30 days of 
administration of the radioactive steroid* 1!he 
levels of conjugated steroids in the urine were 
lower than that of the free radioactivity representing 
unconjugated cblormadinone aeetate and its metabolites. 
•Mtih&ltlMMBi 
S3Ssf«tion of radioaotivlty in the urta© of 
monkay H-8 after an intravenous infection 
of 55,0 «8 of X,2-%-clilormadiaon0 aootate* 
faa radioaotlvity in the M. urine due to 
clilormadirKjae acetate and i t s metabolites has 
bean analysed into free and conjugated radio* 
activity.. 
q. V) 
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Bxc2»©tion of radloaotlvity in the urine of 
monkey M-9 aftor an inti'avanous infection 
of 55.0 Aio of 1,S- H-9W.<>ymadlnoae aoetata. 
The radioactivity in the urine due to 
oiiloraiadinoae acetate and i t s mataboiitea has 
been aaalysad into free and conjugated radio-
aotivity* 
PERCENT DOSE INJECTED. 
MJUJ^ 
Sxcretlon of radioactivity in the urlno of 
monkey U»XQ after aa intravenous injeotion 
3 
of 65«0 Aio of I fS- H-cKtopmadlnone aoetate« 
The radioactivi ty la the urine due to 
chXormadinone acetate and i t s metabolites 
has been analysed into free and oon|^ugated 
radioact ivi ty . 
PERCENT DOSE INJECTED-
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Baroretioa of 3*adloactt*?ity in the urine of 
monkey M~48 after an intravenous Infection 
of 5S,0>ue of 1|2« S-chiormadinone acetate. 
The radioact ivi ty in the xarine duo to 
chlorjaadinone acetate and i t s metabolites 
has Deen analysed into fr®© mid ooa^^gated 
radioaetivity* 
PERCENT DOSE INJECTED-
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The monkey M-9 (Fig* 12) also showed 
h i ^ e r levels of free ehloi^madinone aoetate and I t s 
metabolites than conjugated metabolites of 
ehloraadinone acetate in the urine after the 
administration of ^-ohlormadinone acetate* l i e 
highest level of free radioact ivi ty in the urine 
was achieved Toy l^e 3rd day and i t declined suhse* 
quently. However, detectable levels of both fJ?ee 
and conjugated radioactivi ty tn the urine were 
{sres«it even 30 and 60 day« after the a<^inistration 
of *^R>chlormadinone acetate. 
the pattern of estcretion of free and conjugated 
steroids after the administration of H-chlormadinone 
acetate to monkey M«10, H-48y and M-49 are given 
in Fig, 13 | 14 and IS respectively. In general, the 
patterns were similar to those described above* The 
free radioactivity was generally higher than the 
conjugated radioactivi ty and these steroids could be 
detected in the urine even on 30th or 60th d ^ after 
the administration of Tl-chlormadlnone acetate . 
However, the levels of ohlormadinone acetate end 
i t s metabolites excreted on the different days were 
rather low. 
lxc3?«tloii of radioactivity in the urine of 
monkey M-4j9 after an intravenous Isjeestlon 
of S5#0 MO of l,2-*Tf-(3hloriimaaiinon0 acetate. 
The. radioactivity in the \u*ine du® to 
o]!i3.ormadiHone acetate and i t s m9tal)olite3 has 
been analysed into free and conjugated radio-
ac t iv i ty . 
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A very Interesting feature of the results 
presented in this chapter was t ^ long hdlf*life 
and low metabolic clearance rate of ohloriaadinone 
acetate in the monkey« fhe patterns of dis-
appearance of total radioactlirity due to chlorma* 
dinone acetate and its metabolites showed an 
initial rapid disappearance followed by a slow 
disappearance. A similar pattern of disappescranoe 
was observed in cas© of radioactivity specifically 
analysed as chlormadinone acetate except that the 
latter part of the disappearance curve showed somewhat 
faster rate of disappearance compared with total 
radioactivity due to chlormadinone acetate and its 
metabolites* In this respect chlormadinone acetate 
exhibited a pattern of disappearance from the plasma 
which was much different than that of the natural; sex 
hormones like progesterone and estradiol. She 
average half-life for the first rapid disappearance 
part of the curve for chlormadinone acetate was 
68 min and the second slow disappearance part of 
the curve was 35.1 hrs« The disappearance curve 
showed a biexponential function. In some instances 
there was evidence that the disappearance ourve had 
three different rates and it could be analysed on 
t 113 t 
the basii of & three eoffl|^ £a*taent laodel. Hovever« 
in order to derive some reasonahle Interpretations 
from the datu v l th the help of av^ lab le mathe« 
matioal ooneepitS| ^ « disappearanoe curve has been 
analysed u s ^ g t^e hlescponentiaX equation and a tvo 
compartment model. Sharney« Wasserman and Oevirts 
(1964) have shoun that three or more eompartmental 
systems or for that matter mu l t i ^e systems, oould he 
desorihed t^ the tvo eompartment model, ftm meta^ 
holism of natural sex hormones progesterone and 
estradiol has also heen desorihed using a two 
eompartment model (I*ittlei f a i t | 3?ait and Erlenmeyer 
1966} tongoopoi Layne and Talt 1968). Hbveveri the 
disappearance of these steroids in the plasma i s 
quite fast and ohLormadinone acetate i s uniquely 
different f^ om these hommones* I t i s known that 
progesterone disappears rapidly in t^e plasma of 
women (Short and l£ton| 1959{ Sandberg and 
Slauni^itei 19S8| Dftvis and KLots* 1958} X«ittle| Tait, 
Talt and ErlenmeyeTi 1966, !I!hijssen and Zander 1966), 
L i t t l e e t al (1966) fo\md an i n i t i a l half«>life 
of 0.96 minutes and a second rapid ha l f - l i fe of 
10.7 minutes in ovariectomised women after the 
administration of 617-%-progesterone. For es t radiol , 
Sandberg and Slaun;^ite (1958) reported an i n i t i a l 
t 1X4 s 
half - l i fe of ao mln followed hy a second somawhat 
slowei? hal f - l i fe of 70 mlnutoS. So Information 
on the ha l f - l i fe of progesterone or estradiol 
appears to be available in monkey* df analogy 
i t may be conolnded that these steroids should 
also show a rapid disappearance in the monkey« 
No information on the metabolism of contra-
oeptive steroids in the monkey i s available* The 
onrrently adopted r e f l a t i o n s toy national authori-
t ies in many oountrles for the approval of oral 
contraceptives for use in fertll l tgr regiilatlont 
require toxicity studied In at l ea s t tiSfQQ animal 
species. Monkey being a primate i s chosen as one 
of the species for ftetabolic studies with contra-
ceptive s teroids. 
The plasma disappearance of chlormadinone 
acetate in the monkey showed an i n i t i a l rapid 
disappearance followed by a slow disappearance %^ich 
was comparable to the disappearance of norethynodrel 
(Laumas, Murugesan and Hingorani, 1971). In studies 
with norethynodrel I the disappearance curve has been 
made from data using to ta l radioactivity representing 
norethynodrel and i t s metabolites, which showed 
an i n i t i a l ha l f - l i fe of 76 min followed by a second 
slow disappearance with a half«life of 45«0 hrs . 
t 115 i 
Van dor Molea, Hart and mjmenga (1969) described 
the disappearance of radioactivity due to 
lyneatrenol and i t s aetabolltes as single pool 
kinetics with a half-life of 40,0 hrs. In vlev 
of the differencesI and also the fact that the 
steroids and their metabolites have bem nteasured 
In these Investigations ^Mle ehlormadlnone acetate 
ad such has been estimated in the present 8tud^« 
i t is not possible to make any valid comparisons. 
Xhe metabolic clieaFanee rate (MOH) has been 
defined as Vte amount of plasma vhloh i s cleared 
completely and irreversibly of Its steroid content 
in a unit period of time* IMs is a useful parameter 
to describe and compare the metabolism of different 
steroids* The MQH of ehlormadinone acetate for the 
four mohkeys studied vas 34*8, 66*29 1S^ «S and 
196*7, ^ th an average of 10a#6 litres/day. this 
showed a considerable variation in the HCa values 
of different monkeys* Ul;jmenga and Van der Helen 
(1969) and Bird, Green and (XLark (1969) also found 
a considerable variation in the MCH values for 
mestranol in women and for testosterone in human 
subjects respectively* Nevertheless, the mean HOH 
for ehlormadinone acetate in the monkey vas much less 
than the MCR of estrone, estradiol or progesterone 
>olio C e^aganqe Rate of nataiagal ai^ 4 
xEM'EiMjEsbJal.lJSR*^^ m^.w w'^Qy^ 
No* St6?oi4 iUtttfiU^y Speeles Bsferenct* 
u Estrone Wostdti ton^ope ^ J2I» (1968> 
8, Eatraaioi i,3ao n •oodiO'* 
3« jppogostei^iid 2,443 M l^ittle s^ j i (1966) 
4« teatosteifone 708 men Southopn g^ j i (1967) 
5, ^^dosterone 1,636 woman 3?alt ^ J l (1961) 
6. Noire^ i^ od2rQl and 
its aetabolltoi 
7. Lynestrenol and 
Itt metabolttei 
m 
8. Chlormadinona aoetate 10S*6 
X.a!iiiBas, Murugefan and 
Hlngorani (1971) 
* Van dey Molen ^ ^ (1969] 
monk^s present studsr. 
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in voBeHf tfhertt HCH values of 2S10| 1350 audi 8443 
lltres/dar respedtlvoly have been found* the oompa* 
rlson of the MCR of ohloraadlaone aoetate, in ttio 
ttonkeyi vWx other 8t«roids is given in Table II1« 
Compared vith nattiral steroids ^  low HOB values of 
the order of 30 and 25 litres per das^  have heen found 
for norethynodrel (Iiauiiias et al 1971) and l^ mes trend 
(Van der Molen et al 1969) respeetively in vomen* 
Againi valid comparisons cannot he made because of 
the speoies variations and also the faet that the MOB 
of norethamodrel and lynestrenol has been oslctdated 
for ^ e steroid and i ts metabolites* fhe nonkeF^ used 
in the present siaidy ve i l ed 6 - 8 kg^  while the average 
wei^t of the t«)men may be SO • 60 kg. It is not known 
as to how the wei^t differ^itee affeots ^ e MCR. fhe 
blood volime is generally oonsidered to be one*tenth 
of the body weii^t. M e i ^ t kg monkey should have 
about SOO ml of total blood. In the present treatment 
of the disappearanoe eurve, the results have been 
expressed as per eent of the injected dose per l itre 
of plasma, this approach has been used to make 
comparisons with other data in the literature. However, 
If the plasma levels of the steroid are expressed 
as opm/ml or any such form of expressioui the 
value of the HCR obtained would s t i l l be the same^  
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The slow disappearanoe of ehlormadlnone 
aeetate and i ts low netabolie eXearsaoe z'ate oould 
be attributed to a nuaber of faetoiwi. M important 
faetop oottld be the storage of ^ e tfteroid in the 
bodjr fat* A hlih uptake of ohlormadinone aeetate 
In the fat of rats was observed aa described in 
Chapter X. I t la also possible ^at the steroid 
end its h i ^ polar metabolites may be stored In the 
adipose tissue as has been demonstrated in the case 
of qulnestrol (Meli| StelnetSf Beaohi Wolff and 
Qlanninai 1963). Svldenoe for the storage of 
ohlormadinoite aeetate in the fat has also been 
forthooming from the work of Oallegos ^ 
' Gonsales^Blddi) Merino and Martinex«Manautou .1970). 
The other possibilities eould be its binding to 
plasma proteins and some storage in the red cells 
since small, amounts of CAP eould be found in the 
red cell and i t had a long half'life in red cells , 
Enterohepatio circulation of chlormadinone acetate 
eould also contribute to i t s low KCH value* the 
work of Aral, Qolab, taame and Uncus (1963) has 
suggested the possibility of enterohepatle circula-
tion of norethynodrel in the rabbit. Xn this 
connection i t is important to note that considerable 
faecal excretion ot contraceptive steroids and their 
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metabolitos hoM been noted W ^^^^ investigators 
(Laarnoi Golab, Aral and plnous, 3963)« 
TtiQ dlsappearanoo ourvd for ehlormadlnone 
aoetata has a Moxponantlal Itiaotlon and i t eould 
ba interpreted on ttk9 basis of a tMsdoonpartaent 
model« Talt« fait, l>lttle and Laoaas (1961) bave 
desoribed a model for l^e transport and metabolism 
of ^dosterone in mini vhiob oould be applied idtb 
Some modifioations to desorlbe tbe metabolism of 
obloraadinone aoetate in tbe monke3P« fhe model oan 
be oonsidered to eons is t of two pools | an inner 
pool i^ioh may^  include iplasma and extraeellnlar 
irolnmeSi and an outer pool* ^^ob ineludes anatomi* 
oal eompartmentStt transport between t&e ttio pools 
oan be desorlbed t^ a rate oonstant K^ * If ^ e 
liver voltime is relatively small and transport 
from plasma to netabolio oells proceeds at a 
reasonable ratoi i t can be considered as the part 
of the inner pools, as regards aetabolio events* 
the overall metabolism of this pool iiith a total 
volume (Vj^ ) oan be described by the rate constant Kg« 
1!he total volume of the outer pool is tg* In the 
present ease, i4icn the radloaotivitr i s measured 
as chlormadinone acetate then K^  is ^e fraction 
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of tli« iaieotod doeie/ua laasaa transported to the 
outer pool in milt t l a o | Kg Idthefraotlon of the 
injected dose/nO. of plasaay aetaliolised in the 
inner pool/unit tine* 08ing the fornmlae given 
by Tait s% ^ . (1961) i t i» possible to calculate 
the values of Kgi V^ ^ Vg and K^ by the following 
equation I 
^2 AB + Bo( 
After an intravenous infection of ^ ehlorma* 
dinone acetate to monkeys the radioactivll^ concen-
tration in the inner pool is high^ than that in 
the outer pool for sometiiae after injection. The 
concentration of the steroid in the tvo pools becoaes 
e<!ual at the tine of equilibrium* From this time 
onwards, the concentration of radioactive obloraadinone 
acetate in the outer pool is greater than that in 
the inner pool, fhe final slope of the plasma 
concentration of ehlormadlnone acetate Is the 
resultant of the effects of transport and metabolism 
of the steroid. Kj^  which Is the rate constant 
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for tho transport of the steroid between th« inner 
and the outer pools has an average value of 8S9.3 
as given in fable IV* On tlie other hand| tbe value 
for Kg vhieh i s the ra te constant for the metabolism 
in the Inner pool i s 6 •47* The value of Kg i s 
rather small vhieh indicates a slow r a t e of 
metabolism of ohlormadlnone aoetate In the Inner 
pool* I t*s Kg value when eompared with the K^ 
value for aldosterone i s 10 times less* 
thB value of K^ representing the transport 
of ehlormadinone aoetate from t^e plasma to the 
t issues i s quite h i ^ when compared with K^ of 
aldosterone or progesterone* She reasons for the 
prolonged hal f - l i fe of ehlormadinone aoetate in 
the plasma have been mentioned above* Amon^t these 
reasons the storage of ehlormadinone aeetate in the 
fat was pointed out which was also supported W 
studies on the looalizatlon of ehlormadinone aoetate 
in the fa t . The hig^ calculated values of K^ ftirther 
suggested that ehlormadinone aeetate i s actively 
transferred to the tissues*^ 7he presoit treatment 
of the disappearanee curve does not permit the 
calculation of ra te of metabolism in the outer pool 
since suitable methods for measuring th is ra te 
in the tissue are not available. Vj^  • Vg i s also 
the reoiproeal of the intercept on the ordinate 
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obtained hf extrapolation ufling the slope K2 
from the oonoentration of radioactivity at tiie 
equllibriutt time* 
ITan der Molen ^ ^ (1969) have deserlhed 
the disappearanoe in plasma of Ijmestrenol and i ts 
a4itaholltes by sin^e pool kinetlos; Ifo separation 
of the steroid from the metabolites was carried out* 
In this fieidi i t is reeognised that disappearance 
curve and the treatm^it for the calculation of ICR 
can accurately be represented by the steroid as 
such and not in a mixture with i ts metabolites. 
A» pointed out before^the disappearance curve for 
ehlormadinone in the plasma of monkeyi has in one 
case three rates of disappearance vhioh could 
possibly be analysed as a three compartment model* 
Hovevert the justification for ^ e interpretation 
of the curve on the basis of the tvo-eompartmental 
mod^ was adequately given. 1!he tvo-compartment 
model as given in this presentation can adequately 
represent the metabolism and transport of ehlormadi-
none acetate but i ts presentation as a single 
compartment model can be mere approximation, 
A biological half-life of 26 hrs in urine 
14 
for radioactivity due to CJ-lynestrnol has been 
found by Kamyab, Fotherby and Klopper (1968a). 
Howevert a calculation of the half-life of lynestrenol 
t X22 t 
and its Kdtabolltes in l»lood using the data in 
t«D oas«s of Katajrab ^ 1 Sik (1968a) has shoMt a 
half-lifd of 43 and §0 hou s^* It tlms appears 
that ohiormadinono acetate in aonke^ Ti and no^etlqr-
nddrel and l^mestrenol in vomen disappear at a 
very slow rate ftom the plasma and show a similar 
pattern of ^ansport and aetabolism* 
In the red oells , total i*adioaetivit^ 
representing ohLormadinone aoetate and radioaetivity 
analysed speeifieallir as ohlormadinone aoetate, 
showed an initial rapid disappearanee followed 
hy a Slow disappearanee resembling the pattern 
seen in the oase of {ilasma. lovever, these persisting 
levels of the steroids were snioh less than that 
seen in the ease of plasmai thereby ihdioating 
greater affinity of ehlormadinone acetate for plasma 
than for red cells* The later slow disappearanee 
(Fig* 9 and 10) part of the curve indicated some 
retention of chlormadinone acetate in the red cel ls , 
fhe nature of the binding of the steroid to the 
red cells and the significance of this binding 
needs to be further investigated. Oe Venuto (1967) 
has shown that progesterone could bind to red cells 
to the extent of 70*85^ of the total progesterone 
in the medium. Xt is not known whether red cells 
can aettbolise chlormadinone acetate or other 
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oontraeeptive iteifoids* H^ r«d oaXls are known 
to possess aotlve ensymes lAiieh are able to oonvert 
estrone to estradiol (Ascelrod and Werthosseni 10S9| 
G^ asr and Bisohoff 1955)« !!3ie tiptake and n long 
ha3.f*llfe of ohlormadinon^ aeetate in tlie red oeXls 
majr have a role in t3ie transport and aotion of 
ehlonaadinone acetate. 
the analFSis of total radloaotliritsr in the 
l^ asma revealed tlie ireaenoe of oonsiderable amounts 
of f^ee and oonjugated metabolites* Hie stftioture 
of the metabolites of ehlormadinone aoetate has 
not fet been determined* Moreover^  no information 
is available as to the biologloal aotlTLtjr of the 
metabolites. Xt iS| thereforef not possible to 
asoribe ani* sigiifieanii to the levels of l^e free 
and oonjugated metabolites of ohlormadlnone acetate* 
I t is possible that the concentration of the 
metabolites in the blood ma^r participate in the 
regulation of the availability of free ehlormadinone 
acetate by changing the extent of i t s binding to 
plasma proteins and transport to tissues. tChe »rerage 
value of t^e per cent injected dose/litre plasma 
as ehlormadinone acetate at M hrs in the case of 
the four monkeys was found to be 0.27^. trsing the 
specific activity of the ehlormadinone acetate as 
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222 ui/mg, the calctilated plasaa coiioentratloa 
of ehlormadizioiie aoetate has be^ n found to be 
1»X3 ti^ml* 1% dhows that after 34 hrs the leireXs 
of the order of 1«X8 ng/ml pXaama of ohiornadinoae 
acetate m&f be present itoleh are possibly effective 
for the eoatrol of fertilSt y» 
It is diffieult to extrapolate this result 
and arriire at reasonably valid oonolusiohs oh t^e 
oontraoeptive effeetiireness of this plasma level 
of ohlormadinone acetate if attained in voaen after 
the administration of 0*5 mg of ohlormadinone acetate 
tabletf until more information on the pbysiologiedl 
mechanisms involved in the action of seat hormones 
and eontraeeptive steroids becomes available* Bcveverf 
i t s t i l l gives a basis to judge the ability of this 
level of ohlormadinone acetate for oontraceptive 
effeotiveness and make comparisons with the blood 
levels of progesterone* !Ehe peak luteal phase level 
of progesterone in women has been estimated to be 
about 9 ng/ffll plasma < Thorneycroft and Stone 1972)« 
!Qie concentration of ohlormadinone acetate in the 
blood would be about one ei^th that of progesterone* 
Kind and Dcrftaan (1963) have estimated the biological 
activity of ohlormadinone acetate to be about 40 
times than that of progesterone* Thus the plasma 
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level of ehlornadinono aoetatd 1*18 ng/nil vanlA be 
aijout 5 times adre blologloally potent than the 
»id lu teal ]^a»9 plasma level of 9 ag of proges* 
terone. This oonclusion of high biological poteno^r 
of ehlormaainone aoetate Is based upon the 
administipation of 0.5 mg tablet of ohlormadinone 
aoetatet Warn the dxiig i s a<&iini3tered dail^i i t 
should resul t la s t i l l h l ^ e r levels of the s teroid 
and s t i l l enhaneed biological poteno3r compared 
v i th progesterone^ This plasma level of ohlorma-
dinone aoetate i s effective in producing changes 
in the cervical mucus and inhibi ts ovulation in some 
vom«n as reported by Taymor and L eves que (1971), 
and Saunders, Marcus, Saxena, Bel in g and OonneU (1971) * 
The effect of contraceptive steroids on hormone 
levels and their s i t e of action needs further study* 
A continued excretion of botte free and 
conjugated radioactivity in the urine of monkeys 
upto 30 or 60 days after a single intravenous 
injection of %-ohlorMadinone acetate indicated 
that the progestational steroid i s retained in the 
body «nd sloiAy released from there and then excreted* 
The foregoing evidence of the storage of chlormadi<-
none acetate in the body fa t %fould explain this 
retention in the body and slov excretion* fto'thermoret 
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i t is possible t^at 1»®sides fatf binding to plasata 
proteins masr bo aaothov neohsnisnt i^ioh ma^  ^ontri* 
buto to the retention of the steroid in the bo^* 
Xt is interesting to note that only a small fraotion 
of the order of 4,15 per eent of the aiteinistered 
dose of %«>ohlor]nadinoae aoetate t^ as exoreted in 
the nrine during the f i r s t five days and after that 
0tl6 per oent of the administered dose per dsy ¥as 
exoreted upto the next 30 days* !Shis Shoved ^ a t 
only a very Sfflall percentage of the administered 
dose was exoreted in the urine though there may be 
other routes of excretion of this steroid* the exore« 
tion into the bile md then into the faeoei may be 
another important route of exoretlon of the steroid* 
Gallegos J I j | „ . (1970) reported an average of 17*5^ 
of the total dose of ohlormadinone aoetate in the 
urine daring the f i r s t three days after the adminis-
tration of ^-ohlormadinone aoetate to women* Simi-
lar ly , Besoh, VoiySf lElery, Barry and Oouri (1966) 
reported that the Urinary excretion of ^-aedroxgrpro-
gesterone aoetate over 5 days in pregnant and non-
pregnant ¥omen varied between 0.25 and 4*03^ of the 
total administered dose* Hoveveri for norgestrel the 
urinary exoretion of about 22% in the f i r s t 24 hours 
has been reported by Littleton> Ibtherby and Dennis 
t 127 I 
(1968K An avarage of 32»58^ of the a<lBii»ltt* 
tdred dost of pirogosthrone was exoreted In th« 
tu i^ne vithln thspee da^ rs in vomen (Galldgos 
et aJL* 1970)« Xt tiiufl beeame ovldent that 
compared with progestorotia and 19-nor «tePold«| 
the 17oc*aoet03ey progesterone derivatives» ll&e 
ohlomadinoae aoetate and aedros^ p^ogesterond 
aoetate are exoreted very siouiy In the urine, 
thia evidenee for the exoretion of ehlormadinone 
aoetate in ^ e monkey urine further shoved that 
a small peroentage of the administered dose vas 
exereted in the itriae. !&ie faeoal exoretion may 
also he an important route of exoretion of this 
steroid. 
QMAvmn m 
SIl>a OF ACTIOH OF gflOQlSf AHIOWJIL 8TE80XI38 
"StiB progestational steroids are t i l ^ y effective 
In the oositrol of eoneeptloa* ik nuaDer of se^hanisms 
for their aotion at different sites in the bodar have 
been put forth (see page 9-23 of this thesis). Of 
these iKUflierous ffleehanismsi the suppression of pituitary 
gonadotropins and ihhibltibh of ovulation was proposed 
by iPlMms (1957) as the principal aeehanisitt of 
action of the progestagen-estrogen combinations« 
Over the years | the dose of the piro gestagens and the 
estrogens in the contraceptive preparations have 
been reduced to mlnifflize the side*effects assooiated 
with their use* Low doses of progestagens alone are 
also being investigated for the control of fertil ity, 
fhs low dose progestagens have been suggested to act 
without inhibition of ovulation (Martines-Manautou 
et al* 1966>| ^ i l e in some cases these act by 
inhibition of ovulation (Taymor et al. 1971). I t 
thus becomes evident that the s i te of action of a 
progestational steroid Is 0?eatly dependent upon 
the dosage of the drug used and the mode of adminis* 
tration* In order to elucidate the site of action 
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Of diffefdnt dosdS of the progestational steroias, 
there i i ft need for an experimental cAlaal model. 
Monkejr • a non*human primate • has endoerinologieal 
and nerimixs behavior ver^ r similar to the human* 
I t thus offered a suitable model for the studjr of 
mode of aotion of progestational steroids* 1 ^ 
inhihltion of oimlatlon and corpiis Imteum function 
ooUld be evaluated br the measurement of plasma 
progesterone levels* mie work presented in this 
chapter deels vith the development of a sensitive 
assar for the estimation of |£Lasma progesterone 
loid the assay of progesterone levels in monkeirs 
after the administration of l^avid* the ifork also 
provided guidelines for the studjr of the mode of 
aotion of progestational steroids in an animal models 
mpi^* m^ ,^ ¥^ fflfi Qo;|,X?<?^ <^?Qt Sexually nature 
female rhesus monkeys (Macaoa. mulatta) were chosen 
on the basis of their regolar menstrual oyoles 
varying from 25 . 28 days. They were healthy and 
weii^ed between 9-10 kg^  fheir menstrual oyoles 
were followed at least for 3 suoeessive cycles 
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h9tov0 the^ r ware iised for tlio stu^r* llonk«|rs vePd 
vdip« fd4 dm pellet diet iupplled ^ Hindustan Lever 
Xitd^ i Boabasr* fhis diet was stip i^leiaeiited 1>3r freslb 
frul^ attd vegetaMes* water was provided sS libitam* 
Slodd samples were eelleeted ^ femoral piuietare 
e i^er daily or on alterxiati diQra, tialng lieparinlzed 
s^ingeai in tke morning before '^e animals were 
fed* fim ):^ ood samples were imfsediately oentrlfnged 
and tiie plasma vas separated end stored frozen at 
-lO'^ C nntil assayed for progesterone* To mialmiae 
rednetion in haematoerit values 100 mg of iron* 
dextran Clmferon) was given intramnsonlarly once 
every week tliron^ottt tlie experimmtal oyeles to all 
tlie animals* The first blood sample for eaeh menstrual 
oyole was drawn on day 3 of tile oyole and tlie last 
a day before the onset of next menstrual bleeding* 
Mm'imm%,S^ ,^^ m^^t^" ^^ ©ontrol monkeys did not 
receive any drug nfhile tlie treated monkeys were 
administered •*Snavid** tablets eaob containing 2*5 mg 
norethynodrel and 0*1 mg mestrmiol daily* The 
tablet was dissolved in 1.0 ml of olive oil and 
administered orally to eaoh monkey throu^ a stomaoh 
tube* The treatment was given to monk^s for two 
sueoessive oyoles but the effect of the drug on 
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proeastex'ond levels was atudiidd in tlio Snd 
fh& prlneipl© underlyiag tto© ooaiietltlve proteia 
binding assaar i s the eompetition lietween tlie hot an i^ 
the QQl& steroid tor tbe hinding aitea on l^e i^asma 
protein uhieh has h i ^ ipeoifioitir and affinity tot 
the stei^id* Competitive protein binding assay of 
progesterone is based on the above prinoipXe and is 
explained m follows. il'ogester@ne>like oortisol 
and soffle other steroids, seems to he speeifioally bound 
thoti^ in sttbvalent levels to an '^ I • ^otoiilin 
fraetion of sernm proteins* ISiis protein has boon 
called <*frans0ortin<* (Slatmwhite mi Sandberg, 19^) 
or "eortloosteroid binding globi:a.in* (CBS) (Dan^dayi 
1958) • I t is present in l^e plasma of almost al l 
mammalian species { i t s level being very h i # during 
pregnanoy or during estrogen treatment* for the 
assay of progesterone^ the plaSaa is diluted and 
the eortioosterone binding i^obulin is saturated vith 
\-cortleoSterono« 5!he binding sites on the eortloo-
•a Steroid binding globulin saturated with B-oortloo-
steroAe (CB(W H^B) oan be competed for by non-labelled 
progesterone* The procedure is outlined as follows 
in three steps* 
Step I . CBG -* ®HB • f Ti? CBQP * ^ 
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This itep Shows that after addition of odd 
progesterone (l»> to diluted dBG solution saturated 
with %»c6rtlooitsifone an equllibriunr Is set up 
between bound %»oortiooste3^one (^ HB> and bound 
pro^sterone. 
Step IX* Adsorption of free progesterone and H-
oortieosterone by adding florisll« 
Step ZZI« Ihe separation of eortloosterone. 
bound to CB6 and oountlng. 
If the aiaount of %»oortlcosterone bound to 
CBO >d.th %diloh the process started is knoim, and i f 
known amounts of progesterone are used to ooapete for 
the binding sites , a standard curve ean be established* 
When the unlmoim asiount of progesterone extracted 
from the plasma samples is allowed to compete with a 
known amount of tritiated oortlcosteroney the amount 
of progesterone present oan be calculated with 
reference to the standard curve. 
ISsSESa-aUZiat- the source of CBO used was male <teg 
plasma in 1*0 '^ concentration^human pregnancsr plasma 
in 1«0| 0«3| 0«13, 0«1 and 0,075^ concentrations 
and monkeir plasma from non»pregnant monkey In 0*1^ 
concentration* Monkefa were also treated with 
•Snavid« an oral contraceptive containing S,6 mg 
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noretbynodrel md 0*1 mg mestraaol for 3 months, 
l>rlo7 to th« venlpozicture the monk^s mtve glT«ii 
aexamethaflone for adrenal suppression* flasmft 
CQlleeted from sueh treated monke^ rs vas. used to 
run a standard ourve in oonoentratlons from l«Ot 
0«S, 0»X5| 0*1 md 0«075^« 
One veniimnetttre hlood was dravn into 
he|iarlnljsed s^rrtoges and IJBmediateljr oentrifuged 
to separate plasma* iliipropriate allquots of plasma 
were transferred into sample tubes| frosen and 
stored at wlO^ C and used as a source of CBG« 
Jtedioaotiirq 8tegoidS|> l,2*^«cortioosterone 
(Sp* 4ot* 44 Oi/mH) and lt@«%^progesterone (Sp« Ao« 
50«0 01/mil) were obtained from Hev M^BBA Haclear. 
Boston, Mass. 
Hfon^ Radioaotiira Steroldst- Kon-radioaotive progss* 
terone vas obtained from Si^aa COiemieal Oompan^ r and 
vas purified by repeated orystsllization using 
methanol and water as solvent pair. She crystalline 
progesterone vas dried overnl^t ino-vaouum deslooator 
and used at different eoneentrations in the standard 
ourve* 
Counting woeediypes^* me counting medium used was 
prepared loif dissolving 100*0 ml of Blosolve and 
43*0 ml of Liquiflucr (Beekman Instrument Co*) in 
s 3.34 i 
I l i tre of realstilldd tolii«ne. Ih« iamplet were 
eountod in a Faakard Soiatillatioa Coimter Model No* 
3314 vHioh ga^ 0 oounting offioldnoy of @8 « 30 »^ 
The oomposition of diotoi oounting aedium is given 
in Chaptar X, 
48say proeedarei* fhe progesterone estiaaUoft wai 
oarried out by oompetitlve protein binding aseajr 
aeeording to the prooedure giiren bsr Heilli Johanseoni 
Datta and Knobil (1967}• 
fhe CBG-eortieosterone ! , § -% (OBG-^ HB) was 
prepared ae folIo\iffii 4;(to of ^-eortieosterone in 
ethanol vere transferred to a reagent bottle of ISO sa 
oapaoit^ and evaporated nnder a gentle stream of 
nitrogen^ 100 lal of distilled water vas added to tlie 
bottle, shaken well and placed in water bath at 
4S^ C for 5 min* to bring the %*oortioosterone into 
solution* 1*0 ix3L of male dog plasma was added and 
the solution was refrigerated for 30 min before use* 
Hon-radioactive progesterone^ ©rjwtalliaed and 
dried was used for making standard solution of 
progesterone in different oonoentrations of 0«S, 1, 2, 
3 | 4 | &| 10 and 60 ng/0.06 vol of absolute eaoohol* 
fhe standards were stored in a refrigerator at 4^ 0^  
t^ffl«J(^ C4 mrmr SO All aliquots of progesterone 
solution in absolute ethanol oontaining 0, OfS^  1 | Sy 
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31 4, Sf 10 and 60 ug of |»foge8teroiui respeotlv^ly 
-mvQ added in daplleatd to IS % 100 mm disposable 
isulturo tul»ea «ad evapoi^ atod to drynesfl* 1*0 al of 
solution was added to tlio tubes vhioti vere 
Shaken on Vortex mixer toit 15 seo. and plaoed in 
a vater bath at 45^0 for 5 min to bring the iiroges* 
terone into solution* Hhey were then mixed on 
vertex mixer for 15 see and transferred to an loe 
bath for 30 min to Inereose the affInitjr of CSO for 
steroids (Murphff Engelberg cyid Fattee 1963) • 
1!he unbound labelled oortioosterone was removed 
from CB& solution b^ ad«ojpption to f lorlsi l , Horisil 
(40 »g> vas added to Midh tube idiidh vaS then 
immediately mixed on vortex mixer for exaetlsr 30 see 
and returned to the lee bath« tslhen mixing of all 
the tubes was eompletedi 06 ml of supernatant from eaoh 
tube vas added to 15*0 ml solntillation medium in a viel 
and ooonted* A standard ourve for j( bound oortioo* 
sterone against different ooncentrations of pro§9S» 
tercme vas ilotted. 
iR'1-'1^ .?^ T1Wl^ *^QWI ^ 9f Tffgffit«Wfflf I* ^dioimmunoassay 
is a hif^y speoifio and sensitive me^od for the 
measurement of pioo^ ram quantities of steroids in 
plasma. She prinoiple of radioimmunoassssr is taie seme 
as that of oompetitive protein binding asaajr with l^e 
differenee that in radloimmunoassaar the binding protein 
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is antlsdmm ooatainlng s|>e<slfle antlbodi*8 iraitedi 
against a steroid. This antiseinin is raised against 
the steroid (antigen) \siy eonjugating i t to a protein, 
emxlsifsring i t vith oomplete fre\md*s adjuvant and 
injeeting suboutaneotisi^ r into the host aniasa,(rabhit| 
Sheep, ete . ) . 3%ie antiserum is obtained W hieeding 
the host animaX after i t has deveXoped a high titer 
antiseruua. 
JS^iti^SSIMr ^^ antisemia vai supplied hjr Dr» K* 
Sundaram, Population Ooimollf MonedisaX l^ivisionj 
Hew irork# Jt was raised against Xlo<-h3rdroxyppog9Sterone 
linked to boirine serum aXhumin end is h i^jr speeifie 
for progesterone <HidgLer and Hlsvender X970>* the 
dilution of antiserum used vas 1 t 3000 and at this 
dilution i t bound 50 • &>% of t^e %• progesterone 
(lAicyio aa buffer)* 
Buffer » 0#1 M phosphate buffer (pH 7«2) oontaining 
0.9SJ Nad and 0*ljl Knox unfXavoured gelatin was used 
throu^ut the assi^^ 
Sextran eoated ehareoaa solution » Norlt A (250 mg) 
and Dextran T«70(25 mg)were suspended in 50 ml of 
gelatin-tdiosphate buffer. Fine parti^^es were removed 
from the oharooal by repeated washing with double 
distilled water and drjring at lOO^ o for 2— 3 hours ^ , 
Solvents <• All the solvents that were used in the assa^ r 
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were of h i ^ anslyticsX gradd* ^nlisrdrotti dietiij^ &th&T 
and dmibXe ^ats distilled water vere used« 
(Easavage * l^sposable assa^ tabds vera tided, tl^ e 
other i^assvare that wai uied vas dipped in ehronfio 
aoid overnii^t and than washed with distilled vater 
repeatedly to get rid of all traees of aoid« Before 
using for assay tite glassware was rinsed tvloe with 
double distilled water and methanol and d i^ed* 
aadioaetive progesterone - Specifioaily labelled 
progesterone in 1| 3 | 6^  7«^position was ohtaljied 
from Hew SfigLand Huelear, Boston, Has8« It had a 
high speoifio aotlirity of 100 Oi/nM« 10 MQ of 1, S, 
6y 7«%»progesterone was dissolved in 100 al g^atin-
phosphate buffer to malce a solution of %-progesterone* 
This is referred to as 'Hot* buffer. 
Standard Curvet* irogesteroae in eoneentration of 
0, 25| SOf 1001 3001 400 and 800 pg^SO i^l ethanol 
was transferred in duplicate to disposabla 12 x 7S on 
culture tubes # 3*0 lal of anhydrous diethyl e^er 
was added to eaoh tube« and the solirent evaporated 
by pdaoing tlie tubes in a water bath at 46^ C« Anti* 
serun 0»1S inl in gelatin idiosphate buffer at the 
dilution of 1 I 5,000 was added to eaoh tube and 
mixed on Vortex mixer for 10 sec to bring the 
progesterone into solution* this was followed by 
i$tm^ 
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adding 0*15 aa of *Rot* lauffer to each tube and 
mixing on Vortex nixdr tot IS s«o. The tabes veve 
then lef t overnight in ^ e »eftpigeratoj? at 4^C foy 
inimbation, Pixring inoiabation pePiodf the %-
progestei^ one and the non^i^adioaotive progeatex'one 
oompete for the binding sites on t^ie anitbodies* 
The greater the amonnt of oold progesterone present 
in t^e tubes t^e lover is the H»pro gesterone bound 
to antiserna* 
Separation of free and bonnd steroidst* fhe free 
and boiand '^•progesterone were separated 1^ adding 
preoooled 0»5 iBl of dextran-ooated ohareoal solution 
to eaoh tube* 19)e tubes were laixed on a Vortex 
mixer for 10 see eaoh and eentrifuged in a refri* 
gerated, oentrifage International aiodel PB-S at 
3000 BIN for 10 »in# ftm ^*progesterone was adsorbed 
by dextren ooated ohareoel iMoh settled at the 
igottoja while the one bound to antiserum stayed in 
the supernatant* the supernatant was gently deoanted 
into a vial» 10 nl of seintillatlon li<|uid (page 133) 
was added to eaoh vial and was counted In a ftiearb 
Liquid Sointillation Spectrometer at a oounting 
effieienoy of S8 - SOjf, 
A Standard ourve was plotted on a semi-
logarithmic paper with progesterone concentrations 
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on tlie iogarithiiie scale on a1>80l8sa and th« % 
of l^e eotints bound at 0 progesterone mass on the 
ordinate* 
Samgle eaetraotlon and assist* fXasaia samples 0*2 ml 
from follieular phase and 0*1 ml from luteal phase 
of lbknot«n progesterone ooneentration vere added 
in duiaiaate to eaoh 13 x 12S mm test tubes and 
diluted irith double distilled water to a volume of 
0*5 ml* Bx^aetion was carried out using 5,0 ml 
of anhgrdrous analytical grade diethyl ether per 
sample and mixing i t on Vortex mixer for 1 min* 
this was folloifed by centrlfugation to ensure eleesr 
separation of the two phases, fhe ither extract was 
then trimsferred to 12 x 100 mm assay tubes by 
pasteur pipettes and evaporated in a water bath at 
45^0* ^om here onwards the samples were processed 
as described for the standard curve, with one set 
of tubes for a standard curve in the beginning and 
one at the end, Xhe progesterone value for each 
unknown plasma sample was determined by reading the 
value from the standard curve i&otted by using the 
mean v^ues of the two Set of tubes* A standard 
curve using mean value of 5 sets of •bservations 
is given in Flg*l* 
fb keep a check on the assay system 0.5 ml 
of double distilled water was assayed along with 
fhB p9T oent ttounS %*prog98tex*on« la 
plotted against tli€ log of pro gaa tar one aai«» 
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the uiikiioi«ei plafna sampld* A iraliid hiit^r thio 
zero of the standard curve obtained vith water 
l»laiik neaeasltates h^e repeating of tile essasf* 
Recovery correetiont'* frocedural loss MM corrected 
br adding SOO ep» of 1.3.%.pro«..t.rone In eth««,l 
to 2 eictraction tabes* flie ioivent was evaporated 
and 0.2 ml sale iHlasna vat added ^ eaoli tube and 
extracted as per saaiile pilasma* ^ e extract was 
tranaferred to a vial, evaporated and counted. Hie 
% recovery obtained va« usualXy BB • 98^. 
Reproducibility and preoigion of the aisayt* fltm 
day-to-da^ reproducibility and precision of the assay 
was checked as follows i 200 j>g mA 800 pg of 
progesterone were dried in duplicate and 0»8 ol of 
male ot ovariectomlsed female plasma was added to 
them* the samples were assayed together with unlcnown 
plasma samples* The blank in each case was male 
or ovariectoaiaed plasma without any added pK>ees* 
terone* the value obtained was read from the standard 
curve run with each assay., the recovery wi«i 
200 yg and 800 pg was 0«2 ¥ .08 SD and 0.8 • .07 SB 
(n s» 6) . 
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trst of male dogaerum for CPB aasayi-- flio eortlco* 
tfteroid binding ^obulln or transeortini lyresent 
in th« malt dog plasma iias been used as a binding 
protein in the eonpetitiird binding assajr for 
progesterone (Keillf d'ohanssoni Datta and Knobil, 
1967)* It was proposed to measure plasma proges* 
tei^ one levels of non*>pregnant monke3r<^  in both 
folXioular and luteal phase of the eyloe* !Qie 
assasr should measure as low a»o2 ng/ml i^ asma« fhe 
standard eurve 1 - 4 ng progesterone using 1 ml 
male dog plasma/100 ml water as the binding protein 
gave a curve whioh is shown in Fig* S, It ma|^  be 
Been that the curve obtained did not give satisfaotorf 
displaoement at 1 *> 4 ng progasterone amoimts* However i 
signifieant drop eould be obtained when the proges* 
terone concentrations used were 10 to 50 ng as given 
In Pig.3, me to the low sensitivitsr of the assay 
using male dog serum this binding protein could not 
be used for the assay* 
Pse of pregnancy plasma for CPB assayi* Since the 
levels of corticosteroid binding globulin are known 
to rise during pregnancy, ths pre^ianoy plasma was 
used as the binding protein for competitive protein 
lAaSJSAaMwl 
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l»l&dixig assay. With the use ot i %. „ pregnaaey 
plasma. . In the standardl curre rangixtg from 1 - 5 0 ng. 
(Fig« "4)^lt was seen laiat tht standard ourvf reaalaed 
flat lyom 1 • 5 ag pi^ ogasterone ootusentrationt i ^ l a 
from 6 - SO It showed a slgilfleant drop In par <im% 
botmd eortioost0yon©» Flg« S shows the pattern of 
standard curves obtained using decreasing amotmti 
of pre^aancy plasma 0«S, 0,15, 0*1 and 0.97S % in 
distilled water* 3toe us© of low asjounts of pregnancy 
plasma gave a displacement of the bound steroid to the 
extent of SO to 60j^  ftpoa 1 - 4 ng progesterone. The 
use of 0*075^ of pre^ancy plasma gave a standard 
curve whidh was more linear and gave a higher 
displacement from 1 to 4 ng. However, the required 
50 - €0% displacement at 2 ng level (Stone, Hakaoura, 
Mishell and Thorneyeroft, 1971) could not be obtained 
with 0«075^ pregnancy plasma* 
trse of monkey plasma as a source of CBQ for 
CPB assayt" Monkey was treated with Bnavid for 
6 months and before venipuncture It was administered 
dexamethasone <3.0 mg> in a doso of 0*6 mg every six 
hours. Different amounts of plasma from the monkey 
ranging from 1*0, 0*6, 0*4, 0.3, 0*2 0*1 and 
0,07SjC were used for standard curve (Fig* 6)* Oie 
use of 0.075^ laasma for standard curve gave 30^ 
nstJk 
lb . i bound ^.oortieostooa. U ^ott .d 
against the pvo&^BtBTQtm oonoentratloias of 
0.3 • SO ng, TI10 soured of OBQ is 1^ of 
hvmm prei^ anoir i^ asast* 
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the i botw« ^B-cortlcjosterone i s plotted 
against paK>g9StQfaiit oonesntrations of 1 • 4 ng* 
She SQUFGO of CSQ i» O.S, 0,15| 0.3. and 0»075jil 
of faonan pregntQuogr plasma* 
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dlspIaoeiBdiit of bound oortleosterone at 4*0 ng with 
a uniform drop at X| 3 and 3 ng« Hasita amount 
hl^ar than 0»07S to X»p% gava lesser dlsplaoement 
as t&a amount of lO-asma was Inoraased. v/lth tho 
us« of 1«0^ ^asmai tha standard ourva shoved onljr 
10^ dlsp3fcaeenant of tha hound oortieosterone at 
4 ng* 
the standard ourva obtained with the 0*1^ 
plasma from m untreated monkeir (Fig. 7) did not 
differ from one % e^ro 0*1^ plasma from Bnavld treated 
monke/ iras used* 
yatt^ yiMi of ^BM^^ prgg^sterei^ e M'f^l* %T^ %^ 
norma; mensl^ mal oyole of monkeysi^  fhe average 
values for plasma progesterone levels as determined 
bjr ^ e radioimmunoassay method in 5 normally eyellng 
monkeys is presented in Fig. 8* the itlasma proges-
terone values have been plotted against days before 
the onset of menstruationt It may be seen that 
during l^e proliferative phase of t^e cycle the 
plasma progesterone values were rather low. These 
vera alvays less than 0^6 ng/ml plasma* ^t times 
there vere s l i ^ t fluotuations iihloh increased the 
levels to about 0*5 ng/ml. The plasma progesterone 
levels began to rise from day 18 before the onset 
of next menstraation with some fluctuations* From 
day 16 before the onset of the next menstruation, 
13ie % bound %*Qortioostdroii» 19 i^ottod 
against progestarotiQ eonoontratioa of 1 « 4 ag* 
Tli9 801IV09 of 0B6 Is 0*1^ of imtrdated nonkejr 
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the leTdls rose 9h83*ply md on day 3.4 bofora tli« 
todgitming of aext neitstruation tho vidues rdaohe<l 
3*2 tL n^a« Ffom tliereon It nontlmidd to aalntaln 
a siffiUar or somewhat hinder level of progesterone 
t i l l 6 dagrs before the aeatt iieiiatniation* the iieak 
of progesterone oonoentration reached a veane of 
about 4.1 ng/iBl plasma on day 10 before the onset of 
next ffienstinhatlon* She progesterone level aeolineA 
abruptly on day 5 before the next nenstruatlon 
reaohing a low value of 0*4 ng/nl flasaa, from 
this tiae onvards t i l l the beginning of the next 
Benstruationt vi^ues oontiniied to remala low. 
oyele of individual monkeys t fim mean laasnta progei* 
terone levels during the sienstrual eydle of 5 imx^&f$ 
are i^esented in fig. 8. Other normal patterns of 
pi^ asMa progesterone daring the menstrual oyole migr 
also be Seen in Fig. 10» U and 12* fhese normal 
patterns in general show very low levies of proge** 
terone in the proliferative i^ase, generally less than 
0»3 ngf^ ali with considerable fluotuation. The levels 
then rise from about day S-11 onwards« remain 
elevated with some fluotuations t i l l about day 
38 • 35 followed by a deoline. Considerable day* to*day 
fluotuations in the daily plasma progesterone levels 
have been noted* Fig. 9A and 9B show plasma progeS* 
terone levels during four individusl oyoles with 
tions of five eyoXei jfLotted against dior* Itofore 
tho onsat of nenstruatlon. Yertlaal linei 
Indioata Mean #^  3.D«. 
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extreme variations compared with the normal pattern 
described above* 
13ie plasma irogesterone levels in case of 
monkey M»S (Fig* dA> showed a rise to a level of 
2,4 ng/ml starting from day 7 and continued to 
rise upto day 13* l^ om day 13 * 19, i t maintained 
a hi|^ level with fluctuations. F^m day %B onwards 
i t gpadtoally declined to a low level of 0*3 ng/xsH 
on diQT 35* 
M»48 (Fig. 9A)f ISie i^ asma progesterone 
levels in the case of H*48 showed two distinct sharp 
peaks • one on day 9 and the other on dcgr 14. the 
plasma progesterone levels were baiow 0*2 ng/ml 
upto day 7* on day 8 these abruptly increased and 
reached a sharp paak on day 9 followed by a sharp 
decline on day 10 to about 0*6 ng/mi. From day 13 
these again increased and reached a low peak of 
1*9 ng/ml, followed by a slow gradual decline upto 
day 21, 
H-49 (Fig* 9B)t Daring the follicular phase 
upto day 7i the i^ Lasma irogesterone values remained 
low, at or a l i t t l e above 0*3 ng/ml plasma« from 
day 7 these continued to rise and reached a peak 
of 3*3 ng/ml* From there onwards the progesterone 
levels remained hi|^ with fluctuations upto day 16, 
except that there was a sharp dip on day 12, to a 
Fattoam of iQlaaqia proctsterono levolt In 
th* indlvl^al aoFsallr aenttraating monkey 
M«8 and M-4a, with eailiraBia nuetaatloaa in ttia 
pr#g!8ftar0iio ooaioantration dixring ^a ayola* 
4-5-
M_ 8 CONTROL CYCLE 
m_ MENSTRUAL BLEEDING 
3 0H 
I-5H 
< S. 
in 
< o•^^ 
m 
T —r— 20 10 15 25 
M-48 . CONTROL CYCLE 
m-MENSTRUAL BLEEDING 
20 21 
DAY OF CYCLE 
t 146 I 
XevdX of 0*2 ng/aO.* From day IB^ It abruptly 
deolined to about 0*9 ng/m.» !thls levol was naiti-
taiii«d upto day 23, aad thsn baoama lov of. tha 
order of 0.3 ng/iBl on day 24* 
M«l. fha follietilar phase iitLasina pro gas* 
terona levels in H«l (fig* 91> fLuetuated batwaen 
0*3a3ad 0.6 ng/wH upto day 12 with tha axeaptlon 
of day 3 when i t was 1,1 ng/ml plasma. From day 
12 progsstarona lavals rosa upto 2#4 n|/ml with a 
further Inoraasa to 3*0 ng/ml on day 14* Betwaen 
day 14 and day 23 progesterone levels remained hi^f 
reaohiag a peak of 4*7 ng/ml on day 17 and 3#4 ng/ml 
on day 21. fhese higi progesterone levels were 
interrupted on day 18 and 20 v^ an progesterone 
ooneentration fell to a level of 0.2 n^ml. From 
day 23 tha levels deelined gradually ul^ to day 28 
to a low level of 0*2 ng/ml plasma. 
ItW l^tf 9K Pl^ya pif^ gfSfQrqii^  %^ %he mm^, 
of ,:gnayidt.«> ®ha patterns of plasma ^ogesterona 
levels during a control oyela, 2nd treatment oyola 
and 2nd post-treatment eyole of monkey M-11 are 
presented in Fig. 10. ^ e oontrol oyola exhibited 
a normal pattern of progesterone levels as deseribed 
tmmmSt 
of individaal normnlXsr aeastpuatlng aoiUe^ jrs 
M-40 aad ll«»|. wlt^ <ixtr«»f fluotuatlon in ths 
progssteipoiie oonoeziti'atioa dtnring tbe ojrol*. 
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oarXle?* ttis follicular |^as9 progasteroii* l«v«lf 
wore below 0*3 ng/ca t i l l dagr 8 with a i l l^ i t 
elevation on de^ *. 7« From day* 9 progtsteroae levels 
eotttinued to rl ie lad reaehed a 9^ek of 4,5 ng/iBl 
oti day 19* F^ oiB thereon tim progesterone levels 
started deolining r^adutfllar upto day ^ , when these 
fe l l to a low level of 0«6l n^ adL* Between day 15 
and day 24| i . e . , during ^ e luteal ipliase l^^ e iKLassui 
progesterone oonoentration remained Mghf of the 
order of about 3.2 • 4.5 ng/ial» 
After ^ e adnlnlstration of Bnavid from day 
5 to 25 of the menstrual oyoie, the plasma proges* 
terone levels were meastired in the Snd month of ^eat* 
rnent* She length of the oyole was redoeed from 28 
day to 25 days I and the progesterone levels daring 
the treatment oyole were suppressed* Curing folli* 
eular i^aae of the eyolOt the progesterone levels 
were low and showed a oonsiderable fliuetuation ranging 
from 0,1 ng/ml, to 1.2 ng/ml. In the luteal phase 
of the oyoley the progesterone levels were exoeptionally 
low ranging from 0«1 ng/ml to 0.21 ni/ml, with vei^ 
l i t t l e fluetuations. IThe predominant progesterone 
rise during the luteal phase as B6va in the oontrol 
oyole was abolished* 
After the treatment with Bnavid for 2 months, 
wmm 
tiratloiui in ooxikey M-9| in tht nomial nemstBial 
0yoX9 and in the 2nd tfeatnent ofola with 
"Knayid". 
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the arug adainlfttration vas stopped and tho laatiaa 
ptfogtitero&d X«ir«l» ia tht Slad post^treatnont eyole 
vera measured* ISie progesterone levels shoved a 
pattern sinilar to thtt seen In the nonaal ovulatorf 
esrole* fbid follleular phase levels of progesterone 
vere 0*2 ng/sa or lover t i l l dajr 8. from tliereon 
progesterone ooneentration eontinned to rise reaching 
« peak of 3*4 n^atl on diQr ld| followed W a gradual 
deellne upto A&yt 26 to a level of 0*6 ni/ial vhioh 
oontimxed to persist as such upto dajr 88« 
Fig* 11 shovs the pattern ef plasma progesterone 
ooneentration in a normil ovulatory cycle and in ^ e 
2nd ^eatnent cyole in monkey H-10. fhe plasma 
progesterone concentration during normal menstrual 
cycle of M*10 continued to rise steadily from day 2 
And reached a peak of 3^ 7 ng^ ml on day 13 folloved 
hy a gradual decline upto dsy SO to a level of 0«6 ng/ml« 
The progesterone level continued to remain lov from 
day 90 to day 25, fhe length of the cycle vas 26 days. 
Zn tlie 2nd treatment cyole Bnavid vas given 
from day 6 to 25 of the cycle and {O-asma progesterone 
levels vere measured* Xt vas seen that progesterone 
concentration did not rise in the 2nd half of the 
cycle I as seen in the control eyelet lllirou^out the 
treatment cycle the progesterone concentration remained 
JSAiSMmimt/m — 
in aonkef M*10 in tb» noma! menstrual oyola and 
in ttm S^ A 9yel« of trea^ant vitli **&nairid**« 
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lov and irarlttd between 0#8 ng/iBl and about 0*4 ni/atl* 
The length of the eyoXe vas redueed fron S5 j ^ the 
eontrol efel9 to 21 In ^e ti*eatiient e3^1«« 
Fig. IS shows the pattern of ^asma proges-
terone in monkey H*^  daring a oontrol oyole and 
in the 2nd snavid treated oyole* the progesterone 
concentration in the foIliouXar phase was beXov 
0*3 ng/ol upto day 8 of the ^eie« fttm thereon 
the prog9Sterone oonoentration inoreased abruptly 
to 3*3 ns^ ml on day 11* Worn di^ 11 to day 90, 
progesterone maintained a hi|^ level of 3*3 • 4«00 
ng^ml. the progesterone level declined abruptly 
from day SO to a very low level of 0*3 ng/al* ti^re-
after low levels were maintained t i l l day Ig?, Mhmk 
Knavid was adtninistered apom day S to day SS| the 
plasma progesterone levels were suppressed throu^out 
the eyele* The plasma oonoentration varied between 
0.6 and 0*3 ng/teH plasma throughout the idiole oyole. 
in moak^, M-9, in the normai n^natimal. o^Ole audi 
and tr#ataeat 07o3.« iritH "Baavld'*. 
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^thou^ i t is Imoim tbat progestagen-est^Pogen 
eomblnatl&n oral oontpaoeptives aot W suppression of 
pituitary gonadotropins snd oonsoquent inhibition of 
ovulation} f&t tlio ireoise tteehanisas involved in their 
action and tha effect of ehange in the dosage of the 
oontraoeptives on their action are not fully understood* 
Inhere is a need to develop animal models in vhieh titiese 
meohanisms eould be elucidated* 'lo study the inhibition 
of ovulation and corpus luteua function, the earlier 
studies (Stevens and Vorys, 1967f Piczfalusy e^ a^. 19691 
and Qell^i 1969) investigated the urinary tH and preg-
nanediol* rre^aanedlol is a metabolite of progesterone 
and a study of i ts levels in l^e urine does not reflect 
the true picture of the endogenous levels of progesterone* 
fo assess the changes in progesterone secretion after 
the administration of oral contraceptives, a study of 
the levels of progesterone during the cycle provided 
an extremely useful parameter* The investigations 
were directed to the development of a sensitive assay 
for the measurement of plasma progesterone levels and 
i ts apjlication to the study of progesterone levels 
after the administration of oral contraceptives. 
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Davlonment of > »»ti»ltiv» ma ipeolfjo aiiay 
t&f pgQgaategonet* ISia priAoiDle of cottpetltiv* 
protein binding of steroids (MurplQri JSngelberg 
and Pattee, 1963) lias provided a useful approaoli 
to the develoiaient of a sensitive oompetitive 
protein binding ass«|r for progesterone (>topb^| ld67| 
Keillt Joba&sson, Datta and KnobU, 1967)* Investi* 
gations ware oarried ottt to test the suitabilitsr of 
male dog plasma aso-souroe of binding protein,for 
the progesterone asssar. Significant disi^aoemmt 
of bound oortieosterone oould be aehieved onl^ r «li«a 
progesterone oonoentrations of 10-60 ng were used, 
"tMle at 1 - 4 ng the assaf did not give any satis«> 
faotorjr displaeement, thus limiting l^e sensitivity 
of the assay* In view of these oonsiderations VciB 
use of male dog plasma for a sensitive plasma proges** 
terone determination vas abandoned* 
Kext^ the use of pregnanoy iidasma as a source 
of binding protein for the assay of plasma progesterone 
was examined* Cortioosterone binding globulin levels 
are knovn to be elevated <Sla\mvhite and Sandbarg| 1959) 
during pregnaney* Making use of this information and 
the easy availability of prepianoy ^asmSf i t vas used 
as a source of binding protein for the progesterone 
B.»a«y* i^ egaanoy plasma vas used in different concen-
trations ranging from 0.075, 0*1, 0.2, 0^3, 0*4| 0.5 and 
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1*0 per o«nt for standard etirvt of tht assar* Whtn 
I#0^ pregnant^ laasna vat uaad, til* standard eurve 
ranging from 0.25 • SO ng ratttined flat in th« 
region of 0«2S - S ng Indleatlng no dlsplaoament 
of bound %*eortl60starona« fixe diiplaoomant was 
evident onl|r at hlgltor eoncantrations of pro gas* 
tarone S to SO ng in the standard ouz^o* W^en 
pra^anoy plasma was us ad in deoreasing oonoantrap> 
tion 0.6^ to 0«075^ an inereasing displaoamant of 
botmd %-oortioosterona was obs^vad but s t U l at 
tha lowast oonoantration of 0*075^ the displacement 
was only of the order of 10 - IS^ at 1 ng progesterone, 
This poor disiilaoement at the lowest ooneentration 
(0,07650 of flasma or A flat oitpva from 0*25 ng -
5 ng i^en ItO^ plasma was used indieated the presenoe 
of other binding proteinsbesides the oortioosteroid 
binding gLobolin. !U>s«nth«lt Slaunwhlte and 
Sandberg (1969) reported the pres^ioe of unknown 
binding protein for progesterone tturing pre^aney 
besides the elevated levels of oortioosteroid bindihg 
globulin* It is probably due to the presenoe of 
this unknown progesterone binderi to vhioh the low 
amounts of pro^sterone used in the standard eurve 
bind, thus giving either no displaoeaent at a low 
dilution of l*05t plasma or a very poor displaeement 
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at h l ^ dilution of 0,(}7SJ| of plasaa. In viow of 
thdst ooasiaeratioiii lapegnAnor pOlaisa eoislA iiot 
b« used as a iouroo of binding pi«ot«in for- tibd ^ 
pj^ oiSestdrond assay* 
Cortioosteroid t»indini globulins aro knoim 
to insreass during estrogan trea'tosnt and iregnanoy 
(Sandberg and Slaimi^lts (1969), fim most sonsitivs 
plasma availalild for i^rogsstsrons binding asssir 
06^ bs obtained from patients treatsd with oombined 
oral oontraoeptive and dexamethasone (Yoshimi 
and Lipsetti 1968) • In viair of the non-avail ability 
of plasma from sueb treated vonen the possibil i^ 
of using plasma from oral oontraceptive treated 
monkeys with dexamethasone given before the veni«» 
punoture was explored* the use of plasma from suoh 
monkeys in both high and low oonoentration from 
(0*075 • 1.0^ did not give |»*oper displacement of 
about 50 - 60Jj at 2 ng level (Stone ^  jJi* 1971)* 
AS a result of it the use of monkey plasma was 
abandoned for the assay of progesterone* 
« 
4t this stage of i«ork, studies on the ddvelop-
ment of speoifio end highly sensitive radioimmunoasssy 
for progesterone estimation nere reported* (Abrahami 
Sverdloff, Tulohinhky and Odell, 1971| Faruyama and 
Huegentt 1971). However, the assay lacked speoifi« 
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o i ^ and iJxvoXmA & <shrottatograpliie 8«par«tioii of 
progttteroiio befofe i ts estlxation. ftmvn&^QTott 
anA 3ton«-<19?2> aeir0lop®d»fin-a»ti«@rua against -
Il«^-kyteo3srp3fog9»ter0iit iifiked to boviti« sevuffi 
alfenxnin (B3A) vM.Qh va« nore Sjpeeifio tlian anti* 
sara pro^oed aga^st 9D or 3**keto litikage of 
progesteirotia to BSA (Md^ef aad mav^tideri 1970). 
fJie hifi^ ipeoifioit^ of. the atitiaerom raised, 
againat ilor^Iirdrosqr {»ro|^ at9Foiid linlsed to l^ A 
has been attributed to tlie faot that ooajugation 
of 9SA at li«f>odition i#aves botb audi of tint 
•tei^id fx^ ae to oonfav Sfeoifioit^ to tlie aati* 
fm different lot* of antisera « one from 
Br* X*ll» tlioriie]r«iroft of Los Angeles and tlie otiier 
from Br* K« t^undaraai 9ev Itork, raised against Uo(« 
li^ rdrosqr profesterone linteed to BSA • were obtained 
and used for the deveXopttent of a sensitiire radio* 
ismunoassay^  for the astiaiation of jplasaa progesterone. 
Tbe antisemn obtained froa Br* 1!horneyoroft gave 
56^ binding at a Xov dilution of X t SSO on arrival i 
vhiXt the dilution at ^ ieh i t was used bgr 
Br. Thomegreroft was X § 5000^ fbe antiserum 
received fron BP* K. Siandaraa bound 56JK of progesterone 
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«t 1 I 6000 dilution (fig* 13)* fiiis mtUervm 
vas thai tiidd in «11 sul^ sequent st^dlet* fk9 son* 
flitlirlty-of—tkid-^adloiinwiocuisa^ f0r-p>i>«dstaront- . 
thu« dsvelopdd vm as low am 35 pg* fli« assagr 
was hig^jr speoifie ani did not i*e<|ui]?6 ^lo ofaro* 
ffiatog)raphie s«pa3ratio» of ; pr<»9a$tereiid prior 
to assajy. It gavd aoeurato and raprodiiolM.« 
rsstdita* 
yatft^ y^i^  ,<)f ,„p|.^ ff#,„ff9i§,^ ^^0l|^ ,|,ry^^8 ,i^ 
after tha adaiaiatpatlon of Biayldi«» tha stildiei 
on tlie estimation of plasma progaaterono in a nonbor 
of normallir mons^uating m&tik&s^» aiiovad that ilio 
patterns ^ro t|ttalitatlvely lOJiost siaUar to thoso 
reported in woaian (Hdilli ^Ohanssony Datta and 
Knobil, 1967) axoapt tliat oonsidarable fluot&ations 
in tha daor-to^dar progastoromo lev^s wara oli9erir«d« 
Quantitatiirolsrf tha plmm& progastarona lavola of 
monkey and human ara almost the saato in Itia folli* 
aular phase of tha oyole !••• helow 0.3 to «d ng/mlf 
but in tha luteal phase of the oyolo ^ e immm^ 
progesterone levels are 3 • 4 times mora than that 
seen in the monker (HelUjI sH, 1967^ t X^ args 
fluotuations in the dajr^ to^ dagr progesterone levels 
during the menstrual eyoie of normally aanstruating 
against tl)9 3^ og of antifdipa iiXtitlons • 'Ska anti# 
of oft and tlie aiiti9«rt»i 3 va» suppiiQdJbf OF* 
K« Stindarsss* 
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monkeys were otoerved lay Weill et al« 1967a| Monroe, 
Atkinson and Knoblli 1970)4 Heap and Linzel (1966> 
!iaV3 repotted that plasma progesterone levels oan 
be raised by laparotomy in goat suggesting that 
'^stress'* influenees progesterone secretion in this 
species. !J3ie extreme fluctuations sometimes 
observed in plasma progesterone level of monkey^  
during the ey^e ml#it possibly be due to stress 
of catching and restraining prior to blood sampling* 
Similar extreme variations in the plasma progesterone 
levels during the normal menstrual cyole of B^met 
monkey were reported by Stabenfeldt esid Rendrickx 
(1973)« S i^ f i cant decrease in plasma testosteronei 
LH and FSH levels during surgical operation in human 
males have been reported by AonO| K\uraehi, Mlzutani, 
Hamanakai trozumii Nakas tm«» s Koshiyama and 
Matsumoto (1972), 
A aiipiifleant feature cf the plasma proges* 
terone levels in the normal menstrual cycle of the 
monkey was an early rise of progesterone from day 
17 to 20 before the onset of menstruation* Johansson, 
Neill and Knobil (1968), ^ i l e measuring periovulatory 
progesterone levels in rhesus monkeys^observed that 
increase in the progesterone level occurred at least 
3 days before the day of ovulation and vas signi-
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tlemtlj hX^ me dssjt l^ f^osra <»ruIatioii« freolse 
dorreXatioii of fiaStta j^fogasleroBd wltli liB 
horstone) aad %imir ttoX^ in t ^ oimlatioa proeess 
need to tm furthdr eXuoidatod* Sigmifieantly 
higli iroidsteroae leirels in the Xmteai ^ade were 
o1»sdrved 15 days 1»efi>re ^ e onset of menstruation 
and eontimed to remain liigi in tlie range of 
3*8 « 4«1 ni/ail for alsout XI di^«| before tliese 
deoXined to Xov levels* WIdXe tlie |>attern of ^mtm 
{}roe@sterone as desoribed aboire "^ as frequently 
enoonatered. in noraallir JBienstrnatinf animaXSi 
there were other noraaXXf taenstmating aniiaaXs i^ioh 
shewed pro fester one patterns that nere different 
from the norfflaX <MieS Ctig« 9>« ISiey exhibited 
extreme fXnetnation in pXasma progesterone coneen* 
tration daring mi4»XuteaX phasof idiidi sometimes 
rose to one or more sharp peak or deoXlned to as 
Xov a leveX as seen in the early foXXioular phase« 
The other veoriations seen ia these eyoXes were 
a irery earXy rise of progesterone in the foXlleuXar 
phase, or a very gradual deoXine in the XnteaX phase 
tiXX the day of next menstruation, Sbwever, exi 
these^extreme oyeles" showed a definite rise of 
Plasma progsstarone In the Xmteal u^Mie of the oyolot 
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wbleh Qould be Indlcatiire of ovulation and $ubsd-
quant eorpas lutetua toriaation* 
fha administration of '^ Snavld'* oontalnlng 
2*5 lag nos^ athynodral and Oil mg mastranol to 
monkars f^ om dar 5 to dagr 25 of tba menstrual cyolO) 
9upppe88ed the plasma progavterone levels In the 
luteal phase* Since the hi^^ progesterone levels 
of the luteal ihase are Indleatlve of ovulation and 
subsequent oorpus luteum formatloni i t mejr be 
Inferred that the a<3&aittl3tratlon of "aiavld* 
inhibited ovulation and prevented oorpas luteum 
formation, the inhibitory effect of *»Snavid« on 
ovulation oould be due to tiie suppression of pituitary 
gonadotropins and/or due to i t s direet effeot on 
the ovary* !^an, Qoss and Held (1966) administered 
"snovid" (S mg norethynodrel • 75;ug mestranol) to 
women and found that the midoyele turinary F3H and 
LR peaks vere abolished* Bell M J3I« <1967) 
administered '•Enovid* (2.5 mg norethynodrel • 0.15 mg 
mestranol) and found a suppression of urinary FSH 
and tn levels. It thus appeared that norethynodrel 
m both 5.0 and 2*6 mg doses, was able to suppress 
both FSH and I*R peaks. Mestranol alone in different 
doses of 50 - 100 Aig did not produce any inhibition 
of LH peak (Vorys, tJllery and Stevens, 1965). These 
t XS9 I 
observations taken together thus lead to t^e oon* 
elusion that the suppression of plasma progesterone 
hf Bnavld was a direct effect of the progestational 
steroi<to on Idle LH which inhibited oimlation and 
prevented corpus luteua formation* Betides this 
s ite of action of progestational steroids^ evidence 
of their effect at the uterine level was put forth 
in Chapter 1 of this thesis* Conoluding^one ma^r 
sasr ^at t ^ estimation of progesterone levels 
after the administration of progestational steroidsy 
may be one of the vesjr important parameters to studjr 
the effect of a 6mg on ovulation and that for such 
studies the monkey offers an attractive model# 
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mmm:. MP. mmmim 
The lioiE ^ w b o l i i O t t l i M F i l & i i i Telaitil 
to 8tadl«fl oa iM.9 wmQhmdMm of aotlon ^f pro gesta-
tional stei'oldi* In fartioulari i t attttoipts at 
an landarstatidiiii of tlio i i t a i of aetion and t ^ 
fata of tlia irogestatlonai itaroidi |j i t^a ho0y 
a&d tiia diffafant tltitiaa* 
Stttdidi v l ^ tvo pfogastatlonaX ataroMSi 
aordt^odpai (a is^nor itatold) aiidi oMIoraadincMcid 
aeatata (a X?°<*aoet03qr*iroidstti^oii« darlYativa)| 
irai^ a oarriad out to intaitlgata t^i f* uptaka md 
disappaaraiiaa from tia diffarafit tiiamas of the rat* 
fm tealmlqtiasi oaa imyoliriiig a sin^a inlaotloii of 
tlia radloaoti^a frogastiti sad t^a otiiar using a 
•iov oonstaat inl^airanous adoroiaf^iott of tlia 
labollad ateroidy vara used* i n oontrast to 
astradioli laidok i t takan np and ratainad in tha 
target tlasuai* tlia progoatatlonal ftaroids vera 
rapidly takan up in different tissues of tlie rapro« 
dttotiira traot and tlia brain and ^an disappeared 
init ial l ir rapiCLsr foXloved lay a sioir disappearanoa* 
the Slow disappearanoa |>art of the aurira indioatad 
retention of tlie steroid and i ts aetabolites in 
tlie tissues. In partioular, tba uterus„ ¥ a ^ a , 
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Qvajfy, pituitarir and li^ rpothalooas shoved a hit^t 
uptakt than that of hlood or misolo* Oonstazit 
infusion studioi with the progestational steroids 
supported t^e above ohseriratlons« The aolar 
Qoneentration in the ormef wad hl^er than that 
In the uterus for both nore^ liQmodrel and ohlorma* 
dinone aeetate# 
!Ehe pattern of uptake of ohl(»>iBadihdhe 
acetate in the fat and the aaanary ^and indieated 
retention of the steroid and i ts setiibolites in 
these tissues* She retentioni in the fat| of 
ehlonaadinone aoetate and its suhsatuent slow 
release has been oonsidered to oontribute to the 
longeiritar of i ts aotion* Hie retention in the 
laaamarir gland and the faet that ehlormadinone 
aoetate has a long half l i f e , nagr explain the 
continued exoretlon of the steroid In tilie mills for 
a number of days after the adiainistratlon of one 
tablet of this progestin* 
Brogesterone and progestational steroids are 
generally believed to be antiestrogens* While 
previous studies showed that priming of laboratory 
rodents with progestational steroids inhibited the 
uptake of H-estradiol, in the present work priming 
of animals with different doses of norethynodrel 
revealed that at lower doses, norethynodrel 
t 1<I2 t 
stlnniXated thd uptakt of %*estradlol In the uterus, 
vhi3.# at higltdr dosas i t inliibited tlit uptaks of 
^g-estradloX, Slntilap results v^ra obtained with 
ehlomadiaone acetate* Hiese experiaexits suggest 
that progestational steroids tether preseftt in 
low or hif^ doses, oouid aodifjf ^le response of ^ e 
uterus to endogenous estradiol therelsr pointing 
to their possible effeotiveness at the uterine 
level in {s^eventiag implantation* 
After administrationi ^ e progestationsl 
steroids are taken up in the tissues, isetabolized 
in the bodsr and exorated in the faeoeS| urine and 
milk* Using labelled norethjmodrel and ohlonaadinone 
acetate, i t vas demonstrated that after t^ oral 
adistinistration of these radloaetiire steroids to 
lactating vomeui the steroid and i t s Metabolites 
are exoreted in the milk over a period of 4 « 6 dagrs* 
fhis aspeot of the vork is of oonsidersble praotiedl 
importance since oral oontraceptlTes are used for 
fertil ity oontrol daring laetation« ^ e eoneern 
expressed is that, when exoreted in the milk, these 
ttfigr be transmitted to the infant being mlOtsed* Hie 
demonstration that progestational steroid ^ e 
exoreted In the ttilk did indicate that these are 
transmitted to the Infant. Soveverf idiether the 
exoreted steroids and or their metabolites possessed 
I 163 t 
Mologloal aotlvltsr nedded an ovalmatlon. After 
the administration of progaatational steroids, the 
assay of estrogenio aeti'Tlty in the miXli reirealed 
that administration of norethamodrel in sose oases 
resulted in the deteetlon of estrog^nie aotlvitf 
in the milk. Administration of ohlormadinone 
aoetate and megestrol aoetate did not ^ire rise 
to anir estrogenio aotivll^ in the i&llk* !£he8e 
experiments lead to ^ e oonoltssion that those 
steroids vhioh have an inherent esti?ogenie aotivilgr 
or are oonverted into estrogenio metabolites» 
shotild he avoided for fertility oontrol during 
laotation* the other group of compounds vhioh are 
derivatives of 17o(-aeeto3qr progesteronoi like 
ohlormadinone aoetate, and whieh have neither 
inherent estrogenio aotivity nor are metaholised 
into any estrogenio metaholites nay he reoommended 
for oontraoeption daring laotation« 
Besides exoretlon in the milk| the oral 
contraeeptKeS after administration^ are exoreted 
in the urine* ^le dlsappearanoe of ohlormadinone 
aoetate in the hlood and i t s exoretlon in the urine 
after an i«v» injeotion to rhesus monkeys has heen 
investigated. Badloaetlvity due to ohlormadinone 
aoetate and its metabolites and ohlormadinone aoetate 
as suoh disappeared initially rapidly folloiied hy 
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« slow disftp|iearan<i«« IQie dlsappearanod oiirvd 
In tli« pdaiaa ootCLd 1>e represented bar a biexponential 
e<|uaUon« X « Ae* <^ t •»• ^e"^*. Hie transport 
and aetabolism of «hlornadinone aeetate eonld thai 
be interpreted on the basis of a two-oorapartment 
aodeil« Oblormadinone aoetate disappeared from 
the pa^ asma idth an average initial half l i f e of 
$$ minntes foiloved by a prolonged half l i f e of 
35* 1 hours* the average aetabolio olearanee rate 
(MOB) of dhlorsadinone aoetate vas found to be 
102*^ litres/dar in l^e monkey* It indioated a 
rather slov olearanoe of ohlorntadlnone aoetate 
from the bod|^ * She MCR of ohLoraadinone aoetate 
was found to be imioh less %hm that of estradiol 
or progesterone* 
After administration of oiHormadinone 
aeetate, the hiiiest amount of ohlormadinone aoetate 
and its Metabolites irere excreted in the urine 
generallsr on the 2ad or the 3rd dari vith a gradual 
deoline of the amount of the eaesreted Metabolites 
on the subsequent days, there vas a prolonged 
exoretion of CAT and i t s metabolites in the urine 
of monk^s. In some oases studied, metabolites 
oould be deteoted in the urine upto 30 days* this 
indioated that ohlormadinone aeetate was stored in 
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tho body iponBiblf in tlw fat at suggested Ijgr expeirl* 
seats in tlie vaty and released slouiy into eii^eula* 
tion and aetabolised in tlie urine* These studies 
suggs9t that the Aetaholisn of ehlormadinone 
aoetate is quite different tvon the •etaholisn of 
naturally ooourring steroids estrogen and proges^ 
terone* 
After administration of progestational steroids| 
a irexy small amount of steroid reaohes the target 
tissues and ^ e major part of i t i s metabolised and 
exnreted* I t is the small amount of the steroid 
vhieh produoes aetion at the hypothalamo^pi^itary* 
ovarian axis and thus modifies ^ e release of gonado^  
tropins eonsequently affecting the seeretlon of 
progesterone from the ovary i^leh i s neeessary for 
endometrial development and implantation* lb assess 
the effeot of norethynodrel on t ^ liypothalaoo* 
pituitary-ovarian asis, changes in the level of 
progesterone in ttm blood of monkeys were estiaated* 
Investigations were oarried out to defvelop a stiltable 
method for progesterone estimation in pioograa 
levels in blood* the use of oortloosteroid binding 
globiain (CBO) for the development of a oompetitive 
protein binding assay did not give very satisfaotoxy 
restilts* A radioimmunoassay for progesterone using 
speoifie antibodies,against progesterone (produeed 
t X66 t 
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